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Homeostasis under normal physiologic conditions is maintained by aerobic metabolism. The
cardiopulmonary system provides oxygen delivery from the environment into the body, to
every single cell, to maintain aerobic metabolism.
Figure 1.
From the British Medical Journal 1998, volume 317, pages 1302-13061,
with permission from the BMJ Publishing Group.
The oxygen transport (oxygen delivery) and utilization (oxygen consumption) in an adult of
approximately 75 kilograms, having a cardiac output (Qt) of 5 L/min and breathing air at
standard barometric pressure (PiO2dry) are schematically summarized in figure 1.1-3
Oxygen (O2) is extracted from the environment and bound in the red cells by hemoglobin
(Hb). The arterial circulation carries the oxygenated red blood cells to the tissues. The
circulatory system splits in a fine capillary network in the peripheral tissues. The difference in
oxygen tension drives the oxygen from the blood through the capillary endothelium and cell
barriers into the cells. In the cell oxygen is used by mitochondria, the so-called ‘energy
factories’ of the cell, to maintain aerobic homeostasis. At the level of organs the metabolic
rate may vary extensively, dependent on the state of activity. The cardiopulmonary system has
a large capacity to increase oxygen delivery to maintain aerobic metabolism under
(patho)physiologic conditions. The balance is maintained as long as the amount of Hb, the
rate of perfusion and minute volume of ventilation allow a sufficient delivery of oxygen to the
tissues (figure 1). However, this system may be overcharged and consequently the oxygen
delivery may fail to supply sufficiently for aerobic metabolism. A temporary oxygen debt
may develop that needs to be counterbalanced to prevent an ongoing anaerobic metabolism.
Pathophysiologic conditions at any level of oxygen transfer may interfere with the distribution
to and utilization of oxygen in the tissues. The duration and severity of an oxygen deficiency
may result in damage, dysfunction, and ultimately failure or death of cells or even tissues.
High values of Qt, oxygen delivery and oxygen consumption correlate with the rate of




From the British Medical Journal 1998, volume 317, pages 1302-13061,
with permission from the BMJ Publishing Group.
During the seventies and the eighties of the twentieth century, the relation of oxygen delivery
and consumption in critically ill patients was found to be significantly different compared to
healthy individuals (dotted line in figure 2). It was argued that insufficient oxygen supply to
the tissues played a key role in the development of multi organ failure (MOF) and death
(“oxygen dependency”). The earlier observed high values of oxygen transport and utilization,
found in surviving critically ill patients, were hypothesized to improve outcome in specific
patient categories. The hypothesis was tested in multiple clinical trials of critically ill patients,
including surgical patients. Regarding the value of striving for so-called ‘supranormal’ values
of Qt, oxygen delivery and oxygen consumption, firm conclusions were difficult to make
since various types of patients had been included in these trials. Some authors advocated
hemodynamic treatment as a preventive treatment in noncardiac so-called ‘high-risk’ surgical
patients. However, none of these studies compared the standard preoperative work-up of
patients with the proposed additional hemodynamic treatment to be performed at the intensive
care unit (ICU). We therefore designed a randomized controlled trial of preoperative goal-
oriented hemodynamic treatment (GOHT) on high-risk surgical patients, to study whether a
reduction in complication rate could be achieved. We compared the usual preoperative
preparation on the ward with GOHT at the ICU.
The primary aim of the main study is to demonstrate a reduction of perioperative morbidity by
preoperative hemodynamic treatment in noncardiac major surgery. Secondly, it was
hypothesized that a reduction in complication rate may reduce the length of stay (LOS) at the
ICU and in the hospital. Additionally we compared the two trial groups with a group of
patients that was eligible for the trial but did not participate in it for logistic or personal
reasons.
A critical review of the outcome of the literature before, during and after the study puts our




1. Treacher DF, Leach RM: Oxygen transport-1. Basic principles. BMJ 1998; 317: 1302-6
2. Leach RM, Treacher DF: Oxygen transport-2. Tissue hypoxia. BMJ 1998; 317: 1370-3
3. Leach RM, Treacher DF: The pulmonary physician in critical care * 2: oxygen delivery and consumption











Several risk factors have been identified in surgical patients and attemps have been made to
predict the outcome in such patients. The classification of the American Society of
Anesthesiologists (ASA classification, table 1) was introduced as one of the first scoring
systems for assessment of preoperative physical status that could be used as a predictor of
postoperative morbidity and mortality.1-6
Table 1. American Society of Anesthesiologists (ASA) physical status classification1-4
ASA-class description % mortality rate in
elective surgery2







a normal healthy patient
a patient with mild systemic disease
a patient with severe systemic disease that
limits activity but is not incapacitating
a patient with an incapacitating systemic
disease that is a constant threat to life
a moribund patient who is not expected to











E additional number in case of emergency
During the seventies the attention for perioperative complications was mainly focused on
cardiac morbidity and mortality; Goldman and coworkers developed the Cardiac Risk Index7
(table 2 and table 3), which was modified later by Detsky8 (table 2) to predict cardiovascular
mortality in noncardiac surgical populations. Shoemaker and coworkers identified
cardiovascular risk factors which could only be recognized by invasive diagnostics.9;10 These
studies revealed specific differences in measured hemodynamic values between survivors and
nonsurvivors: higher values for oxygen delivery (DO2I) and oxygen consumption (VO2I). It
was hypothesized that aiming at these specific (‘supranormal’) values for DO2I and VO2I could
benefit critically ill patients. Additional studies were conducted in which these values were
used as criteria for strategies to improve the outcome in different types of critically ill patients,
i.e. patients with sepsis or trauma, and surgical patients. Most of the ‘evidence’ comes from
the work published by the group of Shoemaker; they strongly advocated their findings. Striving
for supranormal values of DO2I and VO2I became widely applied in critically ill patients.




Table 2. Cardiac Risk Index of Goldman2 and modified Cardiac Risk Index by Detsky3. To
calculate the risk of cardiac complications according to Detsky, the index scoring must be
combined with a ‘pre-test’ value related to minor or major surgical procedures; both data
have to be inserted in a likelyhood ratio nomogram to predict the ‘post-test’ probability for
cardiac complications.
Goldman Cardiac Risk Index points Detsky Modified Multifactorial Index points
age > 70 years old
previous myocardial infraction <6
months
S3-sound or jugular vein distension
non-sinus rhythm
> 5 preventricular contractions/min
important aorta stenosis
other medical problems, like pO2 < 60
mmHg, pCO2 > 50 mmHg, K+ < 3
mmol/l, serum urea > 50 mmo/L,
creatinine concentration > 260 µmol/L,
bedridden














more than 6 months ago
Canadian Cardiovascular Society angina
class 3
class 4




suspected critical aortic stenosis
sinus plus atrial premature beats or non-
sinus rhythm
5 ventricular premature beats at any time
prior to surgery
















maximum score 54 90
Table 3. Cumulation of Goldman Cardiac Risk points and risk of cardiac complications.7



















In this chapter the literature till 1996 is reviewed on the rationale and evidence for this type of
treatment in the perioperative phase of high risk, PAC(pulmonary arterty catheter)-monitored
surgical patients and critically ill patients in general. From 1996 till 1998 a randomized
controlled trial on preoperative hemodynamic treatment of high-risk surgical patients was
developed and executed at the University Hospital of Groningen, the Netherlands, 1996-1998.
The literature was reviewed according to the chronology of studies and the opinions based
upon them. The main focus is on patients undergoing noncardiac surgery. Special attention is
paid to the scientific fundamentals of the proposed ‘supranormal values’ that many studies on
perioperative hemodynamic treatment refer to.
A history of goal-oriented hemodynamic treatment (GOHT) in high risk surgical
patients.
The introduction of the pulmonary artery catheter (PAC) revealed specific
hemodynamic patterns, empirically differentiating surviving and nonsurviving
critically ill surgical patients. A causal relationship was presumed for outcome
determinants of preferred or so-called ‘supranormal’ values of general perfusion,
oxygen transport and utilization, since normalization of these values did not improve
the outcome. As it was concluded that normalization of general perfusion, oxygen
transport and utilization did not improve the outcome,  it was hypothesized that for
improvement “supranormal” values are needed.
Shoemaker and co-workers published many studies on hemodynamic monitoring in surgical
and trauma patients, beginning in the sixties, with a particular interest in circulatory changes
during shock.11-19 Multiple series of these patients underwent extensive monitoring. The
primary aim was to clarify the pathophysiologic mechanisms in shock.11;12 It was assumed that
other symptoms than well-known variables, such as increased heart rate and low blood
pressure, were preceded by other undiscernable circulatory changes. The revelation of these
changes were presumed to raise a rationale for the development of new therapeutic
interventions that could improve the outcome.16;20
Introduction of the pulmonary artery catheter (PAC) by Swan and Ganz in the early
seventies,21;22 was primarily meant to manage the cardiovascular condition of patients with an
acute myocardial infarction.23;24 Application of the PAC in the preoperative evaluation of
patients planned for a pneumectomy and postoperative treatment of critically ill surgical
patients was advocated at the same time.25
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Kim and Shoemaker used the PAC to describe sequential patterns of pulmonary hemodynamic
values after operative and accidental trauma in 21 patients to clarify the pathophysiology of
pulmonary complications.26 The time course of shock syndrome was classified into six - later
eight - stages27 (table 4); the time point with the lowest blood pressure, ‘Stage Low’, was used
as a reference point.
Table 4. Periods of shock syndrome according to Shoemaker, as described in studies from
1971 to 1979, to differentiate survivors maximally from nonsurvivors in different stages of
shock.9;10;18;26;28;29









- preoperative period or control period
- initial period of falling arterial pressure immediately after the onset of the etiological
event
- the lowest recorded arterial pressure
- point in time where the reduction in MAP returned halfway to the patient’s control value
- next point in time: the reduction in MAP returned > halfway to the patient’s control value
- late period for surviving patients when arterial pressures were (nearly) normal –
recovery stage
- preterminal period in patients who subsequently died (from stage C to about 1-2 hours
prior to death)
- the final, agonal, terminal event
In 1973 Shoemaker et al. described 98 patients in various degrees of shock undergoing
extensive surgery;18 in the postoperative period 32% of these patients died. This study
elucidated the natural history of circulatory changes in hypovolemic conditions during the first
72 hours after surgery; it also appeared that nonsurvivors had a specific pattern of
cardiorespiratory changes, characterized by a decreased DO2I and VO2 and high PVR in the
early postoperative phase, while at the same time blood pressure, heart rate and CVP were
similar in both groups. In early studies it had already been shown that therapy directed at




It was suggested that the observed values of DO2, VO2 and PVR of the survivors might be
more appropriate targets of treatment than normal values. It was proposed that set points
should be redefined in the direction of these ‘supranormal’ or ‘preferred values’. Table 5 lists
the resulting therapeutic targets.18;28



























normal, 7.36 – 7.48
170-200 mL/min
0.25-0.36
> 500 mL in excess of normal
> 500 mL in excess of normal
> 25 mL/hr






























< 3.5 cm H2O
&KDSWHU

In early studies PAC-derived data were organized according to predefined blood
pressure values and response to therapeutic interventions was directed at
normalization of blood pressure. These data were analyzed by different methods for
maximum differentiation between survivors and nonsurvivors. The results were
summarized in a severity predictive index for the outcome in multiple series of
patients. In later studies identical results were found when data were grouped at fixed
time points around the surgical procedure. Set points of hemodynamic treatment were
derived from this index.
In 1977 Shoemaker et al.  reported results of an observational study of 113 critically ill
patients. 9 The study explored the predictive value of various hemodynamic parameters with
respect to severity of illness and survival. Table 6 summarizes basic patient characteristics,
table 7 lists 35 cardiorespiratory variables obtained by PAC-monitoring. Various methods were
used to analyze data; the authors used all variables to construct a severity index to predict the
outcome.
Table 6. Results in a group of 113 patients undergoing surgery for lifethreatening illnesses.
Data of this population regarding hemodynamic monitoring were used to define goals for
hemodynamic treatment by Shoemaker et al.9
patient characteristics survivors Nonsurvivors
number of patients (%)
M/F – (%/%)
age – yr (SD)
MAP at initial hypotensive episode – mmHg (SD)
relation underlying cause of shock (%):
- major trauma
- ablative surgery for malignancies
- aortic aneurysm
- massive gastrointestinal hemorrhage



























Table 7. List of monitored cardiorespiratory variables, direct measurements and derived
calculations, categorized according to Shoemaker in 1979.30































SI x MAP x 0.0144
CI x MAP x 0.0144
SI/duration of systole
MAP x HR x duration of systole
SI x MPAP x 0.0144






79.92 x (MAP – CVP) / CI

















CaO2 x CI x 10

















The same set of data was used in 1978 to redefine endpoints of therapeutic interventions in
critically ill patients (table 8). Late stage median values (stage D) of survivors were used as
cut-off point. Analysis of 20 of the most commonly monitored PAC-variables from this point
of view showed that the values of survivors were overall significantly more in the ‘preferred
range’ compared to the values of the nonsurvivors that were more frequently in the ‘normal
range’.28 However, differences of monitored values between survivors and nonsurvivors varied
extensively in successive stages.
Table 8. Most commonly measured and calculated variables; normal, preferred and
proposed values as targets of therapy as proposed by Shoemaker et al. in critically ill
patients (immediately) after surgery.28


















































































In 1979 yet another method was used to construct a severity predictive index using the same
data.10 An important difference with the earlier method28 was that now every stage of shock
was involved with its own, maximally differentiating cut-off point between survivors and
nonsurvivors.
The index sensitivity (70% - 93%) and specificity (76% - 92%), was considered reasonably
satisfactory in all shock stages, particularly in stages ‘Low’ (sensitivity 81%, specificity 87%)
and ‘D-F’ (sensitivity 93%, specificity 92%) .
For practical clinical use the index was partitioned in five subindices to reflect specific aspects
of pathophysiologic change during shock, i.e. general volume status, global flow, tissue
perfusion, oxygen transport and bodily response to stress (table 7). It was claimed that the
computerized management of all PAC-derived data provided the clinician with a sensitive
instrument for timely and adequately evaluation and treatment of the consecutive stages of
cardiorespiratory failure in critically ill surgical patients.29
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In 1979 Shoemaker et al. reassessed the data of 113 critically ill patients and reviewed the
relatively predictive value of the cardiorespiratory variables.30 The perfusion-related variables
appeared to be the best predictors. It was also shown that some variables had a stage-specific
high predictive value, for example, PVR in early stages of shock, while DO2I, VO2 and oxygen
extraction ratio appeared to be good predictors in all stages. On the other hand, commonly
used variables as HR, MAP and CVP had a poor predictive performance.
So retrospective analyses strongly suggested that PAC-monitored data can be used to predict
mortality. The targets for hemodynamic treatment were empirically defined in 1973 and 1978
(table 5) and in 1979 for all PAC-derived variables,29 but suitability in clinical practice still had
to be proven.
The group of Shoemaker published another series of 53 high risk surgical patients in 1981, of
whom 27 patients had elective surgery (mortality 15%) and 26 underwent emergency
procedures (mortality 54%).31 All patients were perioperatively monitored with a PAC;
treatment was directed at increasing cardiac output and DO2I (targets for therapy not
specified). An important difference with respect to the earlier studies was made. In the former
studies, comparing survivors and nonsurvivors, all samples were aligned around the lowest
blood pressure as a reference point. Now the profiles were obtained at predefined time
intervals, starting preoperatively. Emphasis in this study was laid on a description of sequential
hemodynamic events; the analysis of differences between survivors and nonsurvivors was
omitted. The mean intraoperative DO2I remained at preoperative values, while there was a
significant decrease in VO2I. Compared to preoperative values, sequential hemodynamic values
of all patients showed a lower cardiac performance intraoperatively, but in the postoperative
period CI, DO2I and VO2I had increased significantly. Remarkable differences in hemodynamic
values were found between emergency and elective patients. Emergency patients showed signs
of a preoperatively reduced ventricular function (lower left ventricular stroke work and higher
pulmonary capillary wedge pressure), while the mean CI of both groups was comparable.
Elective surgical procedures lasted longer and had more blood loss. It was also found that
patients with longer surgical procedures had an increased postoperative oxygen consumption
compared to shorter procedures; this value was even higher than preoperative levels.
The severity predictive index was eventually tested prospectively in a series of 156 patients and
was found to be accurately performing with a positive predictive value of 95% and a negative
predictive value of 91%.32 The authors therefore advocated the use of this global predictive
index as an instrument to assess the cardiorespiratory status of the critically ill postoperative
patient and use it for the evaluation and management of its clinical course.
Another series of 220 critically ill (semi)elective surgical patients underwent invasive
perioperative hemodynamic monitoring.33 Patients with markedly abnormal preoperative
hemodynamic findings were excluded from this observational descriptive study. The sequential
hemodynamic profiles were obtained postoperatively during seven days at predefined time
intervals. These patients underwent a wide variety of surgical procedures: surgery for upper
and lower gastrointestinal bleeding, intra-abdominal abscesses, bowel obstruction,
hepatobiliary pathology, trauma from car accidents and shot wounds, resections for
malignancies and vascular reconstructions. Survivors were younger than nonsurvivors.
Postoperatively the nonsurvivors had a worse cardiac performance compared to survivors.
However, the preoperative CVP, MPAP, RCWI, pH, P(A-a)DO2 and HR also differed
significantly between both groups. The number of differing hemodynamic variables between
survivors and nonsurvivors increased intraoperatively and postoperatively. The authors
describe that stratification for age did not change these patterns.
The natural course of cardiorespiratory variables was described in another series of 280
surgical patients, stratified for type of co-morbidity.34 The physiologic variables followed a
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type and sequence in all subgroups with similar characteristics in survivors and nonsurvivors as
earlier described, irrespective of the variations in co-morbidity and surgical interventions.
Comparable findings came from a prospective, longitudinal, monitoring study performed in 708
patients.35 Post hoc stratification for age and co-existing disease was performed to create
subgroups of patients, comparing survivor and nonsurvivor PAC-derived variables. Within
each group preoperative data were comparable for survivors and nonsurvivors. In the early
postoperative period CI, DO2I, VO2I significantly increased in survivors.
In another study of trauma patients (n=90) the survivors had significant higher values for CI,
DO2I and VO2I too.36 It also appeared that, when survival values were attained within 1 day,
survival was improved and the development of shock-related complications was reduced.
In summary, a number of descriptive studies showed that the pattern of cardiorespiratory
values in survivors differs from that in nonsurvivors. When compared to survivors, the
nonsurvivors had postoperatively a lower MAP and a decreased cardiac performance, their
intrapulmonary changes were characterized by increased vascular resistance, by higher oxygen
extraction ratios in peripheral circulation and by reduced oxygen delivery and oxygen
consumption.
The pathophysiologic concept developed of a failing circulation occuring prior to
classical shock symptoms. According to this concept, to overcome the induced ‘oxygen
debt’ in muliple organ systems, the circulatory deficiency needs to be surpassed by
increased values of global perfusion.
Shoemaker conceptualized the pathophysiologic mechanisms that preceded and followed a
state of hypovolemic shock.9;10;29-31 It was hypothesized that regional circulation was
compromised unnoticed; at the level of the microcirculation an imbalance between oxygen
supply and oxygen consumption resulted in a jeopardized organ function and subsequent
dysfunction or even failure. Shoemaker raised the concept of an intraoperatively developing
‘oxygen debt’, even when patients were treated till ‘normal’ cardiorespiratory values had been
achieved. It was suggested that this ‘debt’ should be traced and treated as early as possible. In
their view the PAC delivered all data needed to counterbalance timely, adequately and
continuously the detrimental clinical course during and after a period of shock.30;31 A causal
relationship between the severity and duration of the postoperative oxygen debt was suggested
by the differences in the clinical course of patients in three studies in which survivors without
complications, survivors with complications or organ failure, and nonsurvivors were
compared.37-39  The estimated VO2 needed and actual VO2 patterns in time showed that the
survivors had a reduced oxygen debt compared to nonsurvivors. The chance to develop
postoperative complications or to become a nonsurvivor seemed to increase when the oxygen
debt lasted longer.
Already in 1980 Del Guercio described a group of 148 elderly ( > 65 years) patients that was
preoperatively evaluated and treated with respect to cardiorespiratory performance.5 A strong
correlation was found between advanced functional deficits and mortality; these deficits were
particular uncovered by monitoring values. A total of 34 elderly patients was indexed as having
severely compromised conditions (‘functional deficits’) that could only be obtained by using a
PAC. Those deficits also appeared to be uncorrectable. It was therefore advised that these
patients should have no or only minor surgical interventions. Nineteen patients were not
operated at all, while 15 were operated eventually; 8 underwent a minor procedure and all
survived, while 7 patients underwent major surgery and all died.
&KDSWHU

Shoemaker et al. showed that increasing preload and additional dobutamine (2.5-10
µg/kg/min) could reset oxygen transport values of critically ill surgical patients with low,
normal and high flow in the direction of supposedly improved survival values.40 Although it
was suggested that earlier defined endpoints of resuscitation were attainable in all patients,
survival rates were not mentioned. This study has to be interpreted as part of a search for the
development of strategies to optimize circulatory values to predefined levels.
Surgery for aorta aneurysm was traditionally associated with a high morbidity and
mortality. Since it became available, the PAC was widely applied in these patients. A
number of studies suggested that careful pressure monitoring with a PAC could
reduce cardiac complications. Therapeutic interventions were directed specifically at
normalization of hemodynamics around crossclamping of the aorta. However, the
obtained evidence was not convincing enough due to the design features of these
studies.
Many patients were monitored with a PAC in the early eighties when major vascular surgery
was performed.
In 1980 Babu described 75 patients planned for noncardiac vascular surgery (lower extremity,
abdominal aorta, carotidectomy); perioperative PAC data were used to evaluate and treat
cardiac dysfunction.41 In 40% of the patients left ventricular dysfunction was only detected by
using a PAC; 2/3 of the patient population needed ‘optimization’ of cardiac function with
fluids and/or pharmacological interventions; the in-hospital mortality was 1.3%.
Grindlinger evaluated PAC-guided preoperative fluid management in two – non-randomized -
groups of patients (total n=50) undergoing abdominal aorta aneurysmectomy. One group
received only fluids and the other fluids with additional intraoperative nitroprusside (NTP).42
Hemodynamic endpoints were discussed, i.e. effects of the protocol on HR, MAP, PCWP and
CI. Patients with fluids and NTP were found to be more stable hemodynamically during
crossclamping of the aorta and release of the crossclamp from the aorta.
Whittemore et al. claimed that by maintaining optimal cardiac performance using a PAC the
operative mortality in aortic aneurysm repair could be reduced; the study was performed in 110
patients. In- hospital mortality was remarkably low (< 1%) compared to a historical control
group in the literature (8-9%).43
Bush et al. performed a retrospective study to evaluate renal function in 34 patients after
abdominal aortic aneurysm resection, comparing preoperative volume loading guided by CVP
or PCWP. The PCWP-group received significantly more preoperative fluids and had
significantly less postoperative renal dysfunction, although none of the patients needed renal
replacement therapy and the hospital mortality in this study was zero.44
Hesdorffer et al. prospectively studied 61 patients operated for abdominal aorta aneurysm and
compared them with a historical group (n=87).45 The authors described a significant reduction
in mortality (15% vs 31%) and a more stable intraoperative hemodynamic course by using a
PAC; a causal relationship between postoperatively improved renal function and survival was
suggested.
Bunt et al. suggested that preoperative nitroglycerine-induced volume loading and PAC-
monitoring significantly reduced perioperative cardiac complications.46 Fifty-five patients were
stratified in three groups, being normal, intermediate or high-risk for the development of
perioperative cardiac complications according to their ejection fraction. Eighty % of these
patients had CAD at clinical or laboratory testing. The mortality in the entire group was 3.5%
and none of the patients had myocardial infarction.
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Two more monitoring studies were performed in patients undergoing abdominal aorta surgery
to evaluate the pros en cons of the PAC.47;48 In both studies there was no protocol for specific
targets of hemodynamic treatment that were to be strived for. Joyce et al. compared CVD-
(n=19) and PAC-monitoring (n=21) in patients undergoing abdominal aorta surgery in a
prospective randomized trial. Patients were considered as ‘low risk’, since patients having
unstable angina pectoris, a LVEF < 50% or a history of recent myocardial infarction (< 6
months) were excluded. A third group of 11 PAC-monitored patients with LVEF < 50% was
used to compare actual results. The CI in the PAC-monitored patients ranged from 2.2 to 2.8
L/min/m2 perioperatively. PAC-monitored patients stayed longer in the ICU than CVD-
monitored patients; clinical data might explain this phenomenon. No cardiac complications
were seen in the randomized patients and the in-hospital mortality was zero, while in the
historical group significantly more pulmonary oedema was found and 1 patient died.
Isaacson et al. randomized 102 patients to a CVD- and a PAC-group planned for elective
abdominal aorta surgery. Preoperatively all underwent extensive screening for coronary artery
disease (CAD). They were all classified as ASA 3 and 4. Fluid management of both groups
was similar. The authors found no differences in postoperative outcome. The operative
mortality was < 1% in the entire group.
None of the above-mentioned studies was designed as a randomized controlled trial on the
issue of early postoperative treatment of hemodynamic values as advocated by Shoemaker.
Already in 1978 Bland and Shoemaker insisted on the need for prospective randomized
controlled trials, but such studies were sparsely conducted.
Prospective trials of perioperative hemodynamic treatment in mixed groups of high
risk surgical and trauma patients were started by the group of Shoemaker et al. in the
early eighties. Others performed comparable studies aiming at specific PAC-guided
endpoints in different groups of patients, i.e. patients undergoing major surgery,
surgery for major trauma and vascular surgery. Studies on preoperatively instituted
therapy were effective in reducing mortality, while therapy that started after
complications had occurred did not improve the outcome or even were shown to
increase mortality.
Circulatory variables were found to become depressed during extensive surgical
procedures.31;33-35;49 It was assumed that preferential maintenance of flow at vital organs
compromised the perfusion of other organ systems. It was therefore hypothesized that
imminent circulatory failure could be prevented by maintaining postoperative DO2I and VO2I
at supranormal levels.29;33;35
The hypothesis that ‘supranormal’ cardiorespiratory values could improve the outcome in high
risk surgical patients was first tested prospectively in 1982 in a group of 100 patients.32 The
control group (n=61) was treated by the current standard guidelines, while the protocol group
(n=39) was treated by values derived from median values earlier described in two series of
survivors of comparable critically ill patients.9;28;29 Patients were ‘randomly’ assigned to one of
the two groups according to a prearranged schedule of services of three medical teams, one of
which treated patients according to the new protocol, while the two other teams used the
standard guidelines. Treating physicians also rotated between ‘protocol’ and ‘control’ services.
Inclusion criteria for participation in the study are not well described: a list of ‘predetermined
clinical criteria’ was used, but also the results of ‘clinical assessment’ could be the reason of
study participation. Execution of the protocol was described exactly for both groups,
concerning the sequence as well as the extent of interventions. In the control group the focus
&KDSWHU

of actions was on normalization of pressure-related variables (MAP > 90 mmHg; CVP 2-6 cm
H2O; Ht > 30%; urine output > 30 mL/hr), while in the protocol group the focus of actions
was on ‘supranormalization’ of flow-related variables (blood volume > 2.7 L/m2 for females
and > 3.0 L/m2 for males; CI > 4.5 L/min; DO2I > 550 mL/min, VO2I > 167 mL/min). The type
of interventions was comparable: fluids, inotropic agents, vasodilators and transfusion of blood
products were applied, although no information was given about the quantity of therapy and
attained protocol values.
The severity of (acute) illnesses of all patients in this very heterogenous population of critically
ill postoperative patients was carefully described using the criteria of table 9. The protocol
group had a slightly more severe state of shock before inclusion and the patients in this group
also had significantly more positive criteria for severe illnesses. Nevertheless the mortality in
the protocol group was significantly lower (13%) compared to that in the control group
(48%).
A series of 603 patients, admitted to the emergency department with hypotension (many
causes) was also evaluated by the group of Shoemaker, comparing the application of an
algorithm (n=212) for management of shock states vs. not using an algorithm (n=391).37 The
mean age in the total population was 35 years; 37% of the patients had a hemorrhage, 26%
were trauma patients, 12% had head injury, 19% was admitted to the hospital because of
sepsis and 6% had an unspecified cause of hypotension. The groups of patients were allocated
according to the shifts of services as earlier described. For the treatment of the protocol group,
the service used a specified flow-diagram; the management of the control was not described.
Endpoints of the study were carefully formulated, including resuscitation time, duration of
hypotension, length of stay (LOS) at the ICU and in the hospital, number of patients on and
duration of mechanical ventilation, and mortality. The protocol group had a significantly
shorter resuscitation time, but no differences were found concerning the in-hospital LOS,
duration of ICU-dependency, number of days on the ventilator or mortality (18% vs. 19%).
Distinguishing the fact that a cross-over in attaining hemodynamic values had happened
between control and procotol group as a result of comparable hemodynamic management
during the study, the authors performed a subanalysis. Patients with head trauma were
excluded, while the rest of the control and protocol population was divided into patients
satisfactorily treated by the protocol and patients in whom treatment deviated from the
protocol. Although in this way data of protocol and control patients were reallocated
according to hemodynamic performance, no differences were found between both groups with
respect to LOS at the ICU- and in the hospital, or mortality.
Shoemaker validated the predictive index of cardiorespiratory values once again in 1983 in a
group of 300 critical ill surgical patients, including the population of 153 patients published
earlier in 1982, showing a comparable positive and negative predictive value (96% vs. 96%
and 85% vs  89%, respectively).50 Results of an accompanying intervention study in 223
critically ill postoperative patients of whom 80 (36%) were hemodynamically treated to
achieve median cardiorespiratory values of survivors.10 In this ongoing study of the series of
patients published in 1982, the protocol group still had a higher number of associated severe
illnesses (table 9). Nevertheless this group of patients had a significantly lower mortality
(12.5%) when compared to the control group (35%).
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Table 9. Criteria for associated severe illnesses (1982, 1983) and inclusion criteria by





high risk surgery criteria
(1988)51
1. MAP < 50 mmHg with systolic
pressure < 75 mmHg
2. multiple trauma-injury of > 3
major organs of > 2 organ
systems
3. head injury with coma; i.e.
unconscious and unresponsive
to verbal or painful stimuli
4. gunshot or stab wound to
major organs (i.e., heart, brain,
lungs, liver, spleen, intestinal
tract, kidney) with bleeding >
1000 mL
5. respiratory failure due to chest




6. massive acute blood loss –
loss of > 4000 mL or Hct < 25;
slow or chronic blood loss and
renal failure not included
7. septic shock-MAP < 60 mmHg,
temperature < 96 0F or  > 101
0F, and WBC < 4,000 or >
12,000
8. cardiogenic shock – acute MI,
CHF, or dysrhythmia
documented by ECG,
laboratory results, or autopsy.
9. renal failure
10. hepatic failure
11. CNS coma (stroke)
1. MAP < 50 mmHg with systolic
pressure < 75 mmHg
2. multiple trauma injury of >3
major organs of >2 organ
systems
3. burn – encompassing > 60% of
the body surface area
4. head injury with coma; i.e.
unconscious and unresponsive
to verbal or painful stimuli
5. gunshot or stab wound to
major organs (i.e. heart, brain,
lungs, liver, spleen, intestinal
tract, kidney) with bleeding >
1000 mL
6. respiratory failure due to chest




7. massive acute blood loss –
loss of > 4000 mL or Hct <
0.25; slow or chronic blood
loss and renal failure not
included
8. septic shock-MAP < 60 mmHg,
temperature < 96 0F or > 101
0F, and WBC < 4,000 or >
12,000
9. cardiogenic shock – acute MI,
CHF, or dysrhythmia
documented by ECG,




2. extensive ablative surgery
planned for carcinoma; i.e.
esophagectomy and total
gastrectomy, prolonged
surgery (> 8 hours)
3. severe multiple trauma, i.e. > 3
organs or > 2 systems, or
opening 2 body cavities
4. massive acute blood loss (> 8
units), blood volume < 1.5
L/m2, hematocrit < 0.20
5. age over 70 years and
evidence of limited physiologic
reserve of one or more vital
organs
6. septicemia, positive blood
culture or septic focus, white
blood cell count > 13,000/mL;
spiking fever to 38.3 oC for 48
h
7. shock, MAP < 60 mmHg, CVP
< 15 cm H2O and urine output
< 20 mL/h
8. respiratory failure: PaO2 < 60
mmHg on fraction of inspired
oxygen > 0.40; intrapulmonary
shunt fraction > 30%;
mechanical ventilation needed
> 48 h






10. acute renal failure: serum urea
nitrogen > 17.9 mmol/L of
urea; creatinine > 265 µmol/L




Schultz et al. randomized 70 elderly patients with hip fractures for a study comparing
preoperative hemodynamic monitoring by using a PAC. They treated cardiorespiratory
variables till a ‘satisfactory physiologic profile’ was achieved. When necessary, surgery was
postponed. The control group received conventional pre-operative assessment. A reduction of
mortality was found from 29% to 2.9% (p=0.003).52 Unfortunately the precise interventions
that were made are not described and also no data are available on the type and extent of
achieved endpoints: ‘correction of physiologic abnormalities’ suggests more a ‘normalization’
of hemodynamic values than aiming at ‘supranormal’ values.52
In 1988 Shoemaker et al. published a study in which the physiologic patterns empirically found
in survivors were used as therapeutic goals in the intra- and postoperative period in a group of
high-risk surgical patients.51 In fact this publication consisted of two prospective studies. Two
series of patients were described. Series 1 contains 252 patients (276 operations) assigned to a
control and a protocol group dependent on service; one of three services managed patients
according to the protocol, whereas the other services delivered ‘standard care’. Every service
was scheduled in time to manage patients according to the protocol, while the other two
services provided standard care.
Series 1 has to be interpreted as a further extension of the clinical trials already published in
1982 and 1983 (table 9); the type of allocation to one of both study groups, the description of
the population and study period make this conclusion inevitable. Patients were included in the
studies when  ≥  1 high-risk factor was present. The definition of high risk was determined by
criteria that were previously found to be correlated with a mortality rate of 34% and are
depicted in table 9.
The authors describe that in both protocol groups supranormal values of CI (> 4.5 L/min),
DO2I (> 600 mL/min) and VO2I (> 170 mL/min) were used as goals of therapy perioperatively.
In series 1, 35% of patients had a PAC inserted postoperatively. The results of normal
hemodynamic values of the control group were compared with the supranormal values that
were aimed at in the protocol group. Endpoints of the study were mortality and number of
complications. The targets of treatment were mainly attained by addition of significantly more
fluids (colloids) in the first 48 hours postoperatively; intraoperative fluid management was
similar in both groups.53
Series 2 was designed as the very first randomized controlled trial on the issue of perioperative
hemodynamic treatment of surgical patients. This series contained 143 patients of whom 88
were randomized for a CVP-group, PAC-monitoring group or PAC-treatment group
(protocol); 10 patients were not randomized (4 deaths) because they needed emergency
surgery and 45 were deemed not ill enough (by treating surgeons) to justify randomization for
Shoemaker’s invasive monitoring study. Additional results of the complete study (series 1 and
2) were published together with the results from other patients in 1990 and 1992 (entire
population of 803 patients).39;53
A signifcant reduction of mortality was found from 38% to 21% (p<0.01) in series 1 and from
28% to 4% (p<0.01) in series 2. In both studies the protocol groups had a significant lower
number of complications; in series 2 protocol group patients were shorter on mechanical
ventilation and had a significant reduction in ICU LOS. The authors described a group of
patients after finishing the study in the same paper; the in-hospital mortality in this group was
25%, suggesting that striving for ‘supranormal’ values would have saved lives.
Scalea et al. PAC-monitored 45 geriatric patients with severe blunt trauma (≥ 65 years) in two
cohorts.54 An unknown number of patients underwent surgery; also information on the type
and timing of the surgical procedures is not available in this publication. The authors focused
on the timing of institution of hemodynamic treatment. In all patients treatment aimed at a CI >
4.0 L/min/m2 and/or VO2 > 170 mL/min/m2 by volume-loading and additional inotropics when
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needed. In the first cohort monitoring was started in 15 patients > 5 hours after hospital
admission. In the second cohort (n=30) monitoring and subsequent hemodynamic treatment
started within 2.5 hours after hospital admission. The second cohort had a significantly lower
mortality (47% vs. 93%, p<0.001). The authors emphasize the importance of timely started
treatment.
In 1991 results of a prospective, randomized controlled trial of preoperative treatment of
cardiovascular hemodynamics in peripheral vascular surgery under general anesthesia were
published by Berlauk et al.55 Eighty-nine patients were allocated to three monitoring groups: a
CVP-group that served as a control group and two PAC-groups, divided into an early and a
late preoperative insertion of the PAC, in both groups used for optimizing left ventrical filling
and oxygen transport (‘tune-up’). All patients with a PAC received nitroglycerine, while
patients of the CVP-group did not. Patients of the PAC-groups were subsequently tuned up
preoperatively with fluids, inotropics and vasodilators, aiming at the combination of a PCWP
between 8 and 15, a CI of ≥ 2.8 L/min/m2 and an SVR < 1100 dyne.sec/cm5 and this was
continued intraoperatively. A significant reduction of intraoperative events, postoperative
cardiac morbidity and early graft thrombosis was found. The overall mortality in this study was
3.4%; 2 patients in the control group died and 1 patient in one of the protocol groups died.
The quality of this study is underlined by the availability of a consistent team of one surgeon
and two anesthesiologists performing the study in all patients. Moreover, anesthesia was
standardized, although general anesthesia is not very common for peripheral vascular
procedures of the lower limb. In this study the reduction in cardiovascular complications is
remarkable in the context of allocation of most patients with angina pectoris to the protocol
groups. The preoperative application of nitropaste in the patients of the protocol group may
have been a confounding factor; the use of other preoperative medication is not mentioned in
this study. The value of perioperative nitroglycerine, however, can be discussed as Dodds
found no advantages of applying perioperative nitroglycerine in a randomized controlled trial in
a mixed group of non-cardiac surgical patients at risk for ischemic cardiovascular
complications.56
In 1992 the group of Shoemaker published a prospective study of attaining supranormal
hemodynamic values in 67 young trauma patients; the majority of patients had shot and stab
wounds (79%) and underwent emergency surgery.57 The day of admission determined
allocation to a control or a protocol group. Groups were comparable regarding age, severity of
trauma, estimated blood loss and time spent in the emergency department. Endpoints of
resuscitation were achieved in 88% of the protocol group patients by volume loading and/or
dobutamine (5-20 µg/kg/min). A significant reduction in organ dysfunction, duration of
mechanical ventilation and ICU-stay was found in the protocol group. A lower mortality was
found in the protocol group (24% vs. 44%, p=0.08); after excluding patients that did not attain
protocol values within 24 hours after ICU admission, a significant reduction of mortality
emerged (19% vs. 44%).
Boyd et al. published the results of a prospective, randomized trial comparing the effects of
perioperative increase of oxygen delivery in 107 high-risk, mainly elective, surgical patients
using dopexamine.58 Criteria for the definition of high risk surgery were used as earlier
described by Shoemaker.51 Eighty-one patients (75.7%) were identified preoperatively as high
risk surgical patients; they were admitted to the ICU preoperatively and had a PAC inserted.
Thirty-eight patients (35.5%) of the entire group underwent emergency or urgent surgical
procedures. The majority of patients (54.2%) underwent vascular surgery. Treatment was
aimed at obtaining DO2I > 600 mL/min with PCWP 12-14 mmHg, supplemental inspired
oxygen and blood products to maintain a hemoglobin (Hb) > 12 g/dl. When a DO2I of less than
600 mL/min existed, dopexamine (0.5-8 µg/kg/min) was added in patients of the protocol
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group to achieve this value. Premedication, intraoperative management and anesthesia were
decided by the attending anesthesiologist and surgeon. Preoperatively started dopexamine was
continued intraoperatively. After postoperative admission to the ICU, the treatment of the
preoperative strategy was continued for another 24 hours or till values of lactate were
normalized. Another 26 patients were randomized postoperatively. Based on data from the
literature a mortality rate of  25-40% was expected for this group of patients. A significant
reduction in mortality was achieved in the entire population (5.7% vs 22.2%) and the
complication rate was significantly lower in the protocol group compared to the control group.
Considering all patients preoperatively admitted to the ICU, 3 (7%) of the protocol group
patients died, whereas the mortality in the control group was 23.7%. Patients undergoing
abdominal surgery (n=37, 34.6%) appeared to benefit most since all patients of the protocol
group (n=17) survived in contrast to 5 deaths in the control group (n=20).
Hayes conducted a randomized, controlled trial of hemodynamic treatment in critically ill
patients.59 One hundred and nine patients were included in the study, 100 patients were
randomized to one of two groups, mainly in the late postoperative period, after complications
occurred at the surgical ward. All patients were treated with volume expansion and a
continuous infusion of 2 µg/kg/min dopamine. The control group of patients only received
additional dobutamine when CI < 2.8 L/min, while the treatment group of patients received
dobutamine to achieve supranormal values of CI, DO2I and VO2I. Patients of the treatment
group were treated with high doses of dobutamine (median 25 µg/kg/min); in addition
norepinephrine (median 1.2 µg/kg/min) was titrated to maintain the MAP > 80 mmHg. The
study was interrupted at the second interim analysis because an unexpected and significantly
higher mortality was observed in the treatment group (50% vs. 30%). The increased mortality
in the study of Hayes has been attributed to the extremely high doses of vasoactive substances
applied; the results showed that CI and DO2I could not and should not be boosted to earlier
defined supranormal levels at any time or at any cost.
Specific attention for the risk of increased cardiac morbidity and mortality as a result of
striving for supranormal values of global perfusion was first addressed in a clinical study in 89
patients with sepsis, septic shock and ARDS.60 Thirty-two patients (36%), generating a DO2I >
600 mL/min after preloading with fluids, were excluded from analysis. The 57 remaining
patients were treated with fluids and vasopressors. Eleven patients already had a myocardial
infarction at study entry (12%) and 5 patients developed a new myocardial infarction during
execution of the study protocol; 2 were receiving inotropic support and 3 were not.
Conclusions about the safety of inotropic support for GOHT in patients at risk for
cardiovascular complications cannot be made based on this study.
Bishop et al. published a randomized controlled study of severely traumatized patients.61 Fifty
protocol patients were treated postoperatively to attain supranormal values of CI, DO2I and
VO2I. The 65 control patients were treated to obtain normal values of blood pressure, HR and
an urine output of 30-50 mL/hr; normal CVP- and PCWP-values were aimed at when central
pressure monitoring was available. The protocol group had a significant lower number of
organ failures (0.74/patient vs. 1.62/patient, p=0.002), as well as a shorter ICU stay (6 vs. 11
days, p=0.017) and a lower mortality (18% vs. 37%, p=0.011).
Gattinoni tested the hypothesis of improving outcome of goal-directed therapy in critically ill
patients in a randomized controlled trial.62 A mixed group of 762 patients was included in a
multicentre trial. Patients were allocated to three groups: a control group in which a normal CI
was aimed at, a protocol group in which CI was directed to a supranormal level > 4.5 L/min
and a protocol group in which the mixed venous saturation was aimed at values > 70 percent.
Treatment values had to be maintained for at least 5 days. A combination of fluids, inotropics,
vasodilators and vasopressors was used to attain the endpoints. It appeared that protocol
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target values could not be achieved in all patients and some needed a more intense treatment;
these patients were older and had higher acute physiology scores. Morbidity and mortality
were comparable between groups (48.4-52.1%). Subgroup analysis, including a group of
postoperative patients, did not reveal any patient group in which goal-directed therapy
improved outcome.
Garrison et al. compared the intra- and postoperative course in a non-randomized controlled
study of  457 elective, non-cardiac surgical patients.63 This study is severely weakened by
design and the selective analysis of only 2/3 of the entire population.Three hundred and six
patients were admitted to the ICU and preoperatively monitored during infusion of 2 L of
normal saline in 2 hours; the mean age was > 60 years; 99% were males. Most patients
underwent abdominal aortic surgery (n = 145; 32,1%) and colon surgery (n = 152; 33,6%).
Allocation to one of both groups was directed by the availability of a preoperative ICU-bed
and judgement of the surgeon. Only patients undergoing aortic and colon surgery were
analyzed. Patients, well known as ‘high-risk’ for postoperative morbidity and mortality, like
patients undergoing oesophageal resection, were excluded from this study. The overall 30-day
mortality in these combined two subgroups was 6.7%. The authors found a significant
reduction in the total number of complications in patients undergoing aortic surgery and a
significantly more stable intraoperative hemodynamic course in patients after saline preloading.
No differences were found between both groups in 30-day mortality. Data about LOS in the
ICU or the hospital were not presented.
Prospective studies of goal-oriented hemodynamic treatment (GOHT) in sepsis (till
1996).
PAC-derived hemodynamic values in surviving patients with severe sepsis also were
significantly different from nonsurviving septic patients. Studies were performed to
test the hypothesis that mortality could be reduced by aiming at hemodynamic values
of surviving septis patients. However, significant reductions were only found after post
hoc randomization or otherwise after manipulation of data.
Edwards et al. used survivor values of CI, DO2I and VO2I as endpoints of hemodynamic
treatment in a group of 29 patients in septic shock.64 Patients were primarily treated by volume
expansion for an optimal PCWP, i.e. till no further increase in LVSWI occurred.
Norepinephrine was added when SVR < 1100 dyne.sec/cm5.m2 and dobutamine if CI was < 3.5
L/min; dopamine served as a rescue drug when predefined values could not be attained. The
mean endpoints of CI, DO2I and VO2I were 5.1 L/min, 843 ml/min and 169 mL/min
respectively; no data are presented whether endpoints were achieved in all patients. In this
prospective, descriptive study the mortality rate was 48%. The authors describe doses of
norepinephrine 0.02 µg/kg/min and dobutamine 22-200 µg/kg/min used without symptoms of
cardiac ischemia, while 29% of nonsurvivors died due to terminal cardiac events. The authors
describe historical mortality rates of 60% in similar patient groups, and even > 80% when
inotropics were needed. Based on their findings, they argued that survival could be improved
by attaining supranormal values of CI, DO2I and VO2I in septic patients.
Martin performed a comparable study in 23 septic patients by using dobutamine and/or
norepinephrine, to achieve a CI > 4.5 L/min, a DO2I > 550 mL/min and an SVRI > 700-800
dyn.s/cm5 and found a mortality of 56%.65
Tuchschmidt published a randomized controlled trial of 51 patients with septic shock,
randomized to a control group (CI 3.0 L/min) and a protocol group (CI > 6.0 L/min) for 72
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hours.66 Groups were similar regarding their cardiorespiratory performance at admission to the
study. Mortality seemed lower in the protocol group compared to the control group (50% vs.
72%, p=0.14). A strong correlation was found for an increased DO2I and survival in a posthoc
analysis: patients achieving values of CI > 4.5 L/min, spontaneously or by protocol, had a
lower mortality when compared to patients with a CI < 4.5 L/min (40% vs. 74%; p < 0.01).
Yu et al. performed a prospective randomized controlled trial of hemodynamic treatment of
critically ill patients with sepsis, septic shock and ARDS. In the intervention group a DO2I >
600 mL/min was aimed at while in the control group patients were treated to normal values of
DO2I.67 Direct comparison of 35 protocol en 32 control patients showed no difference in
survival (mortality 34% in both groups). Only after rearrangement of patients to a group
attaining a DO2I > 600 mL/min, spontaneously or by protocol, or a group of patients attaining
DO2I < 600 mL/min, patients with supranormal DO2I values appeared to have a significant
better survival (56% vs. 14%).
In 1995 a series of 89 surgical patients with sepsis, ARDS and/or shock were randomized to a
protocol group to achieve a DO2I > 600 ml/min and a control group to achieve normal values
of DO2I (450 –550 ml/min), in search of patient characteristics to define strategies of
supranormal hemodynamic values for specific patient groups and the risk of myocardial
complications.67 Although the authors suggest a causal relationship of increased DO2I and
survival,  this conclusion could only be made after discarding patients of the protocol group in
which protocol values could not be achieved. The overall mortality in both groups was around
40%.
Since the prevention of hypoperfusion and hypoxic conditions in every single organ
was considered the ultimate target of GOHT, the attention that was primarily focused
on global perfusion, slowly shifted to methods of detection and treatment of regional
perfusion deficits. In case of insufficient general perfusion the intestinal circulation
was presumed to be compromised in the first place. Devices detecting gastric mucosal
hypoperfusion became available for clinical use and studies were performed in
critically ill patients, in which GOHT was assessed by intestinal pH (pHi)
measurements.
Shoemaker was aware of the fact that PAC-derived variables informed the clinician only about
global perfusion and not on regional deficits. Already in 1981 he therefore tried to find
methods directed at monitoring interstitial and intracellular oxygen and pH to adequately
evaluate cellular oxygenation.31 Monitoring studies on percutaneous oxygen tension and small
vessel flow measurements, in addition to parameters of global perfusion, were performed to
refine the detection and treatment of pathophysiologic changes of the circulation.49;68 However,
introduction of devices to measure oxygen percutanuously and small vessel flow never became
applied in clinical controlled trials. The splanchic perfusion is presumed to be the most
sensitive to become compromised when deficits in global perfusion develop.69 The introduction
of gastric intramucosal pH (pHi) measurements gave access to monitoring regional perfusion in
addition to global perfusion.70 Combined PAC-monitoring and pHi in a mixed group of critical
ill patients at ICU admission and 24 hours hence showed no consistent differences between
survivors and nonsurvivors considering CI, DO2I and VO2I, while the pHi appeared to be a
sensitive marker of mortality.71 In a mixed group of patients undergoing cardiac and
noncardiac major surgery a strong correlation was found between pHi at the end of the
surgical procedure on one hand and complications and costs on the other hand.72 A prospective
randomized controlled trial on increasing global perfusion, guided by oesophageal Doppler in
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cardiac surgical patients, showed a significant reduction in mortality and hospital stay in the
protocol group; the simultaneously monitored gastric mucosal pHi was found to be strongly
related to gut mucosal hypoperfusion and mortality.73 Ivatury performed a randomized trial
comparing PAC-guided and pHi-guided resuscitation in young surgical trauma patients (mean
age 30 years). Although endpoints of resuscitation were achieved in > 90% of both groups, the
mortality in de PAC-guided group, in which supranormal values were aimed at (DO2I > 600
mL/min and VO2I > 150 mL/min), was higher than in the pHi-guided group (31.3% vs.
9.1%).74 Again, pHi as a measure of regional perfusion appeared to be a better predictor of




From a historic point of view, the principal investigators on the issue of development of careful
hemodynamic monitoring and treatment of high risk surgical (trauma) patients are W.C.
Shoemaker and his group. A large number of studies was performed in this type of patients
during hospital admission, surgery and postoperative intensive care (table 10).
Table 10. Publications of the group of Shoemaker till 1990, containing descriptive,
prospective and interventional studies on high risk surgical patients, except for study
number 5, which consists of critical ill patients admitted to the emergency department. A
number of studies is an extension of data published earlier; in this table, study number 4 is
an extension of study number 3; study number 7 is an extension of study number 6; study
number 9 comprises study number 7 and an additional preceding cohort of patients
collected in a period of 5 months. The studies number 4 and 7 were presented in one
publication. Details of studies number 6, 7 and 9 (series 1) are depicted in table 13.
Period number of patients type of study year of publication
1. ?
2. ?
3. Jan. 1976 – Jan. 1979
4. Jan. 1976 – Jan. 1980
5. Jan. 1977 – June 1979
6. June 1978 – Dec. 1979
7. June 1978 – June 1980
8. ?
9. Jan. 1978 – June 1980
May 1983 – May 1984
10. June 1980 – May 1983
11. May 1983 – May 1984



































1988, Chest51; 1990, Arch Surg53
1988, Chest51; 1990, Arch Surg53
1988, Chest51; 1990, Arch Surg53
1988, Chest51; 1990, Arch Surg53
1988, Chest51; 1990, Arch Surg53
D, descriptive; P, prospective; I, interventional; RCT, randomized controlled trial; SGO,
Surgery, Gynecology and Obstetrics; CCM, Critical Care Medicine; AJS, American Journal
of Surgery
Initially it was revealed that in critically ill patients specific patterns of cardiorespiratory values
developed in the course of the first days after a period of shock.27 Monitoring cardiorespiratory
values by the PAC also was directed towards the elucidation of the pathophysiology of
pulmonary complications after shock.26 The next step was the discovery of significant
differences in monitored variables between survivors and nonsurvivors.18
In the early studies, the concept of ‘stages of shock’ needs to be critized (table 4). A
substantial part of the population included in these studies consists of trauma patients.9;18;75
Data are presented as if for any individual patient the lowest blood pressure measured (‘stage
low’) was indeed the first event of hemodynamic instability. Worse values may have occurred
beyond the scope of the reseacher’s monitoring window. Therefor it is unclear whether some
of these patients may have had more than one preceding ‘low stage’ before clinical monitoring
could have started, causing a mix-up of data from different actual stages of shock that were
interpreted as belonging to one specific stage. Such a shift of data could place a nonsurvivor in
‘stage low’, while in fact the patient was monitored in ‘stage D’ (table 4). This problem of a
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rather constructed organization of data around a lowest value of blood pressure was
acknowledged by Shoemaker et al. as they adressed this problem by monitoring critically ill
patients perioperatively at predefined time points.31 Analysis of hemodynamic data confirmed
the existence of specific patterns evolving in time that clearly separated survivors from
nonsurvivors.32;33;50;76
The key findings, however, concerning the predictive value of cardiorespiratory values with
respect to survival were obtained in the population of 113 postoperative critically ill
patients.9;10;28-30 Although comprehensible in the context of focussing on hemodynamic
monitoring, it is remarkable that in the extensive multivariate analysis only PAC-data were
involved, while the differences in both groups, as depicted in table 6, were discarded. Survivors
were significantly younger and clearly underwent different types of surgery, a fact that also had
not been acknowledged in an earlier publication of high-risk surgical patients, in which
survivors also were apparently younger.18 Nevertheless the results found in this population of
113 patients became a reference in defining endpoints of hemodynamic treatment.
Although the higher (supranormal) values of survivors were more sensitive variables to predict
outcome than variables conventionally used as goals of resuscitation, it remained unclear
whether the decreased values of CI, DO2I and VO2I were unnoticed parameters of impeding
circulatory catastrophy that could have been corrected to survivor values, or that survivor
values only reflected a more beneficial baseline condition that resulted in improved chances to
survive catastrophic impact of disease and surgical stress. The monitoring study, published by
the group of Shoemaker in 1985, illustrates that survivors and nonsurvivors do not match:
survivors were apparantly younger, hemodynamic values already differed significantly from
nonsurvivors preoperatively and the 6 nonsurvivors of the 42 trauma patients had a higher
number of injuries per patient (table 11).33
The specific pattern of postoperatively decreased global oxygen transport values of
nonsurvivors appeared to exist in subgroups of different illnesses.34 Surgical patients were
carefully stratified for type of associated ilnesses; when survivor hemodynamic profiles were
compared to nonsurvivor profiles within each strata, the preoperative comparability of both
groups was easily presumed, but in fact never tested. Shoemaker et al. treated critical ill
surgical patients to achieve high values of CI, DO2I and VO2I by volume loading and
dobutamine.40 They observed that values of CI and DO2I increased compared to baseline
values. However, ‘supranormal’ levels were only achieved in patients already spontanuously
having normal or high hemodynamic values, whereas in patients with low hemodynamic values
‘supranormal’ values appeared to be unattainable despite treatment with incremental doses of
dobutamine to 10 µg/kg.min-1.
The presumption of the causal relationship of the severity of oxygen debt, morbidity and
mortality also needs to be criticized. Reviewing the presented data, the group of nonsurvivors
described in 1988 were significantly older, which makes the comparability of the three groups
questionable.38 The series on this issue published in 1992 also shows that nonsurvivors were
not only older, but also had a higher number of high risk criteria/patient.39
It remained unclear whether the increased global oxygen transport values are not only valuable
as predictors of outcome but also could be used as guides of therapy in critically ill patients. A




Table 11. Category of patients included in descriptive and interventional series by the group
of Shoemaker et al., summerized in main groups of surgical procedures or indication for
surgery. The percentage of mortality is calculated as mortality in subgroups. Of the












































































overall mortality 31% 29.3% 24.5%
Shoemaker et al. conducted the first trials, two of those eventually were brought together in
one landmark publication.51 It is unclear why the population of series 1 finally was extended
backwards in time (table 10) and it also was never explained in later publications.
The improved survival in the protocol group in the preliminary reports of series 1 may be
remarkable as this group was described earlier as more severely ill.32;50 However, detailed
consideration of most ‘associated severe illnesses’ (table 9) show that these mainly consist of
acutely acquired conditions rather than it informs the reader about the patient’s preceding
condition and co-morbidity, especially regarding the cardiorespiratory system that would
become the target of therapy.
The type of randomization of series 1 can be critized for its lack of transparancy and potential
cause of bias by differences in quality of treating medical teams. The statement of Shoemaker
that the severity of illnesses and mortality among the three services was comparable does not
alleviate this problem.51 Differences in treatment of patients may also be illustrated by the fact
that survivors apparantly were treated more timely, as monitoring in nonsurvivors was started
a mean of 17.4 hours later compared to survivors.53
Another confounder of importance may have been the case-mix, especially in series 2, that
consists of relatively small numbers of patients per group, resulting in not well comparable
groups considering physical status and co-morbidities that may have influenced outcome. It is
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remarkable that in the first publication on series 1 a detailed list of diagnosis and operations
was presented76, while in the second publication of 1983 and the final publication of 1988
precise data concerning surgical procedures of both series were not presented.50;51 The
protocol group in former publications of series 1 may have been more at risk for postoperative
morbidity and mortality because in this group a higher number of associated illnesses existed;
on the other hand the trauma patients of the control group seem to be more severely injured,
having a mean number of injuries of 2.3 per patient compared to 1.5 per patient in the protocol
group.32 Furthermore, it is of note that the original endpoint of resuscitation in series 1
contained the value of DO2I > 550 mL/min, that apparently was raised to > 600 mL/min during
progression of the study, as was published in the final paper. Concerns also are raised by
potential differences in postoperative treatment, irrespective of direct manipulation of
cardiorespiratory variables. This may be illustrated by the example of interventions in a patient
in an early paper of 1979, who showed an improved postoperative hemodynamic course after
the treatment with prednisolon.29
The concept of a developing oxygen debt that had to be paid for early after the development of
the deficit was postulated in 1981.31 However, in the early eighties the same research group
found that early optimization of global oxygen transport in a mixed group of patients with
shock did not improve the outcome.37 A weakness may have been the inclusion criteria. Using
only two inclusion criteria, the denotion of ‘emergency patient’ at hospital admission and
hypotension defined as a MAP < 80 mmHg, many patients were included, but apparently the
cut-off point for ‘low blood pressure’ was chosen too high, as investigators retrospectively had
to exclude 135 (18%) of the patients who appeared to have a < 80 mmHg MAP in daily life.
Defining a MAP < 80 mmHg as hypotension may have included patients that were not
expected to benefit from the protocol.
Much later, Gattinoni et al. also failed to achieve a reduction in mortality in a mixed group of
critically ill patients.62 Identical conclusions were made after subgroup-analysis that showed
that also postoperative patients did not benefit from GOHT. Hayes et al. even found an
increased mortality in the protocol group.59 Shoemaker criticized both studies for the fact that
patients were included beyond a time point that GOHT could have improved outcome.78;79
However, in Shoemaker’s own study of 1988 monitoring and, as may be assumed, also
treatment in nonsurvivors was evidently started much later than in survivors.53
The results of GOHT in studies concerning severely ill patients with sepsis are
methodologically flawed by rearrangement of patients, allocating them to responder and non-
responder groups, which has to be interpreted as a post hoc randomization.66;67 It can be
concluded that GOHT in patients with sepsis does not improve outcome. Comparable criticism
has to be made regarding the study in trauma patients by Fleming.57
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Table 12. Prospective, interventional studies till 1996 on perioperative hemodynamic
treatment, with or without pulmonary artery catheter for goal-directed therapy.
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supranormal CI, DO2I, VO2I(*)
supranormal CI, DO2I, VO2I(*)
CI > 2.8 L/min (#)
DO2I > 600 mL/min
not specified
*, CI > 4.5 L/min; DO2I > 600 mL/min, VO2I > 170 mL/min
#, combined with 8 ≤ PCWP ≤ 12 and SVRI ≤ 1100
Despite the weaknesses in the design and conductance of the first randomized controlled study
by Shoemaker6, when assessing the efficacy of perioperative hemodynamic treatment the focus
should be on early postoperative treatment of ‘high-risk’ surgical patients.78;79
Promising results of GOHT were primarily achieved in postoperatively critically ill patients in
whom treatment was instituted early, i.e. immediately after or even before the impact of major
surgery.51;58 Improved outcome attributed to perioperative GOHT of surgical patients was
described in three other studies.52;55;63 The main data of these five studies are summerized in
table 12.
The concept of GOHT shifted in time from ‘early postoperative treatment’ to GOHT as a
preventive strategy that should be started before surgery. The importance of early interventions
seems to be underlined by Scalea’s study of elderly patients with blunt trauma.54 In this
context, data presented by Bickell et al. may be confusing.80 These authors prospectively
studied 598 young trauma patients with penetring trauma of the torso in a randomized
controlled trial. Protocol patients who were treated by a delayed-resuscitation protocol had a
lower mortality (30% vs. 38%, p=0.04) and a significantly shorter mean hospital stay (11 vs.
14 days, p=0.006), while intraoperative management regarding fluid resuscitation was similar
for both groups.
The studies in which supranormal values were aimed at also vary significantly with respect to
the type and age of the patients included. The group of Shoemaker primarily focused on
patients who were in need of emergency surgery. A substantial part comprised trauma patients
and the mean age was about 50 (table 11 and 13)32;50;51, while eventually Boyd et al. included
mainly geriatric patients, undergoing elective surgery for vascular disease and malignancies.58
Not only progressed critical illness, but also normal decline in physiologic condition in the
elderly probably made the earlier defined endpoints of hemodynamic treatment, found in
significantly younger patients, more difficult to attain. Difficulties with achieving protocol
values were not reported by Shoemaker in 1988, however, the same group already in 1985
described that elderly patients only attained normal cardiorespiratory values.34 In Boyd’s study
the endpoint of treatment was not attained in all patients and appeared to be difficult to
maintain, particularly postoperatively. Original ‘normal values’ were defined in a group of 10
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The studies are summerized for authors, journal, year of publication, study characteristics,
type of intervention, targets of hemodynamic treatment, primary endpoint and results.
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§, in subgroup of patients undergoing aortic surgery
so-called ‘young, healthy subjects’, undergoing elective surgery.81 In 1987 Hankeln published
‘optimal values’ of a CI > 4.9 L/min and a DO2I > 870 mL/min in a mixed group of patients
and suggested to aim for the highest values in individual cases by trial and error and also to use
lactate resolvement as endpoint of adequate therapy.82 The risk of driving the heart to its upper
limits of performance to achieve ‘supranormal values’ eventually may result in overcharging
the cardiac capacity with consequent severe cardiac complications of tachy-arrythmias,
ischemia and failure.59
The presumption of a causal relationship of the severity of oxygen debt and postoperative
development of complications and mortality after major events was challenged by clinical trials
and discussions concerning the method and timing of DO2I, VO2I and lactate measurements in
mixed groups of patients. Immediately after ICU admission, lactate levels did not reflect an
oxygen debt in patients with sepsis or myocardial infarction.83;84 Follow-up in time in septic
patients, however, suggested the existence of a critical value of DO2I as reflected by a rise in
lactate.84 Silverman showed that in septic patients succesfully increased DO2I and VO2I values
were closely interrelated, but were not accompanied by the resolvement of increased lactate
levels.85 Although Hankeln found an oxygen supply dependency comparing two methods of
independently measured VO2I in patients with ARDS86, others could not confirm the existence
of oxygen supply dependency when methods of calculated (thermodilution) and measured
(indirect calorimetry) oxygen consumption were compared in
critically ill patients, including postoperative patients.87;88 Mathematical coupling of shared
variables was revealed as an important systematic error that accounted for the causal
relationship of increased values of DO2I and VO2I described in a majority of  studies.89;90
The capability to clear lactate appeared to be a strong predictor of outcome. In sepsis, a critical
level of DO2I seemed to exist (15 mL/kg/min); below this level lactate acidosis developed more
frequently.84 Hayes showed that in a mixed group of medical and surgical critically ill patients,
in whom supranormal values could not be achieved simultaneously within 24 hrs after
treatment was started, also lactate levels did not fall and mortality was extremely high (94%)
compared to responders of therapy (7%).91 In the trial of Boyd et al. the value of lactate
measurements is taken into account as therapy in the protocol group not only was directed at
DO2I > 600 mL/min, but also till lactate levels were normalized.
In the context of the abovementioned literature the question is where and when the concept of
perioperative GOHT of high-risk surgical patients should be applied. The concept is only
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supported by five clinical trials when surgical patients undergoing noncardiac surgery are
considered (table 12).51;52;55;58;63 The therapeutic approach was mainly tested in high-risk
patients. However, the margins of what should be described as high-risk are poorly defined and
contain a wide variety of surgical procedures. The original high-risk criteria, introduced by
Shoemaker, were never validated. They were initially used to describe ‘severity of illnesses’
and were more or less modified later to identify the patients that were presumed to benefit
from GOHT (table 9). Boyd et al. are the only investigators who used these criteria to identify
a patient population for their trial.
A major problem in the field of high-risk surgical patients are the mortality rates referred to by
different authors. Within subgroups of the series of patients described in 1985 by Bland et al.,
mortality extensively varies, i.e. 14% in traumapatients, 21% in patients undergoing resection
of malignancies, 29% in patients undergoing surgery for upper gastrointestinal bleeding and
43% in patients undergoing surgery for intra-abdominal abscess.33 Also time bias appears when
early series are compared to late series (table 12 and table 13). This is also illustrated by the
fact that the mortality rate found in the intervention group of series 1 (21%) of Shoemaker’s
study of 1988 is much higher compared to the mortality in the protocol group of series 2 (4%)
(table 11).
Table 13. Overview of development in time of series 1 in three publications during the
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The only study on the issue of GOHT containing a power analysis before the conduction of the
trial was performed by Boyd et al. They confined the numbers used for the power analysis to
nearby available, but unpublished data. The study was interrupted because of achieving
significant results, although without using a predefined interim analysis time point as used by
others.59 Withholding therapy in upcoming patients was deemed unethical, but the authors did
not address the issue that this decision weakened the power of their study.
Irrespective of GOHT mortality rates reduced in time, as was clearly demonstrated by Canivet
et al.92 In many surgical studies the exact mechanism of improved outcome from the sixties to
the seventies into the eighties is unknown, but has to be seen in the historic perspective of
developments in surgery, anesthesiology and intensive care medicine. The introduction of the
PAC in perioperative medicine made many believe that hemodynamic monitoring was of great
importance for improvements in outcome. However, the promising results in many of these
studies on vascular surgery have to be put in perspective; already in 1977, while PACs were
not yet common practice, Young published a series of 144 patients (1968-1976) in which a
reduction of mortality to 6.3% was achieved in 118 patients undergoing elective abdominal
aortic aneurysm resection compared to 15.6% in a historical control group and a mean of 29%
in the literature.93 The context mortality rates of 30-47% cited by Boyd et al., are remarkably
high and therefore questionable as a valuable reference. Half of the patients included in their
study had vascular surgery and only a minority consisted of emergency patients. In the
literature data on mortality vary extensively amongst studies, as shown in the enumeration of
studies on surgery of the abdominal aorta.41-44 In the context of its time the mortality in the
vascular surgery group in the study of Boyd et al. (17.6%) has to be indexed as relatively high.
Even the presented expected mortality is on the side of worse outcome in the spectrum of
other studies reporting mortality rates < 8%94 that were available at that time.
What are the actual, or ‘normal’ mortality rates that were to be beaten by perioperative
GOHT? Mortality rates < 10% were already described for major (high-risk) surgical
procedures like colon surgery92, oesophageal surgery95, pancreat(ic)oduodenectomies96;97,
pelvine exenterations98, and cystoprostatectomies with neobladder reconstruction.99 In most
studies in-hospital mortality is used as an endpoint for comparing therapeutic strategies, but
also 30-day mortality has been used63;98, making it difficult to compare the results of different
studies.
When mortality rates decline in time92;93, other study endpoints may help to evaluate results of
hemodynamic treatment, especially in the context of costs and use of resources. Alternative
endpoints are complication rate, length of ICU stay, duration of mechanical ventilation, length
of hospital stay and costs. Since type and extent of the complication registration varies widely,
this issue fails as an instrument to compare between studies.
In the context of the available literature recommendations are difficult to make. It remains
unclear which surgical patients may benefit most from GOHT, how and to what extent and
duration it should be applied perioperatively, what the possible risks are and at what endpoints
treatment should be aimed. If there is a group of patients that may benefit most, how do we
detect these patients? In this context data published already in 1980 by Guercio raise special
interest, as he used the PAC to ‘test’ the patients’ cardiorespiratory system for its reserve
capacity, besides clinical evaluation.5 Could the seven described deaths in this study have been
saved by any protocol? Although these data suggest that age may be an indication for invasive
monitoring, this argument is not supported by data published later. Schrader et al. described 46
nonagenarians retrospectively, 72% ASA ≥ 3. 100  These patients underwent 51 major general
and orthopedic surgical procedures, without preoperative ICU-admission and management,
mainly under general anesthesia. Only 33% underwent central monitoring, 15 patients having a
CVD-catheter and 2 a PAC; 14% had major complications. However, 30 day mortality was
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zero, suggesting that age is not a worthwile indicator to stratify patients for preoperative
invasive monitoring or hemodynamic treatment to improve survival.
The enormous variations in type of therapy, endpoints of hemodynamic treatment, type of
patients, and risks of detrimental side effects of protocols directed at increasing global
perfusion, make it difficult to complete a systematic review at the level of a meta-analysis of
available trials on perioperative hemodynamic treatment; it also is difficult to achieve valuable
conclusions and formulate indications for recommendations on patients that may benefit from
preoperatively started hemodynamic treatment.
Conclusion
Caution on the proposed strategy of perioperative hemodynamic treatment was put into words
by Shoemaker already in 1983:
“However, this strategy will not alleviate diagnostic errors, anatomic problems or
misadventures at the time of surgery, transfusion reactions, idiosyncratic drug
reactions, iatrogenic ineptitudes, or the patient’s will to live. Moreover, the
optimization of physiologic variables, even if expeditiously managed, does not
guarantee success if the patient’s reserve capacities are inadequate or if the stress of
surgical trauma overwhelms the patient’s physiologic compensatory responses.”32;50
Since 20 years of research in clinical trials on high risk surgical patients have passed,
methodological problems evidently still obscure definite conclusions on the additional value of
perioperative GOHT and its effect on outcome expressed as a reduction of morbidity and
mortality. Few data are available that support the rationale for specific preoperative treatment.
Results were mainly achieved in patients undergoing major surgery. When intraoperative
metabolic changes reflect the development of oxygen debt, which has to be compensated for
after the surgical procedure, it seems logical to do this as soon as possible or, even better to
prevent this. An adequate timing of therapy seems crucial, i.e. starting preoperatively is of utter
importance.
It is common practice in our hospital that high-risk patients are preoperatively prepared at the
ward. In the context of the available literature, we designed an open, randomized controlled
clinical study, stratified for the type of surgery. We compared GOHT preoperatively started at
the ICU to the common practice and studied effects on the primary endpoint complication rate
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As has been outlined in Chapter 1, Shoemaker and co-workers postoperatively identified a
series of specific changes of hemodynamic variables that clearly discriminated survivors from
nonsurvivors in the early postoperative period 1-8.
It was unclear whether these differences were a symptom of reduced cardiorespiratory reserve
capacity to face perioperative stress, or an perioperatively unnoticed deficiency of the
circulation that should have been corrected. Therefore, two studies were conducted to test the
hypothesis that supranormal values of cardiac index (CI), oxygen delivery (DO2I) and oxygen
consumption (VO2I) could improve outcome in so-called ‘high-risk’ patients.9;10  Shoemaker
et al. demonstrated a reduction in postoperative mortality, mean ICU-stay, ventilator use and
costs in high-risk surgical patients who were treated on the basis of invasively determined
hemodynamic variables, obtained from the perioperatively inserted PA-catheter. This study,
however, has been criticized because of a poor control for confounding factors and uncertain
case mix.11;12 Boyd et al. showed that aiming at a DO2I > 600 mL/min significantly reduced
mortality and morbidity. In this study all patients were preoperatively admitted to the ICU.
However, other studies in which patients were perioperatively treated to hemodynamic values
as defined by Shoemaker (i.e. CI > 4.5 L/min; DO2I > 600 mL/min; VO2I > 170 mL/min) did
not show beneficial effects. On the contrary, even an indication of increased mortality was
found.13
Both key studies9;10 on perioperative goal-oriented hemodynamic therapy have to be
criticized for methodological problems (Chapter 1, section ‘Discussion’), but a study
comparing preoperative preparation at the ward to preoperative ICU-admission and
hemodynamic treatment was not available in 1996. Therefore we designed a prospective open
controlled randomized single-center study comparing high-risk surgical patients treated at the
ICU (tune-up group) versus patients treated in a conservative way at the ward (control group).
In this study the complication rate was used as primary outcome variable, and mortality,
length of stay (LOS) in the ICU and the hospital, and costs as secondary end points. In
contrast to all other studies (Chapter 1, table 12), the anesthestic technique was standardized.
The primary intervention was directed at increasing the preload; when needed, also the
vasoactive drugs dopamine and dobutamine were used to reach predefined values.
Methods
The study protocol was approved by the institutional medical ethics committee and informed
consent was obtained from all patients. The inclusion criteria (table 1) were chosen according
to those available in the literature.9;10;14;14-17 Exclusion criteria were non-elective surgery or
any condition that would require additional evaluation or therapy before surgery.
The goal of preoperative tune-up was to reach a cardiac index ≥ 4.0 L/min. The primary
endpoint was the rate of complications. Secondary endpoints were ICU and hospital LOS,
mortality and costs.
Eligible patients were examined by an internist(-intensivist) to optimize medical treatment
regarding metabolic, cardiac and pulmonary comorbidities. Hereafter, the patients were
randomized using blinded envelopes after stratification for type of surgery: major vascular
surgery, extensive surgery for carcinoma, surgery for septic focus or extensive surgery for
non-carcinoma. Randomization took place in blocks of 8 patients – 4 control and 4 protocol
patients – separately in each stratum. Patients allocated to the tune-up group were admitted to
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the ICU the day before surgery. After achieving peripheral venous access and a canula in the
patient's radial artery, a pulmonary artery catheter (PAC) (Baxter Thermodilution Catheter,
Edwards Laboratories, Irvine, California) was inserted via the internal jugular or subclavian
vein. Correct placement was determined by pressure traces and X-ray. A urinary catheter was
inserted. Cardiac output was measured by triple determination  of thermodilution. The first
complete hemodynamic profile was recorded 1 hour after insertion of the PAC and labelled as
"ICU-admission". Subsequently, goal-oriented therapy was started. All patients received a
"background" infusion of 3000 mL/24 hr dextrose 2.5%/saline 0.45%. The first step was to
optimize cardiac preload by repeated fluid challenges of colloids (Haes-steril 6% or
Gelofusine, 500-1000 mL/hr) to evaluate their hemodynamic effects. Whenever cardiac
output failed to rise further despite increase of filling pressures (PCWP 12-15 mmHg),
dopamine or dobutamine was added (max. 10 µg/kg/min) under the following conditions:
heart rate (HR) should not exceed 120 beats/minute and a diuresis > 1 mL/kg/hr was deemed
appropriate. Once started, vasoactive drugs were continued during anesthetic and surgical
procedures.
Table 1. Inclusion criteria for the Groningen University tune-up study (GUTS).
1. patients aged > 18 years.
2. expected duration of surgery > 90 minutes
3. estimated high-risk as defined by any of the following criteria:
- Cardiac Risk Index  > 12
- previous severe cardiac illness (i.e. acute myocardial infarction, heart failure, stroke)
- age > 70 years with limited physiological reserve in one or more vital organs (NYHA
classification II, III or IV)
- sepsis30
- acute renal failure defined as an abrupt decrease of clearance of nitrogenous waste by
the kidneys resulting from a variety of processes. This should be accompanied by an
acute increase in serum creatinine > 30% within 24 hours.
- extensive surgery planned for carcinoma (i.e. esophagectomy, gastrectomy, cystectomy),
or late-stage vascular disease involving aortic disease
4. informed consent
The control group received no specific treatment before surgery. However, patients in the
control group, who were planned for gastrointestinal and major urologic surgery, received an
infusion of 2500 mL/24 hr with dextrose 2.5%/saline 0.45% in the late afternoon at day -1 to
compensate for fluid loss by bowel preparation. Diabetic patients received a background
infusion of 2000 – 2500 mL dextrose 5 %/ 24 hr at day -1.  After a fast from midnight, the
patient was transferred to the operating room.
Anesthesia was standardized and identical for both groups. Before induction of anesthesia the
control group received a venous and arterial canula for BP measurement. For per- and
postoperative analgesia in both groups a thoracic epidural catheter was inserted
preoperatively and tested with 3 mL solution of epinephrine 1:200,000/lidocaine 2%.
Epidural anesthesia was omitted in case of the impossibility to introduce the catheter or when
a neurological disease was present (i.e. multiple sclerosis). Anesthesia was induced i.v. with
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sufentanil (0.2 µg/kg),  etomidate (0.3 mg/kg) and rocuronium (0.6 mg/kg) and maintained
with isoflurane (<1% ET concentration) in oxygen-enriched air. After induction a PAC was
also introduced in the controls for per- and postoperative measurements.
A bolus of 50 µg sufentanil in 10 mL saline 0.9 % was administered in the epidural space,
prior to the start of surgery. Continuous epidural administration of a solution of 50 µg
sufentanil in 50 mL bupivacaine 0.125% was started at a rate of 6-10 mL/hr one hour after
start of surgery. Muscle relaxation was monitored (TOF-Guard, Organon Teknika
Turnhout; TOF count < 2/4) and maintained with intermittent intravenous administration of
rocuronium (0.15-0.3 mg/kg). Additional sufentanil was administered intravenously
according to need. To prevent heat loss intraoperative precautions were taken  using an
esophageal heat exchanger or active warming blankets.
All patients were treated according to the tune-up protocol and adherence to the protocol was
closely verified by the principal investigators. During surgery all patients received dopamine
in a dose of 3 µg/kg/min according to departmental policy at the time of design and execution
of the protocol. Postoperative treatment at the ICU was left to the discretion of the
responsible intensivist. Patients were daily visited by one of the principal investigators to
check protocol adherence and to collect data on the prevalence of 18 potential complications
till 28 days after the surgical procedure.
Patients were discharged from the ICU to the ward when the hemodynamic and respiratory
conditions were judged to be stable by the responsible intensivist, according to the following
4 criteria: 1. the patient did no longer need vasoactive drugs, 2. the patient had an arterial
oxygen saturation of > 90 %, 3. and a breathing frequency of < 30/minute and 4. coughing
force was sufficient to clear secretions. Patients were deemed fit for discharge from ward to
home when they were independent for activities of daily life (ADL) and had a low risk profile
for hospital readmission.
The cost-benefit part of this study is presented seperately in Chapter 4 of this thesis.
Statistical analysis
The study was supposed to include 130 patients in each of the two treatment groups. This
number of patients is required to detect a 33% reduction in the rate of complications, i.e. from
60% in the control group to 40% in the tune-up group with p < 0.05 and a power of 90%.
Data are summarized as mean (SD) or median (IQR25-75%) unless indicated otherwise. The
two groups were compared with respect to the outcome variables by t-test, Mann-Whitney U
test or chi-squared test according to the character of the data. In addition a multivariate
regression analysis was performed to investigate the effects of possible contributions of
potential confounding variables and to correct for pre- and peroperative confounding
variables. A logistic regression was applied to a dichotomized total number of complications,
a Cox-model analysis to ICU LOS and a linear regression analysis to the logarithmically





The logistic preparation and execution of the Groningen University tune-up study started at
July 1996 and patients could be included until september 1998. The first year was designed as
a pilot study to test the logistics and facilities of all participating departments.
Results of the identification of potentially eligible patients (n=294) are summarized in table 2.
Table 2. Number of identified high-risk patients according to administrative data of the






identified as potentially eligible 94 200 294









main reasons for not-participation
-
 logistic problems (%)
-







non-eligible patients (%) 8 (8.5) 14 (7.0) 22 (7.5)
noneligible because of
-
 psychiatric disorder (%)
-
 absolute exclusion criteria (%)
-










It should be realized that these administrative data are incomplete and that they also contain
data of explicitely not eligible patients. Potentially eligible patients were announced by their
treating surgeons or identified during the daily preoperative conference of the department of
surgery. The main reasons why patients could not be randomized were logistical (n=76,
25.9%) and comprise: absence of the investigators, preoperative non-availability of an ICU-
bed and identification of an eligible patient later than 17:00 hr. Other patients had personal
reasons to refuse participation, such as earlier bad experiences in ICU or the perspective to be
admitted to the ICU the day before surgery, to be bedridden, having central lines placed while
awake and staying the night over in a noisy setting amongst critically ill patients.
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The study was planned to continue for three years until July 1999, but had to be terminated
prematurely due to a shortage of ICU-facilities. Only 141 patients were randomized. Fourteen
patients had to be excluded from analysis for various reasons (table 3). The main reason for
exclusion during the trial was the unexpected finding of metastatic disease making the
surgeon decide to alter the surgical procedure, which resulted in a reduction of the length of
surgery to less than 90 minutes.
Table 3. Patients of the Groningen University tune-up study (n=14) excluded from analysis.








percutaneous endoprosthesis of aortic aneurysm
claustrophoby
apparant cardiac ischemia before surgery
change of surgical procedure (high-risk > low-risk)
sepsis from PTCD during tune-up













post-operative phase G – N inoperability (surgery < 90 minutes) 6 2
cumulative 8 6
Sixty-two patients were allocated in the control group and 65 in the tune-up group. Patient
characteristics and type of surgery are depicted in tables 4a and 4b, respectively.
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Table 4a. Groningen University tune-up study, patient characteristics.
control tune-up p-value
number of patients
male / female (%)
age, years
   mean (SD)
ASA Class
    I / II / III (%)
NYHA Class physical tolerance
    I / II / III (%)
cardiovascular risk evaluation:
   Goldman16 CRI, median (IQR)
   Lee(*)31, median (IQR)
number of patients:
   Goldman16 CRI > 12
   current smoking
   CABG in medical history
   CVA
medical condition:
   diabetes
high-risk factors, number of patients:
    previous myocardial infarction
    extensive surgery
    age > 70 & NYHA > II
    aortic disease
    sepsis
cumulative high-risk factors
    1 / 2 / 3 or more (%)
    mean (SD)
    median (IQR, P25-75%)
62
42 / 20 (68 / 32)
66 (11)
1 / 39 / 22 (2 / 63 / 35)
34 / 22 / 6 (55 / 35 / 10)
 6 (3-9)















42 / 23 (65 / 35)
64 (12)
2 / 42/ 21 (3 / 65 / 32)
41 / 22 / 2 (63 / 34 / 3)
3 (3-8)

































(*) Data to perform the Lee Cardiac Risk Index scoring were available in the tune-up data
ase, except for the issue of medical history for CVA/TIA; these data were retrospectively
retrieved beyond 1999, i.e. after publication of the study of risk factors for postoperative
cardiac morbidity and mortality in noncardiac surgical patients by Lee et al.31
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Table 4b. Groningen University tune-up study. Type of surgical procedures performed in the
control and the tune-up group; the procedures are distributed in 4 groups according to the 4




   abdominal aortic aneurysm
   obstructive aorto-iliacal disease
   ilio-femoral bypass
   renal artery reconstruction
B. extensive surgery for carcinoma:
   Esophagus resection
   gastrectomy
   small bowel surgery
   colon surgery
   rectum surgery
   cystectomy
   (modified) Whipple
   hepatobiliary surgery
   miscellaneous (**)
C. septic focus:
   hepatobiliary surgery
D. major surgery for reasons other than malignancy:
   (modified) Whipple
   hepatobiliary surgery













































(**) Nephrectomy, mastectomy, pelvine exenteration.
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With respect to patient characteristics, pre-operative medication and type of surgery, no
significant differences were found between both groups, with the exception that the control
group contained more patients with diabetes mellitus.
In 60 out of 65 tune-up patients (92%) a CI of > 4.0 L/min could be obtained. The mean
preoperative infusion of crystalloids and colloids amounted to 2.50 (0.62) and 1.20 (0.66) L,
respectively. To reach the protocol target in 24 patients (37%) dopamine had to be added, in a
mean dose of 3.6 µg/kg/min, and in 3 patients (5 %)  dobutamine had to be added, in a mean
dose of 3.0 µg/kg/min. No patient was treated with a combination of dopamine and
dobutamine. One patient received a unit of packed red cells during tune-up because of a
dilution drop in Hb below 4.5 mmol/L and in 3 patients nitroglycerin had to be given to
reduce preload. The mean CI before tune-up increased from 3.1 (0.6) to 4.4 (0.4) L/min after
tune-up (p<0.05). The mean HR increased from 68 (11) to 78 (11) beats/minute (p<0.05).
An epidural catheter could successfully be placed in 55 patients (89%) in the control group
and in 58 patients (89%) in the tune-up group. Cardiac index just before surgery was 2.9 (0.9)
and 3.6 (0.9) L/min in the control and tune-up group, respectively (p<0.05). The mean
duration of surgery was 339 (152) and 308 (138) minutes for the controls and the tune-up
group, respectively (p=ns); the mean duration of anesthesia was longer for patients of the
control group [398 (156) vs. 345 (140) minutes, p<0.05]. Median blood loss was 1.85 L (0.80,
3.93) in the controls versus 1.50 L (0.5, 2.75) in the tune-up group (p=0.08). The median total
infusion was higher in the control group [9.90 (7.30, 17.0) L vs. 8.50 (6.00, 11.05) L in the
tune-up group, p<0.05], but when corrected for the duration of anesthesia or surgery no
differences were found (data not shown). POSSUM-scores18 (Physiological and Operative
Severity Score for the enUmeration of Mortality and morbidity) were 17.5 (4.5) for the
controls and 18.3 (5.1) for the tune-up patients. Postoperative APACHE II (Acute Physiology
And Chronic Health Evaluation II) scores were 17 (4) (controls) and 17 (5) (tune-up) (p=ns).
The mortality rate was 1.6 % (n=2) and 2.4 % (n=3) for all patients at 28 and 56 days,
respectively. Details on mortality, complications and complication rate, LOS in the ICU and
in the hospital are depicted in table 5.
&KDSWHU





   mechanical ventilation > 48 hrs
   pneumonia
   sepsis/SIRS
   pulmonary oedema
   pleural effusion (post hoc)
   wound infection
   acute myocardial infarction
   abdominal abscess
   CVA
   Gastric retention > 48 hrs
   pulmonary emboli
   distal ischemia after vascular surgery
   deterioration of renal function
   renal insufficiency
   myocardial ischemia
number of complications
    mean (SD)
    median (IQR, P25-75%)
post-operative ICU-admission:
   number of patients (%)
post-operative ICU LOS, days:
   median (IQR, P25-75%)
post-operative hospital LOS, days



















2 (1 – 3)
53 (85.5)
2 (1 – 3.5)



















1 (0 – 2)
58 (89)
2 (1 – 3)

























Only the median number of complications was significantly lower in the tune-up group
(Table 5, p<0.05). This effect diminished (p=0.07) after adjustment for peroperative blood
loss. Peroperative blood loss was also found to be related to ICU LOS and hospital LOS
(table 6).
Table 6. Groningen University tune-up study, results of regression analyses. Number of
patients: 127.
ICU LOS (first admission): Cox regression analysis
Variable relative risk 95% CI p-value
tune-up
age (yr)
lower abdominal surgery (#)













(logarithm of) hospital LOS: linear regression
regression coefficient 95% CI p-value
Intercept 0.336
Tune-up
Lee risk factors, cumulative
Age (yr)
NYHA-class  (I vs >I)
ASA-class



















complication rate (0 or 1 versus >1): logistic regression
odds ratio 95% CI p-value
Tune-up 0.51 0.25 – 1.12 0.073
ln2 (peroperative blood loss in mL) 1.41 1.09 – 2.82 0.015
#, lower abdominal, nonvascular surgery vs. other
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The regression analysis showed that pre-operative tune-up did not influence any of the
predetermined end points. Non-vascular, non-hepatobiliary surgery was associated with a
longer stay in the ICU; increased scores for NYHA- and ASA-class were associated with an
increased hospital LOS (table 6). The hospital LOS for both groups is presented in a Kaplan-
Meier curve (figure 1).
Hospital LOS after surgery





























Figure 1. A Kaplan-Meier curve of hospital length of stay (LOS) is shown for 60
postoperative days. No statistically significant difference was found for the secondary end
point hospital LOS (log rank analysis; p = 0.5045).
Discussion
The study was supposed to include 130 patients in each of the two treatment groups. This
number of patients was required to detect a 33% reduction of complications (from 60% in the
control group to 40% in the tune-up group) with a type I error rate of 5% and a power of 90%.
When analyzing the data the following problems had to be faced.
First, as the study was terminated prematurely, the power of 90% could not be achieved. This
raised the question whether the statistical tests should be performed at the predetermined level
of 5% and low power should  be ignored, or whether a higher type I error rate should be
accepted, i.e. 10%, to guarantee that the power does not become too low. This issue that had
for obvious reasons not been considered at the design phase of the trial, became difficult to
answer once the results were known.
The second problem concerned the definition of complications. The power analysis was
carried out in terms of a binary outcome variable: presence or absence of complications.
While being sufficient for the purpose of sample size determination, this specification did not
unequivocally specify which statistical analysis should be used for comparison of the two
groups.
Which complications should be looked at was also subject to debate. In this study the
occurrence of 18 different complications was recorded. Initially the list also included the
complication ‘psychosis’, but it was decided to drop this variable from the list since it was
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insufficiently specified. Unfortunately this exclusion took place during and not prior to
analysis. Since ‘psychosis’ had been recorded 4 times in the control group and 8 times in the
protocol group, the decision which complications should be counted and which not would
obviously influence the outcome.
It can also be argued that the dichotomy ‘presence/absence of any complication’ does not use
all available information in an efficient way. It is perhaps more sensible to look at a different
dichotomy, for example ‘one or no complication’ versus ‘two or more’ (table 7; p = 0.033), or
to use the total number of complications.
Table 7. Groningen Universtity tune-up study. Results of the analysis for different levels for



















0 vs. > 0
1 vs. > 1
















- 27 – - 4
- 3 – 37
- 5 – 25
Another possibility would be to construct a weighted complication score in order to take into
account the fact that some complications are more serious than others. Also description of
single complications in stages of severity related to the clinical impact or costs would be an
option. While it is feasible to perform computations for a large number of definitions, the
choice how to integrate, select and interpret possibly conflicting results from such analyses is
not easy. This will certainly introduce bias if it takes place in the course of the analysis and
not prior to it. Moreover, recording of complications is further complicated by the fact that for
each individual patient a single complication may vary extensively in severity and clinical
consequences. For example, a myocardial infarction may only be detected as a complication
by positive indicators found by blood sampling and ECGs at fixed time points according to
the study design. When such a patient would not have been included in the study, this
complication would probably not have been detected. At the other side of the spectrum the
same complication also could have been occurred as a clinical major event instead of a minor
complication. This would have resulted in acute heart failure, necessity of (re)admission to
the ICU and a prolonged stay at the ICU for multi-organ failure or even death. Ideally,
complications should be weighted for the impact on hospital LOS and costs. Therefore, in this
type of studies ICU LOS, hospital LOS and costs seem to be better primary end points –
besides mortality –  than complication rate.
A third problem was whether or not to correct for possible confounding variables in the
analysis. In a simple randomized study with two groups it is legitimate to compare the groups
without any correction. If a stratified randomization took place, it is preferable to perform an
analysis which takes this type of randomization into account. But it makes also sense to
perform additional analyses (for example fitting logistic regression models) with the intention
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to correct possible effects of confounding variables not controlled by the design. This may be
illustrated by the fact that this study included stratification in four main groups to reduce
problems of case mix. The largest group comprises patients having major surgery for
malignancies. After randomization it appeared that patients were not well balanced for the
control and protocol group. When such a study contains an extensive database with variables
that are well known factors to influence outcome, these data should be used to reveal major
confounding variables to prevent simple, but incorrect conclusions.
To summarize, statistical analysis of the present study involves a number of choices. In order
to avoid bias in our conclusions we need to explore the stability of results under different
approaches.
Although the data suggest that complications in the protocol group are reduced, firm
conclusions cannot be made. The strength of the conclusions regarding reduction of
complications is further complicated by practical problems of data management. This is
illustrated by the fact that during the first 3 days at the ICU some complications (for instance
‘pleural fluid’) were collected in a separate file of the data base. This information had to be
conveyed manually to the main study data file. During ongoing data analysis it was found that
omissions in this procedure had brought about that post hoc a higher frequency of the
complication ‘pleural fluid’ was found in both groups (control 33, vs. tune-up 34, p=0.86).
This eventually eliminates the earlier found significant difference for the median
complication rate. Some other complications that may have occurred were also not collected,
since the file did not provide a data entry for other complications than the predefined 18
complications.
Since the aim of the study was to improve clinical outcome and to reduce costs, mainly by a
reduction of hospital LOS, the complication rate may be considered as a surrogate end point.
Since in our hospital mortality rates of high-risk elective surgical patients already were < 5%,
significant differences were not expected. Therefore, this clinical end point was not the right
instrument to evaluate the efficacy of preoperative GOHT.
Originally the trial was designed as a cost-benefit study, specifically aiming at a reduction of
complications to reduce (the costs of) ICU LOS and hospital LOS. Considering the
aforementioned limitations of the complication rate as primary end point in our study, ICU
LOS and/or hospital LOS may be more adequate primary end points. The quantity and
severity of complications are then linked immediately to one or two clinically relevant
outcome variables. This hypothesis is based on the presumption that postoperative costs are
mainly determined by hospital LOS. Considering our data from this point of view it is clear
that the clinical relevance of this finding cannot be demonstrated, even if the complication
rate was reduced by GOHT at the ICU.
We think that our results are meaningful, as they provide valuable information with respect to
the meaning of preoperative hemodynamic treatment, in particular with consequences for the
management of care in high-risk surgical patients. Although the study was designed as a
prospective, randomized controlled clinical trial, differences exist between both groups. Risk
factors tended to occur more frequentely in the control group. To correct for a possible
confounding effect of these differences, we performed a logistic multivariate regression
analysis. The results of this analysis show that the trend towards improved outcome, i.e. less
complications and faster recovery to discharge from the hospital in the protocol group,
appears to be related to other perioperative conditions rather than to preoperative tune-up.
Standard perioperative care in our hospital to so called ‘high-risk’ patients is associated with
a low adverse event rate. Comparison with the results of two similar key studies9;10 is
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hampered, since we used a different data set of complications. In our study the mortality rate
in both groups is equal or lower than mortality rates in previous studies. Shoemaker et al. and
Boyd et al. found an in hospital mortality rate in the protocol group of  4% and 5.7%,
respectively.9;10 But the authors report a significantly higher mortality rate in the controls of
22 to 33%, respectively. One reason for the low mortality rate in the control group of the
present study might be a difference of treatment. Many of our control patients planned for
gastrointestinal and urologic surgery and diabetic patients may have had a favorable outcome
as result of the ‘background infusion’ that is started at the preoperative day in these patients.
In addition anesthesiologic practice at our institute consists of volume loading with at least
750 mL to 1500 mL saline and colloids during induction of anesthesia. It must be emphasized
that all patients were scrutinized for optimal medical treatment before entry in the study.
Although the study was designed as a randomized controlled trial, the frequency of diabetic
patients was lower in the protocol group. To our surprise, the results of the regression analysis
showed that diabetes was correlated with improved outcome (data not shown).
There may be another cause for the differences between our control patients and those in
studies of Shoemaker and Boyd.9;10 Although the inclusion criteria in our study were similar
to those of Shoemaker and Boyd, the application of the criteria to include patients may have
differed as we did not include emergency patients, the consequence being that the studies by
Shoemaker and Boyd contained sicker patients. This may explain the higher mortality rate in
their controls. The younger age of the patients in Shoemaker’s study may have been
advantagous but may have been counteracted by the fact that a substantial part comprised
critically ill and trauma patients needing emergency surgery. The patients in Boyd’s study
were older and also in this population an unknown number of patients underwent emergency
surgical procedures, although the emphasis was on elective surgery. From the literature
concerning ruptured aortic aneurysms the mortality rates for emergency procedures differ
significantly from elective surgery and mortality rates up to 50% are reported for
emergencies.13 Nevertheless, as outlined in Chapter 1, patients in the control group of Boyd’s
study undergoing elective surgery, had a mortality rate of 23,7%.10
The mean number of ‘high-risk’ factors per patient, as defined by Shoemaker et al. and
reported in their study (series 2), was 1.80, 1.21 and 1.23 in the CVP-control,  PAC-control
and PAC-protocol group, respectively, while in Boyd’s study it was 2.07 for the control group
and 2.13 for the protocol group. Considering these numbers, it seems that our patients’ risks
are located in between. But it is unclear which combination of high-risk factors defined the
mean numbers. Also the impact of any of these high-risk factors on clinical outcome is not
known. We conclude that, although we used similar inclusion criteria as others, we may not
have included patients at similar risk of morbidity and mortality. We further hypothesize that
we may have randomized only a selection of eligible patients. We analyzed such potential
selection bias in an additional descriptive study on the entire cohort of elegible patients. The
results are presented in Chapter 3.
An alternative explanation of our results may be that developments in anesthesiologic and
surgical practice and in intensive care management improved outcome in such a way that
further improvements by preoperative GOHT could hardly have any effect of major
importance (time bias). In Chapter 1 we also adressed this issue i.e., remarkably improved
results were presented in  Shoemakers’ landmark study9 (Chapter 1, table 10 and
‘Discussion’): in the protocol group of series 2 mortality was significantly lower (May 1983 –




Our study has a size similar to related studies (as discussed in Chapter 1 and this chapter). In
conclusion, we did not observe benefits from preoperative GOHT at the ICU, while overall
mortality of the entire study population was in the range of the interventional groups of two
other key studies.9;10
Additional retrospective and prospective studies regarding (perioperative) GOHT were
published during and after the Groningen University tune-up study.19-29 These studies are
discussed in Chapter 5 in an overview of the literature on perioperative GOHT in high-risk




1. Shoemaker WC, Pierchala C, Chang P, State D: Prediction of outcome and severity of illness by
analysis of the frequency distributions of cardiorespiratory variables. Crit. Care Med. 1977; 5: 82-8
2. Bland R, Shoemaker WC, Shabot MM: Physiologic monitoring goals for the critically ill patient.
Surg.Gynecol.Obstet. 1978; 147: 833-41
3. Shoemaker WC, Chang P, Bland R, Czer L, Shabot MM, Clifton JF: Cardiorespiratory monitoring in
postoperative patients: II. Quantitative therapeutic indices as guides to therapy. Crit. Care Med. 1979;
7: 243-9
4. Shoemaker WC, Chang P, Czer L, Bland R, Shabot MM, State D: Cardiorespiratory monitoring in
postoperative patients: I. Prediction of outcome and severity of illness. Crit. Care Med. 1979; 7: 237-42
5. Shoemaker WC, Appel PL, Waxman K, Schwartz S, Chang P: Clinical trial of survivors'
cardiorespiratory patterns as therapeutic goals in critically ill postoperative patients. Crit. Care Med.
1982; 10: 398-403
6. Shoemaker WC, Appel P, Bland R: Use of physiologic monitoring to predict outcome and to assist in
clinical decisions in critically ill postoperative patients. Am.J.Surg. 1983; 146: 43-50
7. Bland RD, Shoemaker WC: Common physiologic patterns in general surgical patients: hemodynamic
and oxygen transport changes during and after operation in patients with and without associated
medical problems. Surg.Clin.North Am. 1985; 65: 793-809
8. Shoemaker WC, Appel PL, Kram HB: Hemodynamic and oxygen transport responses in survivors and
nonsurvivors of high-risk surgery. Crit. Care Med. 1993; 21: 977-90
9. Shoemaker WC, Appel PL, Kram HB, Waxman K, Lee TS: Prospective trial of supranormal values of
survivors as therapeutic goals in high-risk surgical patients. Chest 1988; 94: 1176-86
10. Boyd O, Grounds RM, Bennett ED: A randomized clinical trial of the effect of deliberate perioperative
increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 1993; 270: 2699-707
11. Practice guidelines for pulmonary artery catheterization. A report by the American Society of
Anesthesiologists Task Force on Pulmonary Artery Catheterization. Anesthesiology 1993; 78: 380-94
12. Shoemaker WC, Lee TS: Lack of proof is not proof of a lack: it is the singer, not the song. Crit. Care
Med. 1993; 21: 1096-8
13. Gloviczki P, Pairolero PC, Mucha P, Jr., Farnell MB, Hallett JW, Jr., Ilstrup DM, Toomey BJ, Weaver
AL, Bower TC, Bourchier RG: Ruptured abdominal aortic aneurysms: repair should not be denied.
J.Vasc.Surg. 1992; 15: 851-7
14. Berlauk JF, Abrams JH, Gilmour IJ, O'Connor SR, Knighton DR, Cerra FB: Preoperative optimization
of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective,
randomized clinical trial. Ann.Surg. 1991; 214: 289-97
15. Goldman L, Caldera DL: Risks of general anesthesia and elective operation in the hypertensive patient.
Anesthesiology 1979; 50: 285-92
16. Goldman L, Caldera DL, Nussbaum SR, Southwick FS, Krogstad D, Murray B, Burke DS, O'Malley
TA, Goroll AH, Caplan CH, Nolan J, Carabello B, Slater EE: Multifactorial index of cardiac risk in
noncardiac surgical procedures. N.Engl.J.Med. 1977; 297: 845-50
&KDSWHU

17. Detsky AS, Abrams HB, Forbath N, Scott JG, Hilliard JR: Cardiac assessment for patients undergoing
noncardiac surgery. A multifactorial clinical risk index. Arch.Intern.Med. 1986; 146: 2131-4
18. Copeland GP, Jones D, Walters M: POSSUM: a scoring system for surgical audit. Br.J.Surg. 1991; 78:
355-60
19. Durham RM, Neunaber K, Mazuski JE, Shapiro MJ, Baue AE: The use of oxygen consumption and
delivery as endpoints for resuscitation in critically ill patients. J.Trauma 1996; 41: 32-9
20. Hayes MA, Timmins AC, Yau EH, Palazzo M, Watson D, Hinds CJ: Oxygen transport patterns in
patients with sepsis syndrome or septic shock: influence of treatment and relationship to outcome. Crit.
Care Med. 1997; 25: 926-36
21. Sinclair S, James S, Singer M: Intraoperative intravascular volume optimisation and length of hospital
stay after repair of proximal femoral fracture: randomised controlled trial. BMJ 1997; 315: 909-12
22. Ziegler DW, Wright JG, Choban PS, Flancbaum L: A prospective randomized trial of preoperative
"optimization" of cardiac function in patients undergoing elective peripheral vascular surgery. Surgery
1997; 122: 584-92
23. Bender JS, Smith-Meek MA, Jones CE: Routine pulmonary artery catheterization does not reduce
morbidity and mortality of elective vascular surgery: results of a prospective, randomized trial.
Ann.Surg. 1997; 226: 229-36
24. Chang MC, Meredith JW: Cardiac preload, splanchnic perfusion, and their relationship during
resuscitation in trauma patients. J.Trauma 1997; 42: 577-82
25. Flancbaum L, Ziegler DW, Choban PS: Preoperative intensive care unit admission and hemodynamic
monitoring in patients scheduled for major elective noncardiac surgery: a retrospective review of 95
patients. J.Cardiothorac.Vasc.Anesth. 1998; 12: 3-9
26. Valentine RJ, Duke ML, Inman MH, Grayburn PA, Hagino RT, Kakish HB, Clagett GP: Effectiveness
of pulmonary artery catheters in aortic surgery: a randomized trial. J.Vasc.Surg. 1998; 27: 203-11
27. Yu M, Burchell S, Hasaniya NW, Takanishi DM, Myers SA, Takiguchi SA: Relationship of mortality
to increasing oxygen delivery in patients > or = 50 years of age: a prospective, randomized trial. Crit.
Care Med. 1998; 26: 1011-9
28. Curran JE, Grounds RM: Ward versus intensive care management of high-risk surgical patients.
Br.J.Surg. 1998; 85: 956-61
29. Pargger H, Hampl KF, Christen P, Staender S, Scheidegger D: Gastric intramucosal pH-guided therapy
in patients after elective repair of infrarenal abdominal aneurysms: is it beneficial? Intensive Care Med.
1998; 24: 769-76
30. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ:
Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The
ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of
Critical Care Medicine. Chest 1992; 101: 1644-55
31. Lee TH, Marcantonio ER, Mangione CM, Thomas EJ, Polanczyk CA, Cook EF, Sugarbaker DJ,
Donaldson MC, Poss R, Ho KK, Ludwig LE, Pedan A, Goldman L: Derivation and prospective

















Studies aiming at a reduction of postoperative morbidity and mortality by perioperative goal-
oriented hemodynamic treatment (GOHT, tune-up) remained controversial till 1998. In
Chapter 1 we discussed all relevant literature till 1996 on GOHT in high-risk patients,
irrespective of targets of GOHT to be attained and maintained. Emphasis was laid on GOHT
as a preventive strategy and it was believed to be efficacious in reducing postoperative
morbidity and mortality in high-risk patients. In Chapter 2 we described the results of the
Groningen University Tune-up Study (GUTS, 1996-1998). The study was preliminarily
terminated and consequently the power of this study was too low to allow firm conclusions
regarding the complication rate (primary end point). Improving clinical outcome by GOHT
was tested in prospective studies by others.1-5 Some found remarkable reductions in
mortality2,4, but others could not reproduce these results in similar populations.6-8 In the
GUTS mortality (secondary end point) in the control and protocol groups was in the range of
the protocol groups of earlier studies.2,4,9 GOHT in the GUTS neither reduced ICU LOS
(length of stay) nor hospital LOS. Therefore we decided to look at issues that possibly could
explain why our findings differed from those of other studies.
We discussed the limitations of our study in Chapter 2 and hypothesized that patient selection
could have biased outcome. Although a large number of patients were eligible for the GUTS,
the principal investigators may have targeted on a specific category of patients, avoiding
inclusion of patients that were more compromised by comorbidity (for example pulmonary
disease). On the other side, control patients of the GUTS may have benefitted from the
preoperative screening and optimized medical treatment, which meant management in
perioperative medicine except for GOHT. The investigators were not directly involved in
postoperative care. However, when the investigators identified postoperative complications
earlier than the responsible doctors, they communicated their findings and made suggestions
for treatment. Such interventions may have favored overall outcome in both groups of the
GUTS. We hypothesized that analysis of the entire group of eligible high-risk patients might
reveal selection bias and/or differences in perioperative treatment, in favor of secondary end
points in the GUTS-group. We decided to review the cohort of eligible patients that could
have been included in the GUTS, but were not enrolled in the study. This cohort covers the
period July 1996 to September 1998. We aimed for an evaluation of differences in patient
characteristics and perioperative anesthesiologic and surgical data and investigated the
relationship between these data and mortality, ICU LOS and hospital LOS.
Methods
− Context of the study.
The principal investigators collected data of potentially eligible patients for the GUTS during
the entire study period assessing the logistics of the study. Summarized data of potentially
eligible, but nonrandomized patients were available (Chapter 2; table 2). The main reasons
why these patients were not included in the GUTS were reviewed. We were aware that this set
of data did not comprise all eligible patients for the GUTS. The main reason for this is the
method the principal investigators used for the selection of eligible patients (table 1). First
potentially eligible patients were tested by using the main inclusion criteria. The indication for
surgery, the surgical plan and the medical history of an individual patient were evaluated
subsequently. During enrollment of the GUTS, relative and absolute exclusion criteria were
employed (table 2). These exclusion criteria were important guides to decide which patients
should be asked for informed consent. Primarily patients were selected for whom preparation
of the surgical procedure already contained a plan for postoperative ICU-admission. If such
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patients were not available on the surgical schedule, patients could be selected who were
eligible according to the inclusion criteria, but without planned postoperative ICU-admission.
In that case, the principal investigators focussed on criteria such as an extensive and expected
long-lasting surgical procedure and/or patients > 65 years of age.
The primary search for the retrospective cohort study had a wide scope to find any potentially
eligible patient by using the three main inclusion criteria (table 1). Subsequently these patients
were screened for the existence of any of the absolute exclusion criteria. This procedure came
close to the methods the principal investigators used to select patients for the GUTS from the
entire surgical population.
Table 1. Criteria used for the primary search of potentially eligible patients for the GUTS.
inclusion criteria for GUTS
-
 age > 18 years
-
 high-risk patient (see Chapter 2, table 1)
-
 (expected) duration of surgery > 90 minutes
‘unwritten’ relative exclusion criteria for GUTS
- fulfilling inclusion criteria, but preoperatively planned to return to the ward via the recovery room
- non-(thoraco)abdominal extensive surgery (for carcinoma)
- cardiac pacemaker in situ
- continuous intravenous heparin preoperatively
- psychiatric disorders: claustrophobia, minor symptoms of dementia praecox
‘unwritten’ absolute exclusion criteria for GUTS
- anesthesiologic management
-




 laparoscopic surgical procedures
-
 emergency surgery (surgery between 06:00 p.m. and 08:00 a.m.; ASA-E number)
-




 any surgery for pheochromocytoma or carcinoid
-
 extensive surgery for gynecologic oncology without a planned postoperative ICU-admission
-
 endovascular repair of aortic aneurysm
-
 medical criteria, specifically concerning the risk of cardiovascular complications by tune-up
-
 severe aortic stenosis (peak pressure gradient over valve > 80 mmHg)
-
 NYHA class III and IV angina pectoris, despite optimal medical treatment
-
 severe metabolic dysbalance – Na < 130 mmol/L, glucose > 12 mmol/L
-
 severe obstructive pulmonary disease (FEV1 < 55 % and FEV1 < 1000 mL)
-
 severe restrictive pulmonary disease (continuous oxygen therapy at home or NHYA-class IV)
-
 symptoms of liver failure
-
 preoperative therapeutic treatment with intravenous heparin
-
 dementia
additional exclusion criteria for the retrospective cohort study
− actual duration of surgery < 90 minutes
−




Mortality, ICU LOS, number and LOS of ICU readmissions, hospital LOS and discharge
location were defined as clinical end points. Perioperative variables on physical status and
laboratory tests were collected comparable to the clinical data collected in the GUTS, as these
data were used for multivariate regression analysis (Chapter 2).
− A data base of eligible patients for the GUTS.
We aimed at completing a data base comprising all patients fulfilling the high-risk criteria and
eligible for the GUTS. Since the GUTS focussed on (semi)elective surgical patients, the
ultimate source of information on patients undergoing elective surgery was the daily schedule
for the operating room (OR-list). This OR-list is published the day before surgery and is
available around 03:00 p.m. It contains information regarding patient, type and expected
duration of the planned surgical procedure and the need for postoperative ICU-facilities.
These OR-lists were available from January 1997 till September 1998. They were scrutinized
for patients positive for the 3 main inclusion criteria and therefore potentially eligible for the
GUTS (table 1). Since the GUTS focussed primarily on major (thoracic)abdominal surgery,
specific patients, planned for postoperative ICU admission after other extensive surgical
procedures, were excluded (table 1). Any patient undergoing a laparotomy because of an
endocrine tumor, like pheochromocytoma or carcinoid, had to be excluded. The use of
vasoactive substances (dopamine or dobutamine, as part of tune-up procedure) in such a
patient could have resulted in serious cardiovascular and hemodynamic complications.
Laparotomy for inflammatory bowel disease per se was not denoted as high-risk surgery.
OR-lists were not available for the period of the first 6 months of the GUTS; therefore an
alternative search was performed. First we composed a data set of operation-codes (OPERA-
codes, table 2) related to types of high-risk and/or major (abdominal, thoracic-abdominal or
vascular) surgery. The archives were screened by using these operation-codes to find any
potentially eligible patient for the GUTS.
Perioperative data of identified patients with regard to indications and actually performed
surgery were collected using electronic data bases (ZIS, Poliplus). Eligibility for participation
in the GUTS was tested using inclusion and absolute exclusion criteria (table 1). It is assumed
that by using this design all eligible patients were found for the GUTS between July 1996 and
December 1996.
Since tune-up did not significantly influence ICU LOS, hospital LOS and mortality, it was
decided to combine both groups of the GUTS into one group. The GUTS primarily focussed
on patients who had been scheduled preoperatively for postoperative ICU-admission.
Therefore, patients who had been denoted as high-risk by the main inclusion criteria, but who
were sent back to the ward via the recovery room postoperatively, were excluded from the
analysis. GUTS patients (group A) were compared with the non-GUTS patients (group B).
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Table 2. ‘OPERA’-codes. Every single code is restricted to a specific type of surgical
intervention, mostly comprising major surgical procedures lasting > 90 minutes.
subspecialty surgical procedures codes in ‘OPERA’





pancreatic resection, cryosurgery of
the liver, roux-y-anastomosis,
hepatico-jejunostomy, biliairy
reconstruction; abscess drainage of
the liver
035210, 035220, 035320, 335211,
335212, 335223, 335414, 335415,






surgery of the oesophagus, stomach,
duodenum, jejunum, ileum, colon,
sigmoid and/or rectum
034436, 034440, 034531, 334322,
334337, 334342, 334343, 334345,
334431, 334432, 334433, 334433,
334435, 334436, 334436B, 334437,
334438, 334439, 334440, 334441,
334442, 334443, 334444, 334630,
334631, 334632, 334638, 334702,
334731, 334732, 334751, 334752R,
334752L, 334753, 334755, 334756,
334800, 334801, 334802, 334804,
334810, 334811, 334814, 334821,
334822R, 334822L, 334823, 334824,
334894, 335020, 335022, 335023,
335024, 335025, 335026, 337109
surgical oncology retroperitoneal lymph node dissection 333742R, 333742L
urologic surgery laparotomy for tumor nephrectomy,
cystectomy with and without enteral
urinary conduit (Bricker, Indiana
pouch)
036043, 036252, 036253, 036255,
336041, 336043A, 336043B, 336430E,
336130, 336254
vascular surgery vascular surgery for aneurysmatic and
obstructive vascular disease
(iliofemoral or aortic surgery)
333500, 333510R, 333510L, 333511R,
333511L, 333520T, 333520S, 333531,
333533, 333535, 333536, 333537,
333541, 333550, 333550R, 333550L,
333550C, 333551, 333552R, 333552L,
333553, 333553R, 333553L, 333555,
333556, 333556R, 333556L, 333557R,
333557L, 333558, 333559R, 333559L,
333561R, 333561L, 333572R, 333572L,
333672L, 333673, 333687R, 333687L,
333679R, 333679L, 333679B, 333679A,
333680R, 333680L, 333685R, 333685L,
333687R, 333687L, 333688R, 333688L,




− Collection of perioperative data on eligible patients, who had not been randomized for the
GUTS but had been planned electively for posteropative ICU admission.
Perioperative data of non-GUTS patients were obtained from the archives of the department
of Anesthesiology and from electronically available hospital data (ZIS, Poliplus). All files
were scrutinized for perioperative data according to a script as depicted in table 3. The
existence of an electively planned postoperative ICU admission was verified by screening the
OR-lists and the preoperative information in the anesthesia files.
Table 3. Collected perioperative data of non-GUTS patients.
preoperative
−
 patient characteristics: age, length, weight, systolic and diastolic blood pressure, heart
rate, sinus rhythm or nonsinus rhythm
−
 preoperative medication and intoxications (cardiovascular medication, oral antidiabetics,
insuline, smoking)
−
 laboratory data: Hb and creatinine
−






 Cardiac Risk Index according to Goldman10
−
 Revised Cardiac Risk Index according to Lee11
intraoperative
−
 thoracic epidural catheter before induction of anesthesia
−
 estimated blood loss
−
 infusion/transfusion (red blood cell concentrate, fresh frozen plasma, thrombocytes,
colloids, cristalloids)
−













 28-day mortality, in-hospital mortality
−
 mortality location (ICU, ward)
−




The distribution of various perioperative variables in the GUTS- and non-GUTS patients were
compared. For univariate analysis the Chi-square-test, oneway-ANOVA and Mann-Whitney-
U were used when applicable. For evaluation of the joint effect of the perioperative variables
the logistic regression analysis was used, with the group membership considered as the
outcome. Methods of survival analysis (Kaplan-Meier curves, log rank test, Cox regression
analysis) were used to study the distribution of the hospital LOS and first postoperative ICU
LOS. In these analyses the patients who died during the first postoperative stay in the ICU and
those who died in the hospital were censored for the end points ICU LOS and hospital LOS,
respectively.
A p-value of 0.05 or less was considered to be statistically significant.
Results
More than 10,000 patients were screened for the retrospective cohort study. Four hundred and
eleven patients fulfilled criteria of high-risk and were deemed eligible for participation in the
GUTS when the 3 main inclusion criteria were used and no medical contra-indications existed
for GOHT (table 4). Two hundred and eighty-four eligible high-risk patients were not
randomized for the GUTS (figure 1). Basic patient characteristics and clinical outcome
variables of the entire group are depicted in table 5. Patients are grouped according to the
postoperative location (figure 1).
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Figure 1. Diagram of postoperative location, ICU or recovery. Groups A (GUTS) and B (non-
GUTS) were compared for differences in mortality, ICU-LOS and hospital LOS. Additional
information on subgroups can be found in the gray boxes; readm-ICU: late ICU-admission
(i.e. after primary postoperative admission to the ward) or re-admission to ICU after a former
direct postoperative ICU- admission (the percentage between parenthesis is given as a
fraction of the subgroup).
One hundred and seventy-four non-GUTS patients were admitted to the ICU postoperatively.
Thirteen of them were originally planned for postoperative admission to the ward via the
recovery room, but had an unexpected ICU-admission. Three patients of this subgroup died in
the hospital. One hundred and ten patients were planned for postoperative admission to the
recovery room and were successfully admitted to the ward. Hospital mortality in this
subgroup was 2.7%.
The proportion of patients admitted to the ICU postoperatively was significantly smaller in
the non-GUTS group than in the GUTS-group (table 5). Hundred and eleven GUTS patients






















high-risk surgical patients eligible for the GUTS
undergoing elective surgery > 90 minutes
high-risk for medical and/or surgical reasons.
n = 411
readm. ICU
n = 0 (0%)
readm. ICU
n = 9 (8.1%)
readm. ICU
n = 13 (11.7%)
readm. ICU
n = 14 (8.7%)
readm. ICU




Table 5. Patient characteristics and perioperative data of 127 GUTS and 284 non-GUTS
high-risk surgical patients.
postoperative location






- number of patients
- male (%)
- age in years, mean (SD)
duration of surgery
- minutes (SD)
scheduled preoperatively for postoperative
ICU admission
postoperative hospital LOS, days
- mean (SD)
- median




postoperative mortality, number of patients
- 28-day mortality (%)















































Nearly all anesthesiologic files of the non-GUTS patients, admitted to the ICU




Table 6. Preoperatively collected data of all patients planned for postoperative ICU
admission; GUTS-randomized vs. non-GUTS patients.
GUTS non-GUTS p
number of patients, n
male / female (%)
age
- years (SD)
- > 70 years, n (%)
physical examination
- weight, kg (SD)
- length, cm (SD)
- Quetelett index, kg/m2 (SD)
- body surface area, m2 (SD)
- HR, beats/minute (SD)
- SBP, mmHg (SD)
- DBP, mmHg (SD)
medical history
- DM, n (%)
pulmonary function test
- performed, n (%)
intoxications and medication
- smoking, n (%)





cardiovascular testing for CAD
- reversible ischemia, n (%)
- missing
systemic corticosteroids, n (%)




- salbutamol, ipratropium and steroids
laboratory tests
Hb, mmol/l (SD)
creatinine, µmol/l  (SD)
- median
111
















































































Non-GUTS patients were significantly younger, smoked less and used more pulmonary
inhaled medication. Non-GUTS patients had higher ASA- and NYHA-class-scores, but were
comparable regarding the number of high-risk criteria as defined by Shoemaker (table 7).
Stratifying patients for cardiovascular risk, the Goldman risk classification showed a higher
risk for the GUTS-population (table 7).
Table 7. Risk stratification of high-risk surgical patients, GUTS vs. non-GUTS patients.
GUTS Non-GUTS p












































































































However, using the more recent Lee Risk classification, no differences were found. When
patients were compared for category of surgical procedure, i.e. vascular surgery, hepatobiliary
surgery for carcinoma and nonhepatobiliary surgery, patients are distributed equally (table 8).
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   - aneurysma
   - aorta-iliacal occlusive disease
   - renal artery reconstruction
   - superior mesenterial artery reconstruction
limb salvage of the lower extremity
   - ilio-femoral obstructive disease
upper intestinal tract surgery
   esophageal, gastric and duodenal surgery for
carcinoma, hepatobiliary surgery excluded
      - gastric cardiac resection
      - esophageal resection
      - gastrectomy
      - small bowel surgery
hepatobiliary surgery
       - pancreatoduodenectomy, (modified) Whipple
       - hemihepatectomy / biliary tract surgery
lower intestinal tract surgery
colonic and rectal surgery for carcinoma
       - colonic surgery
       - low anterior resection
       - abdomino-perianal resection
pelvine exenteration for carcinoma
resection of the bladder for carcinoma
resection of solid retroperitoneal tumors or tumors of the
torso
      - solid tumors of torso
      - retroperitoneal lymph node dissection, laparotomy


























































- hepatobiliary surgery for carcinoma, laparotomy












Intra- and postoperative data are depicted in table 9. The proportion of epidural anesthesia
was somewhat smaller in the non-GUTS patients; intraoperative fluid management was
similar in both groups. In the GUTS-group the mean postoperative Hb was 0.4 mmol/L lower.
Mortality was higher in the non-GUTS patients (table 9); the difference in mortality was 4%
(95%-CI: -1 to 9%, p = 0.167). Uncensored for mortality, ICU LOS was significantly shorter
in non-GUTS patients (table 9). Considering hospital LOS the difference did not reach
statistical significance. Clinical data of nonsurviving patients are summarized in tables 10A
and 10B.
Table 9. Intraoperative and postoperative data of high-risk surgical patients, GUTS vs. non-
GUTS patients. Data presented in this table are uncensored for mortality.
GUTS non-GUTS p
number of patients (n)
anesthesia & intraoperative data:
-
 combined general and epidural anesthesia (%)
-
 duration of surgery, minutes (SD)
blood loss
-





 crystalloid, mL (SD)
-
 colloids, mL (SD)
-
 n with packed cell-transfusion (%)
-
 packed cell transfusion, units/patient (SD)
post-operative data: ICU & hospital LOS
- Hb, mmol/l (SD)
ICU LOS, first postoperative ICU-admission
- mean, days (SD)
- median, days (IQR25-75%)
hospital LOS
-
 mean, days (SD)
-
 median, days (IQR25-75%)
secondary postoperative ICU-admission, n (%)
overall ICU LOS
- mean, days (SD)
- median, days (IQR25-75%)




 nursing home (%)
-
 other hospital (%)
postoperative mortality:
-
 28 day mortality, n (%)
-


































































Table 10. Clinical data of nonsurviving patients of the GUTS (n=3) and non-GUTS (n=11).


































































































S 660, BL 7.0 ;
unexpected PuH,
LC & PoH
S 250, BL 0.5


























































































































S 360, BL 0.6
S 505, BL ?;
unexpected LC &
PoH
S 660, BL 3.2
S 240, BL: 2.2
S 450, BL: 9.0
S 720, BL: 2.5
S 185, BL: 2.0
S 330, BL: 1.3
S 250, BL: 2.0
S 585, BL: 2.0
























































AF, atrial fibrillation; AP, angina pectoris; BL, blood loss in liters; CA, circulatory arrest; CABG, coronary bypass grafting; CHF, chronic heart failure; COPD,
chronic obstructive pulmonary disease; CVM, number of cardiovascular medication (beta-blocker, ACE-inhibitor, diuretics, alpha-blockers, digoxine); DM,
diabetes mellitus; LC, liver cirrhosis; MI, myocardial infarction; MOF, multi organ failure; PODM: postoperative day of mortality; POSSUM, Physiological and




Multivariate logistic regression analysis of preoperative risk stratifying variables as listed in
table 3 showed that GUTS patients and non-GUTS patients were significantly different as
found by univariate analysis, except for age and use of epidural anesthesia. Similar results
were found when the intraoperative variable blood loss was in- or excluded.
Univariate analysis suggests that non-GUTS patients had a shorter ICU LOS. However, using
Cox regression analysis and correcting for differences between both groups, no difference was
found for  postoperative ICU LOS (excluding LOS caused by ICU-readmissions).
Multivariate regression analysis, uncensored for mortality, was performed on hospital LOS.
Conform Chapter 2, analysis showed that non-GUTS patients had a significantly shorter
hospital LOS, irrespective of correction for the intraoperative variable blood loss (p=0.049
with and p=0.041 without correction for blood loss).
When censoring for mortality no differences were found between groups for ICU LOS and
hospital LOS (figures 2 and 3).
Analysis aiming at elucidating factors that determine mortality rate was not performed
because the GUTS mortality rate was very low.
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Figure 2. KM curve of ICU LOS of high-risk surgical patients preoperatively planned for
postoperative ICU-admission, GUTS vs. non-GUTS patients. ICU LOS caused by ICU-









































Figure 3. KM-curve of hospital LOS of high-risk surgical patients preoperatively planned for
postoperative ICU-admission, GUTS vs. non-GUTS patients (NRP). Analysis is censored for
hospital mortality.
Discussion
When table 2 of Chapter 2 is compared to table 4 of this Chapter, this retrospective study
shows that the principal investigators did not find all high-risk patients potentially eligible for
the GUTS. This is a result of the wide scope of the retrospective cohort study and the design
of the GUTS, searching primarily for high-risk patients already planned for postoperative
ICU-admission the day before surgery. When a potentially eligible patient fulfilled the main
inclusion criteria, but also appeared to have one of the relative exclusion criteria, this patient
was less likely to be randomized.
As a result of this process only 16 (12.6%) of the GUTS-patients bypassed the ICU
postoperatively and returned to the ward via the recovery room (Chapter 2).
The 411 patients found in this retrospective cohort study do not necessarily comprise the 294
patients found in the administration of the principal investigators (Chapter 2, table 2). Details
of individual patients regarding the reason of refusal for participating in the GUTS were not
available. When searching for potential selection bias it seems logical to have restricted the
study to the 126 non-GUTS patients available in the data base of the principal investigators
(Chapter 2, table 2). However, we were not able to reconstruct exactly whom of the 126
eligible patients identified between July 1996 and September 1998 matched to the inviduals of
the 284 patients (figure 1) found in the retrospective study. We therefore decided to use the
284 non-GUTS patients for comparison with the patients of the GUTS, of whom 161 patients
were electively scheduled for postoperative ICU-admission. This may hamper our search for
elucidating effects of a priori selection bias by the principal investigators. At the same time
we aimed at reconstruction of a complete overview of the actual clinical practice. From this
point of view we increased the chance to find posteriori bias by differences in treatment.
Considering preoperative data the non-GUTS patients seem more at risk for postoperative
morbidity and mortality than GUTS patients. The prevalence of pulmonary disease is
probably higher in the non-GUTS patients as may be concluded from the significantly higher
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number of patients using inhaled pulmonary medication. This finding confirms our
impression that inclusion of patients compromised by (chronic obstructive) pulmonary disease
was less likely. With respect to the Goldman CRI scoring, ASA-class and NYHA-physical
tolerance, non-GUTS patients also seem more at risk.
The results of using different scoring systems for preoperative assessment of cardiac risk are
remarkable.10,11 This is probably attributable to the difference in age. The newer Lee-
classification does not weight age, whereas in the original Goldman Risk Index age > 70 years
adds 5 points to the risk score (Chapter 1, table 2).10,11 We consider the Lee-classification
more correct to stratify for cardiac risk since this classification was developed and validated
in a period close to the period in which patients were enrolled in the GUTS.
The higher mean value of preoperative creatinine may be explained by the fact that none of
the patients of the GUTS had renal insufficiency, while some of the non-GUTS patients were
dependent on hemodialysis. Renal insufficiency has been described as an independent risk
factor for postoperative complications11,12, but not for mortality.13
Comparing both groups in a multiple regression analysis the difference in the use of epidural
analgesia  was not significant. The benefits of thoracic epidural analgesia have become a
matter of debate.14-17 The GUTS patients may have been at lower risk for postoperative
complications because more GUTS patients had thoracic epidural analgesia. The potentially
beneficial effects of postoperative epidural analgesia can only be presumed since the duration
and efficacy of this treatment in postoperative care was neither monitored in the GUTS
patients, nor in the non-GUTS patients.
Smoking is described as an independent risk factor for postoperative pulmonary
complications.18 With respect to this issue, non-GUTS patients are at lower risk than GUTS-
patients.
In summary, univariate analysis revealed that non-GUTS patients differed significantly
regarding preoperative characteristics. This result remained relatively consistent during
multivariate logistic regression analysis. Overall, regarding the presented preoperative
variables and sample size and considering certain variables, the non-GUTS patients tended to
be more at risk for postoperative morbidity and mortality, whereas for other variables patients
of the GUTS were more at risk. It should, however, be noted that these results must not be
overemphasized, as the Bonferroni correction was not applied. The investigators may have
selected patients on specific characteristics (i.e. absence of pulmonary inhaled medication,
etc.). When both groups are to be compared on clinical outcome, these differences may be
counfounding and therefore should be corrected for when groups are compared for ICU LOS,
hospital LOS and mortality.
Two perspectives after regression analysis are described. Not censoring for mortality focuses
on actual effects of participation in the GUTS. ICU LOS was similar for both groups. But
non-GUTS patients stayed significantly shorter in the hospital. The conclusion seems to be
justified that participation in the GUTS is unfavorable. This perspective can be chosen when
cost-benefits are to be evaluated (Chapter 4). However, from the perspective of patient
treatment and outcome, results ought to be censored for mortality. In that case no differences
were found, neither on ICU LOS nor on hospital LOS.
Mortality rate tends to be higher in the non-GUTS patients. Although no statistical difference
could be found, we consider this finding as potentially and clinically relevant. The overview
of nonsurviving patients makes it clear that a mix of surgical and nonsurgical mechanisms
resulted in a complex postoperative course, primarily characterized by the development of
multi organ failure, that could not be reversed by surgical reinterventions and ICU-treatment.
Participation in the GUTS may have resulted in accelerated medical, life saving diagnostics or
interventions. In the context of this thesis, the question arises whether preoperatively started
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GOHT at the ICU would have improved survival in non-GUTS patients. Such considerations,
however, remain a matter of speculation.
Mortality rates in our hospital regarding elective, major (thoracic)abdominal surgery are low
when compared to values reported in tune-up like studies of Shoemaker et al. and Boyd et
al.2,4 As already discussed in Chapter 2, this difference may be a result of excluding
emergency surgery. However, Boyd et al. in their study described a subset of electively
operated patients, presenting mortality rates of 23.7% in the control group and 7% in the
protocol group.4 In our hospital, without any specific protocol on perioperative GOHT of
high-risk patients, a similar result was obtained as in Boyd’s protocol group. In Chapter 1 we
discussed the value of comparing mortality rates found in our study and in previous studies.
Also in prospective studies of preoperatively started GOHT in major vascular surgery7,19-21 it
was shown that this treatment did not improve outcome and mortality rates were ≤ 8% in the
controls. An alternative explanation may be that during preoperative evaluation patients were
selected on their operability. The criteria applied for such a selection may then have serious
impact on the results. But often such criteria are not specified. The effects of such a selection
on surgical outcome in elective surgery are not addressed in any of the perioperative GOHT
studies or restricted to evaluation of the risk on cardiac complications. Another explanation is
a lesser quality of perioperative care in the older studies, i.e. relative undertreatment of the
controls compared to current practice.2,4 However, in Boyd’s study also patients of the control
group, undergoing elective surgery, were preoperatively admitted to the ICU to have their
preload optimized. Undertreatment of these patients does not seem logical from the
perspective of GOHT.
Of special interest are patients who were planned for postoperative admission to the recovery,
but for whom intraoperative events made postoperative ICU-admission necessary (figure 1;
n=13, 3 died in the hospital). The number of these patients in this retrospective study is small
(8.1% of all ICU-patients). We did not differentiate for surgical or patient-related reasons of
the postoperative ICU-admissions of these patients. Apparently they were not judged
preoperatively as having a serious risk of intraoperative morbidity. When patient-related
factors are the main cause of the necessity for postoperative ICU-admission, a sufficiently
sensitive and specific test would be desirable to identify these patients as high-risk.
Shoemaker et al. defined criteria for identification of high-risk surgical patients (Chapter 1,
table 9). We used these criteria to find such patients in our hospital, undergoing elective,
major, noncardiac surgery. We found more than 400 high-risk patients over a period of 25
months. One third of these patients were included in the GUTS. Apparently the principal
investigators primarily included patients who were admitted to the ICU postoperatively. The
hypothesis that secondary end points may have been biased by the investigators as a result of
patient selection or protocol treatment had to be rejected. On the contrary, when data were
uncensored for mortality, non-GUTS patients stayed significantly shorter in the hospital.
Censoring for mortality showed that non-GUTS patients had a similar clinical pathway as the
GUTS patients regarding ICU LOS and hospital LOS. Although mortality was higher in the
non-GUTS patients (4%, 95% CI: -1 to 9%) compared to patients of the GUTS, overall
mortality of GUTS-eligible patients did not reach the high mortality rates found in control
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“Any new policy that is to be implemented in modern
healthcare needs to be considered in terms of its
influence on recources. Cardiovascular optimization will
initially require more time, more beds, greater skill mix,




Preoperative goal-oriented hemodynamic treatment (GOHT) of high risk surgical patients has
been described to reduce mortality in some studies2-4 and to improve clinical outcome in
others.5,6 Costs were calculated and analyzed as secondary end point in the context of resource
management.2,7,8 In these studies preoperative investments resulted in a significant reduction
in costs. Others found no benefits of preoperatively started GOHT9-12 and it may be assumed
that in these studies costs of this preoperative intervention at the intensive care unit (ICU)
surpassed costs of current practice.
In chapter 2 we described an open, randomized, controlled, clinical trial of the efficacy of
preoperative GOHT in our hospital on postoperative complications, ICU LOS, hospital LOS
and mortality. No firm conclusions could be made regarding the primary end point. With
respect to secondary end points, i.e., ICU LOS, hospital LOS and mortality, no relevant
differences between the control and protocol (tune-up) group were found either. In Chapter 3
we described the cohort of all high-risk surgical patients eligible for inclusion in the
Groningen University Tune-up Study (GUTS). We compared clinical end points, ICU LOS
and hospital LOS and mortality of patients participating in the GUTS to patients eligible for
the GUTS, but not participating (non-GUTS), mainly because of logistic or personal reasons.
Regarding ICU LOS and hospital LOS the non-GUTS patients had a clinical course closely
resembling that of the GUTS patients (Chapter 3).
Hospital LOS is the major attributor to hospital costs13. GOHT in the GUTS targeted to
reduce costs as a secondary end point. We calculated costs of high-risk surgical patients,
using a simplified design, assuming that costs generated by ICU LOS and hospital LOS
comprise the main part of all costs. First, we compared the costs of both groups of the GUTS
as described in Chapter 2. Secondly, we studied patients preoperatively scheduled for
postoperative ICU-admission and compared the costs of both groups of the GUTS and the
non-GUTS group, i.e. patients that were described in chapter 3 as group A and group B
(Chapter 3, figure 1).
Methods
Costs of stay at the ward and the ICU were obtained from data available from national and
local resource data management (Centraal Orgaan Tarieven Gezondheidszorg, COTG;
College voor Zorgverzekeringen, CVZ; Afdeling Inkoop, University Medical Center
Groningen, UMCG; OPERA-codes related to anesthesiologic procedures; Dienst
Automatisering & Informatie UMCG). Costs of different issues for calculation of cumulative
costs are presented in table 1. Costs of nursing and medical staff are included in the price of
one day of stay at the ICU or the ward. Costs of surgical interventions were not included.
Follow-up of patients took place till the day of discharge from the hospital.
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Table 1. Overview of different costs (Euro).
unit Hospital and staff cumulative
Year 1996 2003/4 1996 2003/4
day at the ward





















































ICU, intensive care unit; CVP, central venous pressure; PAC, pulmonary artery catheter;
RBC, red blood cell concentrate.
Two analyses were performed.  First both subgroups of the GUTS (Control, n = 62, Tune-up,
n=65) were compared for costs regarding ICU LOS, hospital LOS and RBC-transfusion
requirements. A description of the patients of the GUTS and their surgical procedures can be
found in Chapter 2 (Chapter 2, tables 4a and 4b). In this cost analysis special attention was
given to RBC-transfusion requirements, since the control patients tended to have more blood
loss (Chapter 2, Results) and costs of RBC-transfusion increased tremendously in time (table
1). Data of other transfusion products were not available since thrombocyte transfusion,
colloids and fresh frozen plasma were not included in the data base as separate variables.
Study protocol related similarities (PAC, arterial line, epidural catheter) of both groups were
not taken into account.
Costs of hospital LOS were separated in costs of ICU LOS and costs of LOS at the ward. The
preoperative day was calculated as a ward-day for the control patients and as an ICU-day for
the tune-up patients. Postoperative ICU-days included the day of ICU-admission after surgery
and the day of discharge from the ICU to the ward. The remaining days the patient spent in
the hospital were defined as ward-days. The LOS at the ward was calculated as the hospital
LOS minus ICU LOS (table 2). Cumulative costs of the control group and the tune-up group
were compared.
A second analysis was performed on the costs of GUTS vs. non-GUTS patients
postoperatively scheduled for ICU-admission. Measurements for calculations started at the
preoperative day; calculation of ward- and ICU-days are similar as described for the first
analysis. Differences in costs between GUTS- and non-GUTS patients were to be expected,
since all patients of the GUTS received a pulmonary artery catheter (PAC) for the purpose of
study treatment and/or measurements, whereas in the non-GUTS patients a PAC was only
placed when clinically deemed necessary by the anesthesiologist. In Chapter 2 and 3 also
differences were described regarding the use of epidural anesthesia/analgesia and
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intraoperatively given RBC. Therefore, in this analysis costs generated by these additional
items were accounted for (table 1). Only patients with a planned postoperative ICU-
admission, as described in Chapter 3, were analyzed, i.e. 111 GUTS-patients (53 controls, 58
tune-up patients) vs. 161 non-GUTS patients. Patient characteristics and type of surgical
procedures performed are described in Chapter 3 (Chapter 3, table 6-9).
The calculation of cumulative costs of both analyses is presented in table 2. Costs were
calculated for the period that the GUTS started (1996) and current prices from 2003/2004
were used.
Table 2. Calculations of overall costs for a patient of the control and the tune-up group of the






1996 (ICUds x 1093.08) + ([Wds + 1 – ICUds] x
318.78) + (RBC units x 21.78)
(ICUds + 1 x 1093.08) + ([Wds – ICUds] x
318.78) + (RBC units x 21.78)
2003/
2004
(ICUds x 1684) + ([Wds + 1 – ICUds] x
476) +  (RBC units x 179)
(ICUds + 1 x 1684) + ([Wds – ICUds] x 476) +








1996 (ICUds x 1093.08) + [(Wds +
1 – ICUds) x 318.78] + (PAC
x 171.30) + (AC x 7.50) +
(EC x 69,83) + (RBC units x
21.78)
(ICUds + 1 x 1093.08) +
[(Wds  – ICUds) x 318.78] +
(PAC 171.30) + (AC x 7.50) +
(EC 69.83) + (RBC units x
21.78)
(ICUds x 1093.08) + [(Wds +
1 – ICUds) x 318.78] + (PAC
x 171.30) + (CVC x 63.17) +
(AC x 7.50) + (EC x 69.83) +
(RBC units x 21.78)
2003/
2004
(ICUds x 1684) + [(Wds + 1
– ICUds) x 476] + (PAC x
226) + (AC x 9.30) + (EC x
95.72) + (RBC units x 179)
(ICUds + 1 x 1684) + [(Wds–
ICUds) x 476] + (PAC x 226)
+ (AC x 9.30) + (EC x 95.72)
+ (RBC units x 179)
(ICUds x 1684) + [(Wds + 1
– ICUds) x 476] + (PAC x
226) + (CVC x 83.70) +  (AC
x 9.30) + (EC x 95.72) +
(RBC units x 179)
ICUds, ICU-days; Wds, days at the ward; PAC, pulmonary artery catheter; CVC, central venous
catheter; AC, arterial catheter; EC, epidural catheter; RBC unit, red blood cell concentrate unit. When
a PAC, CVC, AC and/or EC were used in individual patients, the abbreviation is numbered 1 for the




The Mann-Whitney test and Kruskal-Wallis test were used to compare the patient groups with
respect to the cost variables; 5% was used as the level of statistical significance.
GUTS-patients


































Figure 1. Frequency distribution of ICU LOS (days), including ICU-readmissions, and
postoperative hospital LOS, in 127 patients of the GUTS.
Results
Figures 1 and 2 present the frequency distribution of ICU LOS and hospital LOS. Data
involved in the calculation of costs in the first analysis are summarized in table 3. This table
also contains a summary of data on secondary end points of the main study (Chapter 2).
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GUTS & non-GUTS patients
electively scheduled for postoperative
ICU-admission







































Figure 2. Frequency distribution of postoperative ICU LOS (days), including ICU-




Table 3. GUTS-patients. Details on issues used for calculation of costs related to





intraoperative RBC transfusion, all patients:
- mean (SD)
- median (IQR25-75%)
number of patients having RBC transfused (%) if RBC ≥ 1
- mean (SD)
- median (IQR25-75%)
via recovery admitted to the ward, number of patients (%)
postoperative ICU LOS, readmissions included, days
- mean (SD)
- median (IQR25-75%)
postoperative hospital LOS (days), ICU-days included
- mean (SD)
- median (IQR25-75%)
ICU readmissions, number of patients







































GUTS, Groningen University Tune-up Study; GOHT, goal oriented hemodynamic treatment; ICU,
intensive care unit; RBC, red blood cell concentrate; LOS, length of stay.
Results of overall costs are presented in table 4. We found no statistically significant
differences in mean costs/patient between controls and tune-up patients. Ward-related costs
tended to be lower in the tune-up group, but ICU-costs were significantly higher in this group.
In this model the significantly higher overall ICU-costs in the tune-up group surpass the cost
savings achieved at the ward, counterbalancing overall costs at similar levels (table 4).
Data of anesthesiology-related devices and procedures of the second analysis are summarized
in table 5. Additional information on RBC-transfusion, postoperative ICU LOS, hospital LOS,
ICU-readmissions, discharge location and mortality are also to be found in this table. Costs of
single items used for the final calculation and cumulative costs are depicted in table 6.
Overall costs in the control and the tune-up patients of the GUTS were higher when compared
to costs in the non-GUTS patients (table 6); according to prices in 2003 this difference
reached significance. In 1996 the mean difference expressed as costs/patient of a non-GUTS
patient was 2,026 and 2,385 Euro compared to a control and a tune-up patient of the GUTS,




Table 4. GUTS patients. Costs are calculated for stay on the ward, stay at the ICU and
intraoperative RBC-transfusion; preoperative treatment at the ward (control group) vs.
preoperative treatment at the ICU (tune-up group).
costs/patient (euros) 1996 2003/4
control






























































Table 5. GUTS vs. non-GUTS patients. Data on perioperative epidural anesthesia and
analgesia, invasive hemodynamic monitoring and RBC-transfusion. Data of epidural
anesthesia/analgesia, hemodynamic monitoring and transfusion were available in 157








epidural catheter, number of patients (%)
invasive hemodynamic monitoring
number of patient with
- arterial canula (%)
- CVP-line (%)
- PAC-introducer (%)
- PAC, complete (%)
RBC transfusion
- mean, all patients (SD)
- number of patients & RBC-transfusion (%)
- transfused mean, if RBC ≥ 1 (SD)
postoperative ICU LOS, days
- mean (SD)
- median (IQR25-75%)
postoperative hospital LOS, days
- mean (SD)
- median (IQR25-75%)
ICU-readmissions, number of patients
- first readmission (%)
- second readmission (%)
discharge location, number of patients
- home (%)
- nursing home (%)
























































GUTS, Groningen University Tune-Up Study; ICU, intensive care unit; RBC, red blood cell
concentrate; CVP, central venous pressure; PAC, pulmonary artery catheter.
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Table 6. Costs of GUTS patients (control and tune-up group) vs. non-GUTS patients. All
































































   - mean
IV-monitoring
   - mean
RBC
   - mean
postoperative ICU
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postoperative ward
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GUTS, Groningen Univeristy Tune-up Study; ICU, intensive care unit; EC, epidural catheter; IV,
intravascular; RBC, red blood cell concentrate
Discussion
ICU LOS and hospital LOS, defined as secondary end points of the GUTS, reflect the severity
of the primary end points and are the main determinants of costs. Preoperative tune-up at the
ICU did not reduce overall costs in a model in which the emphasis is laid on LOS in the ICU
and the hospital. At first glance it seems that costs are saved regarding LOS at the ward, but at
the same time extra costs of tune-up and ICU-readmission offset these savings. It should be
realized that the result of this nearly zero cost balance is flattered by the fact that tune-up
patients in many aspects seemed to be in a clinically more favorable condition. Confounding
patient factors and blood loss appeared to explain differences in outcome, and not tune-up as
such (Chapter 2). If both groups would have matched better it could be hypothesized that the
minor difference in costs/patient in favor of the control group would have been larger. In
addition, the second analysis, when the GUTS groups were compared to the non-GUTS
group, the perspective is shown that significantly lower costs already were achieved in this
model applied to the conditions of 1996 and also could have become lower in 2003. From this
perspective it seems appropriate not to implement tune-up as a regular procedure of
perioperative care in patients described as high-risk according to the definitions used till now.
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When ICU LOS or hospital LOS are not reduced by tune-up, in our institution the related
additional costs may be an extra argument not to implement such a therapy in high-risk
surgical patients, according to the protocol of the GUTS. On the other hand, if a selection of
these patients may still benefit clinically from tune-up, it is questionable whether to confine
tune-up to the ICU. Facilities of a high dependency unit or recovery room could also have
been used for tune-up and also the timing of tune-up can probably be restricted to a few
hours.5 This latter possibility would have resulted in considerable cost savings of the tune-up
procedure.
Limitations of our study have to be considered. In Chapter 2 (Results, table 2) we described
that 14 patients had to be excluded, obscuring an actual intention to treat cost-analysis. It has
to be expected that the actual difference in costs would have become enlarged because of
these patients, who had been incorrectly enrolled in the GUTS. Another problem is that a few
patients were discharged to another hospital. From a macroeconomic point of view these costs
should have been included in overall costs, as they influence overall results. Similar
considerations have to be made regarding hospital readmissions related to late postoperative
complications of the primary surgical procedure.
The calculations may seem crude as it would have been more correct if a differentiation of all
costs involved could have been presented (medication, diagnostic and therapeutic additional
postoperative interventions at the ICU and the ward, including surgical reinterventions). We
also discarded the period of the day when patients were discharged from the ICU to the ward,
where others calculated ICU-costs in Euro/hr of ICU LOS and ward LOS.8 When ICU-costs
are dependent on mechanical ventilation, we should have separately differentiated the ICU-
costs for patients on and off the ventilator. We decided to calculate actual costs, therefore the
calculations also do not take into account the survival status of the patient at the end of the
hospital stay.
This study was performed in a tertiary hospital. It has also been shown that in the Netherlands
large differences exist between hospitals regarding overall costs of one day stay at the ICU or
at the ward.13
Therefore, the conclusions of this study have to be restricted to our hospital.
Taheri et al. showed that by a reduction of one hospital day cost savings are limited, since the
costs of the last days of hospital admission cover a small proportion of overall costs.14 This
phenomenon specifically considers patients undergoing major surgery and being admitted to
the hospital > 15 days.
Preoperative-ICU admission in abdominal aortic surgery has been shown to increase costs
specifically by increase in ICU LOS and hospital LOS.15 More recently specific perioperative
management has been developed on (major) vascular surgical procedures, without
preoperative ICU-admission, to achieve a ‘short track’.16,17 Reducing LOS by 33% resulted in
major cost savings.17 Reducing hospital LOS by ‘short track’ also has been described for other
high-risk surgical procedures.18,19 However, rapid discharge from the hospital may increase
costs in out of hospital health care.
We were not able to reduce ICU LOS and hospital LOS by GOHT. At the same time GOHT-
related costs appeared to be significantly higher when compared to a mixed group of high-risk
patients in our hospital who had not been exposed to a GOHT protocol. Moreover, others
have shown that perioperative management, directed at accelerating early postoperative
recovery by other strategies than GOHT, could significantly reduce ICU LOS and hospital
LOS. High-risk patients who evidently benefit from GOHT still have to be defined. Given the
absence of clear criteria to identify these patients we conclude that in our current practice
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The use of the pulmonary artery catheter (PAC) in critical care was heavily debated shortly
after the start of the Groningen University Tune-up Study (GUTS).1 Connors et al. published
a prospective cohort study on critically ill patients who were monitored and treated by using a
PAC. In this study comprising 5735 patients, case-matching analyses revealed that PAC-
monitored patients had a significantly higher mortality and ICU length of stay (LOS) than
non-PAC-monitored patients. The results raised much discussion on the methodology. The
accompanying editorial even called to ban the PAC. The earlier presumed benefits of using a
PAC in critically ill patients became, at the very least, a matter of dispute.
In Chapter 1 the literature till 1996 was reviewed to investigate the rationale of goal-oriented
hemodynamic treatment (GOHT) in high-risk surgical patients. Five prospective studies were
identified in which perioperative interventions were performed to correct hemodynamic
values to normal or ‘supranormal’ levels, mostly by using a PAC. In Chapter 2 the results of
the GUTS (1996-1998) were presented and discussed. Meanwhile GOHT in high-risk patients
was investigated in prospective clinical trials. In this chapter studies from 1996 on are
described that aim at improving clinical outcome in high-risk surgical patients since 1996.
The focus lay on studies regarding GOHT by using a PAC. Other non-PAC methods related
to optimization of general or regional perfusion are also described. These studies are
discussed in the context of perioperative medicine in high-risk patients undergoing major
noncardiac surgery.
GOHT in prospective clinical trials.
GOHT in patients undergoing major noncardiac surgery.
We used Pubmed to search for studies on GOHT, using combinations of the terms:
hemodynamic, optimization, pulmonary artery catheter, tonometry, pHi, cardiac index,
oxygen delivery, oxygen consumption, noncardiac surgery, major surgery, high-risk,
noncardiac, cardiac, surgical procedures, complications, critical(ly) ill, intensive care unit,
sepsis, sepsis syndrome. We could trace 13 prospective studies of GOHT in patients
undergoing (major) noncardiac surgery reported after 1996. The characteristics of the studies
are summarized in tables 1A – 1D. The studies comprise three main categories of surgical
patients: surgery for hip fractures, major vascular surgery and major noncardiac abdominal
and/or thoracic surgery. There are large differences in hemodynamic treatment. In three
studies ‘supranormal’ targets as defined by Shoemaker et al.2 were used as endpoints of
GOHT or were closely related to those targets.3-5 In two studies of vascular surgery, GOHT
was rather directed at a normalization of cardiac performance.6,7 Others used mixed venous
saturation8 or pHi9 (gastrointestinal pH, tonometry) to guide treatment to predefined values.
Treatment was started preoperatively in most studies. In four studies patients of the control
group stayed at the ward to compare the usual practice with preoperative interventions at the
ICU.3,5-7 Transesophageal echo Doppler (ED)-guided treatment protocols were restricted to




Table 1A. Prospective intervention studies on perioperative GOHT, with or without PAC
catheter, from1996 till 2005, summarized for year of publication, type of intervention, targets
of (hemodynamic) treatment and results.
major surgery







1. Sinclair, BJM, 199710
2. Ziegler, Surgery, 19978
3. Bender, Ann Surg, 19976
4. Valentine, J Vasc Surg, 19987
5. Pargger, ICM, 19989
6. Wilson, BMJ, 19993
7. Takala, CCM, 200015
8. Lobo, CCM, 20004
9. Venn, BJA, 200211
10. Gan, Anesthesiology, 200217
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(mc)-RCT, (multi-center) randomized controlled trial; ED, transesophageal Echo Doppler; SV, stroke volume; OR,
operating room; LSP, limb salvage procedure; AoR, aorta reconstruction; #, combined with 8 ≤ PCWP ≤ 12 and
SVRI ≤ 1100; ## pHi > 7.32; ###: DO2I > 550-600 mL/min, CI 3.5-4.5 L/min, MAP > 70 mm Hg, PCWP 18, HR <
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Table 1C Prospective intervention studies on perioperative GOHT, with or without PAC
catheter, from1996 till 2005, summarized for year of publication, type of intervention, targets
of (hemodynamic) treatment and results.
major surgery















reduction of cardiovascular complications
intra- and postoperative events, 0 vs. > 0, % of pts
intra- and postoperative events, 0 vs. > 0, % of pts
mortality
reduction of complications, minor or major (% of pts)
hospital mortality
morbidity, % of pts
28-day mortality
60-day mortality
time for medical fitness for discharge, days
hospital LOS ± SD
hospital mortality
postoperative morbidity, % of pts ≥ 1 complication
30, 60, 90, 120, 365-day mortality
20 vs. 12,  p < 0.05
27% vs. 25%, p=ns
7/53 (13.2%) vs. 7/51 (13.7%), p=ns
17% vs 25%, p=ns
5% vs. 2%, p=ns
31% vs. 24%, p=ns; 38% vs. 41%, p=ns
17% (control),  2% (adren), 4% (dopex), p=0.007
 61% (control), 50% (adren), 30% (dopex), ?
13% (placebo), 7% (dopex½), 15% (dopex2), p=0.13
50% vs 15.7%, p < 0.05
C 14 vs. CVP 10, p=0.008; C 14 vs. ED 8, p=0.035
7 ± 3 vs. 5 ± 3, p=0.03
7.7% vs. 7.8%, p=0.93
25% vs. 19%, p=ns
4.5% vs. 9.6% (30 day mortality), p=ns
9.6% vs.  12.6% (60 day mortality), p=ns
*Unless otherwise indicated, LOS is expressed as mean number of days; HDU, High Dependency Unit; OF, organ























(hospital mortality, median ICU/hosp. LOS)
hospital LOS
ICU or HDU LOS
serious adverse events, %  pts
organ dysfunction, % pts
ICU LOS, surv/nonsurv
Hospital LOS, surv/nonsurv
infectious complications, % of pts
postoperative morbidity, % of pts
(postoperative morbidity)
(hospital mortality, %)




(5%  vs. 9%)
(2% vs 2%; 12.0 vs. 12.5 days)
(13 vs. 13 days)
(8% vs. 3%, 1 vs. 1, 14 vs. 14)
22 (control), 19 (adren), 13 (dopex)
5.5 (control), 4.2 (adren), 3.3 (dopex)
43 (control), 39 (dopex½), 46 (dopex2)
13-73 (control), 9-75 (dopex½), 9-75 (dopex2)
6/6 (control), 5/10 (dopex½), 6/9 (dopex2)
24/10 (control), 21/15 (dopex½), 27/12 (dopex2)
67% vs. 32%, p<0.05
C 49%, CVP 26%, ED 23%, p=0.078
 (Oral intake ,p=0.01)
(4% vs. 6%, p=ns)
(10 vs. 10, p=0.41)
(13 vs. 13, p=ns)
22.5 vs. 17.3 days, p=ns; complic, p=ns
When secondary endpoints were not explicitely mentioned, data are placed in brackets.
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Peroperative ED-guided GOHT was beneficial in the two studies of elderly patients
undergoing surgery for a hip fracture.10,11 Patient recovery was faster, indicated by a
significantly shorter hospital LOS10 or by achieving a condition that was denoted as
“medically fit for discharge”.11 The study by Venn et al. consists of three study groups.11 Both
CVP- and ED-group monitored patients were significantly faster fit for discharge than
patients of the control group. All patients received general anesthesia, which may be unusual
nowadays. Additional regional anesthesia (‘3-in-1-nerve block’) was provided in 55%, 67%
and 67% of the control, CVP- and ED-group, respectively. The ED-group had less blood loss
and shorter surgical procedures, which may have confounded the results. Differences were
found regarding distribution of surgical interventions; significantly more dynamic hip screws
were placed in the CVP-group compared to the ED- and control group. Total hip arthroplasty
in the control group was 55% and 33% in the CVP- and ED-group. No differences were found
in mortality rates: 2/29 (6.9%) control, 6/31 (19.4) CVP; 3/30 ED (10.0%); p > 0.05. Overall
mortality was < 5%. Actual hospital LOS was similar. In the study of Sandham et al.5, 8.6%
of the patients underwent surgery for a hip fracture. These patients did not benefit from
GOHT regarding the primary endpoint mortality. Other investigators described the outcome
of a simple intervention of preoperative fluid challenge of 500 mL colloid or saline in patients
scheduled for fractured hip surgery.12 Although related to perioperative GOHT, this study
lacks a control group without preoperative fluid challenge as the study focused on potential
benefits of colloid vs. saline and not on GOHT. No differences were found in mortality,
neither in postoperative complications nor in hospital LOS.
GOHT in vascular surgery did not reduce mortality, postoperative complications or LOS at
the ICU or in the hospital (table 1).5-9 In two of those studies6;7 the protocol was used that was
developed earlier by Berlauk13 who deemed a CI > 2.8 L/min/m2 as ‘optimal’. Others used
continuously mixed venous saturation ≥ 65% as endpoint.8 In one of those studies the mean
number of postoperative complications per patient was higher in the protocol group (0.43 vs.
0.23) nevertheless the percentage of patients, ICU LOS, hospital LOS and mortality were
similar in both groups.7 In most studies from the late nineties, mortality was between 0 and
9%. It is of note that the in the earlier GOHT-studies by Shoemaker and Boyd, mortality rates
of the protocol groups were also in this range.2,14
In patients undergoing elective major noncardiac abdominal and/or thoracic surgery,
including vascular surgery, two randomized controlled trials on GOHT report a significant
reduction of mortality in the treatment group.3,4 Both studies had an exceptionally high
mortality in the control group. Wilson et al. found a reduction of 17% in the control group to
2% and 4% in the GOHT-groups3. This study was criticized for the unusually high mortality
rate in the control group and for the lower quality of care for patients of the control group.
The latter is illustrated by the fact that postoperatively 16 (34.8%) patients in the control
group and only 1 patient (1.1%) of both intervention groups postoperatively returned to the
ward via the recovery room, while the other patients were admitted to the HDU (high depency
unit) or ICU.
Lobo et al. described a reduction in 60-day mortality of 50% in the control group to 15.7% in
the protocol group in a mixed group of patients undergoing elective major surgery. Both
groups were treated by preloading and dobutamine, but in the treatment group higher values
of DO2 were strived for. The significant difference in mortality appears to be caused by 3 late
deaths in this small sample-sized study (table 1). Others, however, found no effects of GOHT
on any of the primary or secondary clinical endpoints in mixed groups of patients undergoing
major surgery.5;15;16 Only Gan et al. described a significant reduction in hospital LOS
(median: 1 day, mean: 2 days, p=0.03) in patients undergoing major surgery, who were
treated hemodynamically to achieve maximal cardiac stroke volume.17 The reduction in
&KDSWHU

hospital LOS was interpreted as a result of improved postoperative gastrointestinal function
(enteral feeding tolerance). Mortality in both groups was less than 6%.
The study of Sandham et al. is important because of its large number of patients (n=1994) and
the restrictive inclusion criteria applied (age, ASA-class). They investigated the impact of
GOHT in high-risk patients, who underwent elective or urgent surgery.5 Eligibility was
confined to elderly patients (≥ 60 years) with ASA-class III or IV. The majority of patients
underwent major vascular surgery (n=1108, 55.6 %). The study was designed to assess the
safety of perioperative application of a PAC and the influence on clinical outcome of
perioperative GOHT that started at the ICU the day before surgery. Although a higher rate of
pulmonary embolism was found in the treatment group, this did not effect clinical outcome.
Perioperative PAC in these patients was deemed safe but not benificial in the field of
perioperative care. The study was criticized regarding the chosen endpoints of hemodynamic
treatment, especially the limits of maximal values of HR (<120/minute) and PCWP (<18) and
for the fact that endpoints of GOHT were achieved postoperatively for CI in only 79.0% and
for DO2 in 62.9% of the patients. In the correspondence that followed the authors presented
additional results, showing that patients were not forced to achieve endpoints of GOHT at the
expense of tachycardia and overfilling.18
Stone et al. performed a randomized controlled trial of low-dose dopexamine (0.25
µg/kg/min) for 24 hours after surgery in 100 patients older than 60 years, who had undergone
elective major abdominal surgery. Cardiac performance was monitored in all patients by ED.
Fluid challenges were given with colloids till no further increase of SV was achievable
(increase of SV < 5% of the SV before the last fluid challenge). No differences were found
regarding postoperative morbidity. Interestingly, this group of investigators showed a
significant reduction of mortality by PAC-guided GOHT in an earlier similar study published
in 1999.3 They used POSSUM (Physiological and Operative Severity Score for the
enUmeration of Mortality and morbidity) to describe patient groups. POSSUM is a scoring
system specifically defined for surgical audit in the United Kingdom.19 In the recent study a
mortality rate of 4% in the control group and 6% in the protocol group was found, while its
predictions based on POSSUM-scores were 13 and 27%, respectively.
GOHT in patients undergoing cardiac surgery.
Polonen et al. immediately treated cardiac surgical patients during postoperative ICU-
admission to achieve supranormal values of DO2.20 This randomized controlled trial included
403 patients. The treatment group received more fluids and inotropes to achieve an SvO2 >
70% while lactate remained < 2.0 mmol/L during 8 hours postoperatively. The treatment
group had a significantly shorter hospital LOS (median 6 vs. 7 days in the control group, p <
0.05) and less morbidity at hospital discharge. Mortality rates 1, 6 and 12 months were less
than 5% in both groups.
GOHT in trauma patients, critically ill patients and patients with sepsis and septic
shock.
The design and results of studies of GOHT in trauma patients, critically ill patients at the ICU
and patients with sepsis and septic shock are summarized in tables 2A – 2D.
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Table 2A. Prospective interventional studies on perioperative GOHT, with or without
pulmonary artery catheter, from 1996 till 2005, summarized for year of publication, type of
intervention, targets of hemodynamic treatment and results.
trauma & sepsis
Authors, journal name, year of
publication
number of patients,
number of study groups
surgery study design
1. Durham et al., J Trauma, 1996
2. Chang et al.J Trauma, 1997
3. Yu et al., CCM, 1998
4. Alia et al., Chest, 1999
5. Velmahos et al., Ann Surg, 2000
6. Gomersall et al., CCM, 2000
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supranormal CI, DO2I, VO2I(#)
RVEDVI > 80 mL/m2, adeq syst perf
DO2I 450-550 vs. > 600 ml/min
DO2I > 600 ml/min
supranormal CI, DO2I, VO2I(#)
gastric tonometry guided treatment






















TED, transoesophageal Echo Doppler; SV, stroke volume; OR, operating room; LSP, limb salvage
procedure; AoR, aorta reconstruction; RVEDVI, indexed right ventricle end diastolic volume; EGDT,
early goal-directed therapy;
#DO2I > 600 mL/min, VO2I > 150 mL/min;  #, combined with 8 ≤ PCWP ≤ 12 and SVRI ≤ 1100; ## pHi
> 7.32; §, in subgroup of patients undergoing aortic surgery
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Table 2C Prospective interventional studies on perioperative GOHT, with or without
pulmonary artery catheter, from 1996 till 2005, summarized for year of publication, type of
intervention, targets of hemodynamic treatment and results.
trauma /  sepsis













ICU mortality, hospital mortality
30, 60 day and hospital mortality
11% vs. 10%, p=0.85;  67% vs. 73%, p=0.58
9% vs. 33%, p <0.01;  11%  vs. 33%, p<0.05
21% vs. 52%, p<0.01
66% vs. 74%, p=0.46
15% vs 11%, p=0.742
39.6% vs. 38.5%, p=ns; 45.3% vs. 42.3 p=ns
46.5% vs, 30.5%, p=0.001




trauma /  sepsis








(ICU LOS, LOMV, hospital LOS)
(ICU LOS, hospital LOS)
(ICU LOS, hospital LOS)
organ dysfunction per patient
(OF, complications, LOS)
(OF, ICU and hospital LOS)




2.1 vs. 2.6. (p=0.12)
(ns)
(ns)
p < 0.001 at 6 and 72 hours after therapy
OF, organ failure; LOMV, length of mechanical ventilation in days, APACHE II, Acute Physiology and
Chronic Health Evaluation II, SAPS, Simplified Acute Physiology Score.




Durham et al. randomized 58 critically ill trauma patients to a control (n=31) and a protocol
group (n=27), using entry criteria as defined earlier by Shoemaker et al.2 Treatment in the
protocol group was directed at achieving and maintaining DO2I > 600 mL/min or VO2I > 150
mL/min for 24 hours after study entry, whereas in the control group a MAP > 60 mm Hg and
CI > 2.5 L/min was deemed satisfactory. No differences were found in mortality, ICU LOS or
hospital LOS. The occurrence of organ failure was significantly higher in patients with a DO2I
< 600 L/min (88% vs. 59%, p < 0.02).
Velmahos et al. resuscitated 75 trauma patients in a prospective randomized controlled trial in
which control patients were to achieve a CI of 3.5 L/min, whereas in the protocol group
treatment was directed at achieving a CI > 4.5 L/min.21 Patients were monitored
hemodynamically using both bioimpedance and a PAC. Patients with brain and spinal cord
trauma were excluded. Similar results were achieved in both groups. An interim analysis was
performed after 2 years of patient entry. It was expected that a difference in mortality was
extremely difficult to detect. Therefore the study was terminated preliminary; its projected
sample size exceeded 500. Comparing achievers (n=33) and nonachievers (n=42) showed that
nonachievers had a significantly higher mortality rate (30 vs. 0%, p=0.0001), organ failure
(70 vs. 29%, p=0.0005) and a longer ICU stay (21 ± 24 vs. 10 ± 11 days, p=0.017). The
authors concluded that these findings support the concept that achieving high values of
hemodynamics are an indication of preserved physiologic capacity. They also note that
interventions directed at achieving predefined values may have been detrimental as the
mortality rate of nonachievers in the protocol was 50%, compared to 19% in the nonachievers
of the control group (p=0.11). Age was the most important predictor for achieving predefined
values of GOHT.
o Critically ill patients, patients with sepsis and septic shock.
In Chapter 1 the study of Hayes et al. was discussed.22 In 1997 they showed that survivors
were also responders to treatment, whereas in nonsurvivors DO2I and VO2I were significantly
lower and these patients were not able to clear lactate.23
Yu et al. reported a significant reduction of mortality in a subgroup of patients aged 50-75
years, who were treated to achieve a DO2I > 600 mL (21% vs. 52% in the control group,
p=0.01).24 From earlier work of this group it is comprehensible that they choose to include
patients older than 50 years in their study.25 They clarify the stratification into these age
groups (50-75 years vs. > 75 years) with the fact that older age is accompanied by reduced
values of DO2I and VO2I. The authors suggest that the study was designed as such, but the
choice of the cutoff point at 75 years seems arbitrary. The overall mortality in the control vs.
the protocol group is not significantly different (protocol group 33% vs. control group 56%,
p=ns).
Alia et al. randomized 63 patients with severe sepsis and septic shock. Patients were treated
till hemodynamically stabilized by preloading with crystalloids, blood transfusion to maintain
Hb > 6.0 mmol/L, ventilatory conditions to achieve SaO2 > 90% and dopamine to maintain
MAP > 60 mmHg. The controls were treated to achieve a DO2I > 330 mL/min, while in the
protocol patients the endpoint of therapy was a DO2I > 600 mL/min. ICU-mortality was
similar (66% in the control and 74% in the treatment group, respectively, p=0.46), neither
were differences found regarding the number nor organ dysfunctions per patients (table 2).
The tonometry values were similar for both groups during a follow-up period of 4 days.
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Gomersall et al. conducted a randomized controlled trial in critically ill patients who were
resuscitated using tonometer-guided therapy. No differences were found regarding ICU or
hospital mortality, organ failure or ICU or hospital LOS. Tonometer results correlated with
outcome. The authors concluded that tonometer results may be better indicators of severity of
disease than a pathophysiologic substrate that can be used to guide therapeutic interventions.
Rivers et al. used central venous SvO2 to diagnose at hospital admission the severity of a
compromised circulatory condition in severely septic patients. All patients were resuscitated
immediately. They were treated to achieve predefined classical endpoints (CVP ≥ 8-12
mmHg, MAP ≥ 65 mmHg, UOP > 0.5 mL/kg/hr), whereas patients of the treatment group
were concomitantly SvO2-monitored and therapy was directed to achieve SvO2 ≥ 70% (Early
Goal Directed Therapy, EGDT). The treatment group received more fluids to achieve a
central venous saturation ≥ 70%. Significant reductions in APACHE II and SAPS II scores
were found and the in-hospital mortality was lower in the treatment group. (46.5% vs. 30.5%,
p=0.009).
GOHT in retrospective studies
GOHT in mixed groups of surgical patients undergoing major noncardiac surgery.
Four retrospective studies concerning GOHT in surgical patients were published since
1996.26-29 The retrospective studies by Curran et al. and Flancbaum et al. show a large
difference in mortality rates.26,27 Flancbaum et al. present a significant reduction of
cardiovascular complications in noncardiac and nonthoracic surgical patients who had been
normalized preoperatively to values of PCWP > 10 mmHg and Hb > 8 g/dL (4.85 mmol/L).26
They report an in-hospital mortality of < 2.5% in both groups. Curran et al., however, found a
much higher mortality rate, up to 30% in high-risk surgical patients as defined by Shoemaker
and Boyd.27 Half of the patients underwent emergency operations. The authors compared
actual with predicted mortality rates using POSSUM scores. They found a significant
reduction of mortality in patients with the highest risk for perioperative complications and
mortality (predicted mortality, 57% vs. actual mortality 30%, p=0.024).
Sandison performed a partially retrospective and prospective study on urgent or emergency
surgery for aorta aneurysm in two hospitals in the United Kindom.28 One hundred forty-five
patients were reviewed with 68% undergoing urgent surgery. The rate of PACs used in one
hospital was 96% of the patients, while in the other hospital 18% of the patients had a PAC.
Preoperative patient characteristics and intraoperative data were similar in both hospitals.
Postoperative management in the hospital in which more PACs were used was characterized
by the use of significantly more fluids and vasoactive substances for the first 24 hrs after
surgery at the ICU. In the hospital in which PAC monitoring was common in the
perioperative management of patients with aorta aneurysm surgery, postoperative mortality
was higher (28% vs. 9%, p=0.0068) and both ICU and hospital LOS were significantly
longer. The authors suggest that PAC-guided postoperative interventions, such as a more
liberal use of fluids, had a negative impact on clinical outcome in these patients.
Kavarana et al. performed a retrospective study in patients > 65 years, undergoing elective
colon surgery.29 Two hundred and seventy-seven patients were studied in a ten-year period
(1985-1995). They compared patients who were monitored perioperatively with a PAC (PAC
group) to patients who were not monitored with a PAC (no-PAC group). Patients of the PAC-
group (n=60) received GOHT. Setpoints for preoperative GOHT were used as defined earlier
by Berlauk et al.13 Patients within the groups were stratified using the Goldman-CRI scoring
(< 10 vs. ≥ 10).30 Twenty patients (33.3%) of the PAC group and 38 patients (21.2%) of the
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no-PAC group had a CRI ≥ 10. The PAC group had a significantly higher CRI (10 vs. 8, p <
0.05). The cardiopulmonary history of both groups was comparable. Mortality in the entire
population was 4.3% (PAC-group 3.3%; no-PAC group 4.6%). However, patients with a CRI
≥ 10 in the no-PAC group had a higher mortality (15.8% vs. 5% in the PAC group and CRI ≥
10, p < 0.001). The authors attributed this result to the effects of the PAC-guided GOHT.
Other prospective (observational) studies in high-risk patients. PAC-monitoring & pre-
operative fluid optimization.
Prospective observational studies.
Shoemaker et al. continued their monitoring studies on critical ill patients, without
interventions to achieve ‘supranormal’ values of global perfusion. Noninvasive monitoring
(bioimpedance and percutaneously measured O2 and CO2 tension) was compared to invasive
monitoring (PAC) in an observational multicenter study on 680 critically ill emergency
patients.31 Two hundred and sixty-eight patients were monitored at the emergency department
(139 trauma patients, 129 nontrauma patients), 274 patients were monitored during
perioperative emergencies and 138 patients after ICU admission. Noninvasively obtained
values of perfusion and circulation correlated with invasively acquired values. Nonsurviving
patients were found to have significantly different patterns of hemodynamics and regional
perfusion compared to surviving patients. It is unclear whether management of these patients
contained a specific protocol on GOHT. The publication was severely criticized by an
accompanying editorial in the context of the earlier published study of Connors et al.1,32 The
criticism was specifically directed at the limitations in the methodology and the clinical
relevance of the monitoring as proposed by Shoemaker et al.
The group of Shoemaker et al. published another prospective study of 356 high-risk surgical
patients.33 They used the earlier defined criteria to select patients, who underwent major
surgery.2 The focus of this study is solely on the early development of circulatory deficiencies
after surgery. The in-hospital mortality was 25%. Nonsurvivors’ circulatory conditions were
characterized by cardiac failure and deficiencies of global perfusion that gradually developed
during surgery. The authors did not comment on the fact that many of these values already
differed preoperatively. Survivors’ and nonsurvivors’ demographics were not presented. Such
preoperative differences may explain differences in circulatory performance. It cannot be
excluded that the described differences may result from other confounding perioperative
clinical variables.
Polanczyk et al. performed a prospective, observational study in elective, high-risk,
noncardiac surgical patients ≥ 50 years (n=4059).34 Two hundred and twenty-one patients
were monitored perioperatively by a PAC. The entire population was used for a case-matched
controlled study on the perioperative use of a PAC. Two groups of 215 patients were
compared for major cardiac and noncardiac events. Perioperative usage of a PAC was
associated with significantly more heart failure (13 vs. 5%, p=0.006) and major noncardiac
complications (10% vs. 5%, p=0.04).
Preoperative fluid optimization in low/medium risk surgical procedures and ambulant
surgery.
Preoperative fluid administration (20 mL/kg) significantly reduced postoperative incidence of
thirst, drowsiness and dizziness in patients undergoing short ambulatory surgery.35 A study of
fluid preloading (15 mL/kg) in patients planned for a laparosopic cholecystectomy
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significantly reduced postoperative nausea and vomiting (PONV).36 A similar study in
gynecologic patients showed that 30 mL/kg cristalloids was more effective than 10 mL/kg to
reduce PONV. Others found a significant reduction of PONV and a facilitated postoperative
recovery in patients undergoing major noncardiac, surgery after the intraoperative usage of
colloids instead of saline.37
These studies were not performed on high-risk patients and the surgical procedures were
restricted to minor or medium size abdominal surgery. Nevertheless, in these studies it was
tried to improve the hemodynamic performance by fluids. In these studies a liberal
perioperative use of fluids resulted in significant improvements in postoperative recovery.
However, it is unclear whether these differences in postoperative side effects are a result of
improved preservation of organ function and more stable hemodynamic performance, or that
the improved outcome is a result of accelerated clearance of anesthetics and analgetics in the
patients who received significantly larger amounts of fluids.
Restrictive perioperative fluid regimens – the opposite of GOHT.
A key issue of GOHT is the liberal perioperative use of fluids. Recently two studies were
published that contain an ‘anti-Shoemaker’ approach as these studies investigated effects of
perioperative fluid restrictions and its effects on clinical outcome in major abdominal surgery.
Standard (≥ 3 L, 154 sodium mmol/day) and restrictive postoperative fluid management (< 2
L and 77 mmol sodium/day) was compared in a randomized controlled trial of 20 ASA I and
II patients who underwent colon resection.38 The 10 patients of the treatment group had a
significantly faster recovery of gastrointestinal function, less complications and a faster
discharge from the hospital (postoperative median LOS 6 vs. 9 days, p=0.001).
Brandstrup compared two perioperative fluid regimens in a randomized clinical multicenter
study, containing 176 patients undergoing colorectal surgery.39 Twenty-nine patients were
excluded from analysis for several reasons. The treatment group had a restricted fluid
management that aimed at maintaining the patient’s body weight unchanged. More patients of
the standard group had postoperative complications (51% vs. 33% of the treatment group,
p=0.013). Postoperative mortality was 4.7% and 0% in the standard group and treatment
group respectively (n=0 vs. n=4, p=0.14).
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Meta-analysis and reviews / expert opinion on GOHT in noncardiac surgical patients.
Six meta-analyses have been published on GOHT in surgical patients since 1996. Table 3
depicts an overview of all included studies in order of the year of publication. Heyland et al.
critically reviewed the literature on PAC-monitored patients by discerning studies that started
hemodynamic treatment preoperatively and after ICU admission.40 Intervention studies using
the PAC to guide treatment to ‘supranormal’ values of CI, DO2 and VO2 was considered
effective when started preoperatively (combined odds ratio 0.2, 95% CI 0.07-0.55). The meta-
analysis of Ivanov et al. focused on the outcome variable ‘morbidity’ and found that GOHT
was effective (odds ratio 0.58 , 95% CI 0.36-0.94).41 This meta-analysis included most of the
studies analyzed earlier by Heyland et al. Others restricted the meta-analysis to patients
undergoing major vascular surgery and found that the use of a PAC in these patients did not
improve outcome when applied routinely.42 Studies included in this analysis have in common
that the PAC was used for GOHT perioperatively.
Kern and Shoemaker compared studies that started GOHT before and after the development
of organ failure.43 They concluded that mortality rates could be reduced by GOHT in high-
risk patients with a mortality rate of > 20% only if instituted before signs of organ failure
developed.
Boyd reviewed 17 GOHT studies and calculated a reduction in mortality of 0.45 (0.33-
0.60).44 He found that the higher the mortality rate the more improvement could be achieved
by GOHT. He states, however, that “it is difficult to assess which patients may benefit most
from cardiovascular optimization, information is lacking and there are as yet no formal
scoring systems that have been shown to be useful in this situation.”
Recently a meta-analysis was published on perioperative fluid optimization in patients
undergoing surgery for a hip fracture.45 The authors concluded that ED-guided hemodynamic
treatment may shorten hospital stay.
Discussion
At first sight the results of the described studies of perioperative GOHT seem controversial.
These studies have in common that treatment was directed at improving general or regional
perfusion to normal or supranormal levels in order to reduce mortality rate and accelerate
discharge from ICU and hospital by reduction of complications and/or improving
postoperative recovery.
The conflicting results and the differences in the design of the described studies raise many
issues and need clarification: which patients should be treated, i.e. only high-risk for medical
or surgical conditions, whether a cut-off point should be handled for age, whether only
patients for elective surgery should be included or also patients admitted for emergency
surgery and trauma patients, whether only patients should be included undergoing
intraperitoneal surgery or also other categories of extensive surgery, and, when effective, how
early before surgery GOHT should be started, which hemodynamic parameter should be
treated and to what level, whether colloids should be part of such a strategy, what type of
inotropic support should be applied if increase of preload is insufficient to attain protocol




Table 3. An overview of the studies included in the six meta-analyses on GOHT in different
groups of patients.
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A meta-analysis could help to clarify the differences in outcome. Mackenzie commented that
this method is hindered by methodological problems, as the studies are characterized by large
heterogenity in patients, surgical procedures and treatment strategies.46 Nevertheless, a
number of meta-analyses were performed.40-45 When the results are compiled, arguments in
favor of GOHT may emerge in specific conditions of perioperative medicine: GOHT is
effective when started before the development of organ failure and in patients with a risk for
mortality greater than 20%.43,44 It would then be reasonable to identify patients with a
mortality risk greater than 20%. Emergency procedures are well known for higher mortality
rates compared to elective surgery. However, mortality rates greater than 10% in series of
patients undergoing elective surgery should raise concerns. We deem such outcome as
abnormally high in the context of mortality rates reported in elective major surgical
procedures (Chapter 1). When this criterion is used it seems impossible to select patients
electively undergoing major noncardiac surgery who may benefit from GOHT.
Combining demographic patient data also does not provide a simple instrument that may
easily identify such patients. Takala has suggested that 3 or more high-risk criteria according
to Shoemaker may help to identify the patients that may benefit from GOHT.15 However, a
prospective randomized controlled trial in such a selected group still has to be performed.
Sandham et al. only included a selection of high-risk patients (patients > 60 years and
classified as ASA-class ≥ 3).5 GOHT however, did not surpass perioperative management of
the control group in this large study.
Also, GOHT does not reduce morbidity or accelerate postoperative recovery in most studies.
Measuring efficacy of GOHT by variables such as a reduction of postoperative morbidity,
LOS in the ICU or the hospital raises some methodological problems. Different sets of
complications are used in the reviewed studies. Some only present percentages of the number
of patients who developed complications. Others denote complications arbitrarily as minor or
major. The relevance of a reduction of complications would be evident when the result could
directly be translated into a reduction of ICU- or hospital LOS. However, these clinical
endpoints are also influenced by variables other than clinical recovery of the patient.47
When perioperative GOHT could be beneficial for a selected group as some have suggested,
these high-risk patients have to be identified. The next step should be that prospective
randomized controlled trials of GOHT in such carefully selected patient groups are performed
to demonstrate the efficacy of GOHT. Till now, only ED-guided treatment of elderly patients
undergoing hip fracture surgery has been shown to have short term benefits.45 Considering
major surgery, in particular abdominal surgery, GOHT of any type has remained
controversial.
Identification of patients at high-risk for morbidity and mortality is the major problem.44 For
risk assessment of an individual patient a lot of population based data are available in
different risk stratifying systems (Chapter 1). Assessment of the risk of cardiac morbidity and
mortality has been well established.48 Recently a risk index to predict postoperative
pneumonia has been developed and validated.49 Others have been variably successful in
finding better predictors of outcome than the ASA-class stratification that was mostly used.50-
54
 The POSSUM-score was developed in the United Kindom. It seemed a promising
instrument that accounted for many clinical variables which could be easily performed and
help in predicting outcome.19 This scoring system, however, has not been validated
sufficiently. Recent studies show that the predicted and actual morbidity and mortality do not
correlate outside the United Kingdom, nor in the United Kingdom recently.16,55,56 The
predicted morbidity and mortality rates overestimate actual data. Widespread application of
POSSUM as a tool to identify high-risk patients still is not helpful to identify the patient at
high-risk for postoperative morbidity and mortality.
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The strong correlation of high (‘supranormal’) values of global perfusion and survival has
been explained as a result of à priori existing differences in cardiorespiratory performance
(Chapter 1). Most scoring systems provide an estimation instead of performing a test of the
actual preoperative condition of an individual patient or a specific organ system. Studies on
exercise testing before surgery are available to get specific information about the reserve
capacity of the cardiorespiratory system in individual patients. Results of a simple bicycle
exercise test strongly correlated with postoperative cardiopulmonary morbidity and
mortality.57 Another simple exercise test has also shown to be a sensitive marker for the
prediction of postoperative cardiopulmonary complications.58
Older and Smith first used preoperative invasive monitoring at the ICU for assessment and
treatment of cardiorespiratory and renal function, in addition to the usual preoperative work-
up in patients planned for major noncardiac surgery.59 Later they turned the focus on the
actual dynamics of the cardiorespiratory performance in individual patients to predict
outcome.60 They used preoperative exercise testing to identify cardiac failure in addition to
cardiac ischemia. Patients with an anaerobic threshold (AT) < 11 mL/kg/minute had a
significantly higher mortality rate (18 %) when compared to patients with an AT > 11
mL/kg/minute (0.8%, p < 0.001). The combination of cardiac ischemia and heart failure was
associated with a mortality rate of 42%. They successfully used exercise testing as an
instrument to decide for pre- and postoperative admission to the ICU or postoperative
admission to the HDU or ward in 548 patients.61
In the study of Sandham et al. 16% of patients had a history of heart failure and they describe
symptoms of heart failure in 12% of patients during the study.5 Heart failure was not
incorporated in their regression analysis to correct for potential confounders. Therefore it is
unknown whether this variable could have helped to identify a subgroup of patients that may
have benefitted from PAC-guided GOHT.
Girbes and Groeneveld emphasized that in general perioperative GOHT-protocols are
insufficiently directed to the individual condition of patients.62 Fixed values of global
perfusion as advocated in the past by Shoemaker et al.2 do not fit to the individual condition
of patients. Velmahos et al. found indications that treatment to achieve ‘supranormal’ values
in ‘nonresponders’ even may result in worse outcome.21 Limitations in achieving such values
were met in different studies.5,31 The unattainability of such values should not be interpreted
as a result of insufficient treatment but as a result of limited cardiorespiratory capacity.
ED-guided treatment is the only method until now that takes the patient’s individual cardiac
performance into account when the goal of treatment is defined as achieving maximally
attainable global perfusion. This treatment is characterized by administration of fluids till no
further increments of SV occur. The optimal value is then primarily the patient’s individual
maximal value instead of a fixed, population-derived hemodynamic endpoint. Efficacy of ED-
GOHT in randomized controlled trials has been shown in patients undergoing surgery for hip
fractures and in one study of patients undergoing major abdominal surgery.17,45
When the findings of Older et al. are combined with results obtained in prospective
randomized controlled trials of GOHT as summarized in tables 1A and 1B, it can be
hypothesized that in these studies subgroups of patients, who may have benefit from GOHT,
are masked by the entire group. Although exercise testing may help to identify patients who
may benefit from GOHT with a high sensitivity and specificity, the additional value of GOHT
in such selected groups still has to be proven. Older et al. preoperatively admitted patients to
the ICU when they were at high-risk (AT < 11 mL/kg/min) or when they had been planned
for surgery of the aorta or the esophagus.61 These patients were hemodynamically treated, but
the authors did not specify interventions nor did they present data of obtained endpoints of
any kind of GOHT. The hospital mortality in the subgroup of patients with an AT < 11
mL/kg/min was 4.6%. This is a reduction compared to the mortality rate of 18% in 1993.60
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This may indicate that preoperative ICU admission and hemodynamic treatment is beneficial
in selected patients. Identical suggestions come from the retrospective study by Kavarana et
al.29 They stratified patients using the Goldman CRI that partially may help to identify
conditions of heart failure. However, a prospective randomized controlled trial evaluation of
efficacy of GOHT in high-risk patients selected on basis of exercise testing has yet to be
conducted. It is of note that in the study of Older et al. patients with an AT < 11 mL/kg/min
noncardiac causes accounted for 58% of mortality.61
Treatment directed at maximal values of global perfusion aims to achieve optimal regional
perfusion to prevent or reverse organ dysfunction and/or failure.63. Although gastric-pHi
(tonometry) has been shown to be a strong predictor of outcome,64-67 pHi-guided GOHT in
prospective studies of elective surgery was not shown to be efficacious.9 Since adequate organ
perfusion and oxygenation are presumed to play a key role in prevention of organ dysfunction
and failure, new devices were developed for continuous monitoring of regional oxygen
supply, perfusion and/or metabolism.68,69 Direct measurement of regional flow, pHi or derived
parameters have been suggested to be helpful to guide perioperative management that may
improve overall outcome.70,71 Studies in vascular surgery have focused on perfusion-related
dysfunction of the intestine.72-75 In a study of colonic surgery and regional measurement of
organ perfusion, a reduction in blood flow correlated with postoperative anastomotic
leakage.76 Regional perfusion and oxygenation during esophageal surgery can be monitored
and modified; this may improve results of the operative procedure and eventually patient
outcome.77,78
The novel approach of perioperative fluid restriction in patients undergoing colon surgery
constitutes the opposite to the liberal use of fluids as proposed in all studies of perioperative
GOHT. A few studies have been published and results suggest that fluid-restrictive regimens
are efficacious in improving clinical outcome.38,39 This adds fuel to the ongoing controversy
of perioperative fluid management and whether ‘supranormal’ or normal should be the ideal
targets. It has to be emphasized that both studies included mainly ASA I/II patients and in one
study fluid restriction was explicitly confined to the postoperative period.38 It also illustrates
that the term ‘high-risk’ is insufficiently defined. Fluid restriction may benefit outcome in
colon surgery. Whether such a regimen should have a place in other categories of surgery and
in patients classified as ASA ≥ III is unknown.
Kehlet has advocated to combine different proven and/or presumed beneficial strategies in
perioperative medicine into one multimodal approach to enhance postoperative recovery.79;80
Studies that included perioperative pain management, early postoperative enteral feeding,
early mobilization and other interventions in patients that fulfill ‘high-risk’ criteria have been
shown to be very effective in reducing complications, hospital LOS and costs.81-86 These
multimodal approaches or strategies denoted as ‘short track’, ‘fast track’ or ‘clinical pathway’
obviously have a major impact on clinical outcome without any specific interventions that
could be described as GOHT.
Conclusion
Studies of GOHT performed during and after the GUTS show that in a majority of the studies
GOHT-outcome, expressed as a reduction of mortality, was only improved in populations
with a mortality rate greater than 15-20 %. These are unusually high values of mortality in
electively operated patients.
However, data from the literature do not exclude the possibility that patients with a restricted
cardiorespiratory condition could benefit from preoperatively started management of
continuous cardiopulmonary monitoring and treatment. Individual titration of interventions
might be crucial. Stroke volume may be the variable of global perfusion that should be
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modified in relation to patient’s individual performance. The location and timing of such a
GOHT has to be defined.
The majority of patients undergoing major noncardiac surgery, however, do not benefit from
additional preoperative hemodynamic treatment. It is of major importance that in
perioperative medicine the combination of therapies, that specifically aim for a fast recovery
by different modalities, have been shown to be efficacious in multiple studies. GOHT should
be employed neither alone nor in combination with other therapies aimed for a fast recovery
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Heart rate (HR) and blood pressure (BP) are classical variables that can be monitored
continuously for evaluation of the hemodynamic condition of critically ill patients. The
introduction of the pulmonary artery catheter (PAC) allows clinicians to be informed about
central hemodynamic pressures and cardiac performance. PAC-derived values of global
perfusion (CI, DO2I, VO2I) significantly discriminated surviving from nonsurviving patients.
The pathophysiology of oxygen transport and utilization was conceptualized as an oxygen
debt that should be timely corrected. The effect of this treatment was studied in prospective
studies, in high-risk surgical patients and also in other groups, such as patients suffering from
septic shock or trauma.
The study published by the group of Shoemaker in 1988 became a reference for identification
and treatment of surgical patients who could benefit from goal-oriented hemodynamic
treatment (GOHT). During the early nineties of the twentieth century promising results of
perioperative GOHT were published. Others criticized these studies for weaknesses in design
and bias from case mix and other potential confounding variables (Chapter 1).
The Groningen University Tune-up Study (GUTS) was designed to study the impact on
clinical outcome of GOHT in patients undergoing major elective noncardiac surgery.
Standard preoperative management was compared with GOHT, starting at the ICU
preoperatively.
Conclusions from the thesis
The major problem that had to be faced was that the study could not be completed for logistic
reasons. The study is now underpowered. Therefore, firm conclusions cannot be drawn.
Nevertheless, the analyses performed suggest that GOHT does not improve outcome.
The study was focused on a reduction of complications. Although at first sight GOHT seemed
to reduce postoperative complications, a more thorough analysis showed that these results
were confused by clinical variables. The same conclusions were made regarding secondary
endpoints: ICU length of stay (LOS) and hospital LOS. Also, the hospital mortality was very
low in the GUTS (2.4%).
A large group of patients eligible for the GUTS and planned for postoperative ICU-admission
was not randomized. This group was comparable regarding preoperative scoring and
underwent similar surgical procedures as randomized patients who were admitted to the ICU
postoperatively (n=110; hospital mortality 2.7%). Mortality was somewhat higher in this
group (6.8%), but no differences were found regarding ICU and hospital LOS when corrected
for potential counfounding variables.
Costs for patients enrolled in the GUTS were calculated, using a model of overall hospital
costs that mainly accounted for costs of ICU and hospital days. In the GUTS, overall costs in
both groups were similar. Costs of patients admitted to the ICU postoperatively were
calculated separately for patients of the GUTS and nonrandomized patients. Costs of the
GUTS-groups were significantly higher.
Mortality, ICU LOS and hospital LOS of high-risk patients were evaluated and the results
compared to those described by others in similar patients. In our (underpowered) study GOHT
did not significantly improve the outcome in high-risk patients.
A critical review of the literature shows that GOHT only improved clinical outcome in a few
prospective studies of mixed groups of high-risk patients. These studies have in common an
unusual high mortality (15-20%) in the control group. The efficacy of GOHT in the reduction
of mortality and faster postoperative recovery may have been caused by an undertreatment of
the control groups. However, the conclusion that GOHT is efficacious in high-risk patients
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has faded with time. Nevertheless, it can not be excluded that some high-risk patients indeed
may benefit clinically from any kind of preoperative GOHT. These patients and their
appropriate hemodynamic management, however, still need to be identified.
Perspectives – the problem of defining ‘high-risk’
The definition of ‘high-risk’ in surgery has been poorly defined. It is unclear whether the risk
refers to the patient’s condition, the surgical procedure or both. The content of risk may be
specialty-related. From an anesthesiologic perspective, perioperative cardiorespiratory
function, airway management, metabolic changes and pain management are key issues. From
the surgical perspective the emphasis lays on postoperative complications of the surgical site
and detrimental effects on organ function and recovery that may lengthen hospital stay or
even increase the risk of death. Some postoperative complications are related to specific
surgical procedures, i.e. anastomotic leakage in surgery of the intestinal tract or ischemia of
the colon after abdominal aortic surgery. The ACC-guidelines for perioperative management
are confined to the cardiac risk.1 Limitations in other organ systems and its related risk for
postoperative morbidity and mortality are reflected in the physiologic part of the POSSUM-
score. Factors that are associated with the postoperative pulmonary complications have
recently been identified and validated in a large study.2,3
Major noncardiac surgery is usually labeled as high-risk, yet many patients uneventfully
undergo major surgical procedures.
These issues at least make it necessary to redefine, qualify and quantify the content of ‘high-
risk’ in the future.
Perspectives – defining endpoints in strategies of perioperative medicine to improve
postoperative outcome
In case of management of disease, disease-free survival and survival rates are primary
outcome measures. In perioperative medicine the focus in high-risk surgical patients is on
improving outcome by reducing hospital mortality and morbidity. Mortality is expressed
mostly as surgical mortality (30-day mortality) or hospital mortality; in some studies the
window of follow-up extends to a postoperative period up to 12 months or even more.
In this thesis problems are discussed by measuring the quantity and quality of perioperative
morbidity. Different studies use different lists of complications. When a significant reduction
in complications is found, this may be a result of a narrowed focus on the overall clinical
image. The selection of complications may result in biased conclusions in advantage of new
therapeutic strategies, while the clinical relevance of the selected complications is not taken
into consideration. The clinical impact of complications should be accounted for, especially
when complications result in ICU-readmission or lengthen hospital stay. A single
complication may vary extensively in severity and clinical impact. It is of note that a majority
of complications occur in a minority of patients.4 The percentage of patients without
complications has been presented as an alternative endpoint. The clinical impact of
complications is best reflected in hospital mortality, ICU LOS and hospital LOS.4,5
Improving outcome in high-risk patients – the perspective beyond GOHT
The problem of postoperative mortality and morbidity in major noncardiac surgery has been
approached by other strategies than GOHT. Combining such strategies was shown to be
highly effective in reducing mortality, morbidity and LOS in specific categories of patients
undergoing major noncardiac surgery, or so called ‘high-risk’ patients.6,7 Implementing
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clinical pathways in elective abdominal aortic surgery was successful in reducing ICU LOS,
hospital LOS and costs.8-10 Modification of perioperative medicine in colon surgery and other
major abdominal procedures has also been shown to be effective in reducing postoperative
hospital LOS and/or costs and appeared to be safe.7,11-15 In none of these studies GOHT was
part of the overall strategy to accelerate and improve postoperative recovery. First, this shows
that other factors than GOHT can significantly improve postoperative outcome.6,16 Secondly,
this shows that many of those factors may interfere with postoperative outcome in studies
specifically designed to test the efficacy of GOHT. Whether postoperative outcome represents
the quality of perioperative medicine is still a matter of discussion.17,18 But identification of
the factors involved may result in modified patient care to improve outcome.
Preoperative nutritional condition has been established as a patient factor that determines
postoperative outcome19,20; treatment in selected patients (weight loss ≥ 10%) improved
outcome.21
Patients with increased cardiovascular risks may benefit from medical treatment by beta- and
calcium blockers or alpha-2-agonists.22
Other items have become key issues in major surgery. Maintenance of normothermia has
beneficial effects on postoperative outcome.23 New developments in blood transfusion
strategies have been suggested to improve postoperative outcome.24
Postoperative pain treatment by epidural anesthesia25,26, early postoperative enteral feeding27
and early mobilization are beneficial, i.e. improve postoperative outcome. Combining such
strategies into one multimodal approach has been strongly advocated in patients undergoing
major noncardiac surgery.6 Careful postoperative clinical monitoring for early detection of
postoperative abnormal or detrimental course may further reduce the impact of postoperative
complications28 Postoperative admission to different levels of care was shown to reduce
postoperative ICU-admissions29
For esophageal resections and pancreaticoduodenectomies in cancer surgery, modification of
the surgical procedure significantly reduced postoperative morbidity, ICU los and/or hospital
LOS.30,31 Introduction of new surgical techniques to minimize the extent of the surgical
procedure have now reached procedures in vascular and intestinal surgery that were formerly
described as major and high-risk surgery. Endovascular repair of the abdominal aortic
aneurysm and laparoscopic major abdominal resections have now been shown to improve
postoperative outcome significantly.32,33
Surgically technical imperfections have a significant and large impact on postoperative
outcome in esophageal surgery.34 In general, increased surgeon volume and hospital volume
of a certain treatment are associated with reduced postoperative morbidity and mortality in
major surgery.35-39 The experience of the surgeon and the surgical team involved in all aspects
of perioperative medicine account both for half of beneficial postoperative outcome.40
Concentrating major surgical procedures in high volume hospitals have become the target of
further improving postoperative outcome in the Leapfrog Initiative.41 New standards were
defined for a set of five major surgical procedures to change the health care system, including
abdominal aortic aneurysm repair and esophageal surgery for cancer. Leapfrog standards have
been shown to be more efficacious than solely concentrating specific surgical procedures in
high volume hospitals.42
It is in this wide context of improving postoperative outcome by different strategies in (high-
risk) patients undergoing major noncardiac surgery that the clinical relevance of any kind of
GOHT has to be evaluated. It was concluded that the majority of such patients do not benefit
from GOHT. However, when the factors are considered that are related to postoperative
outcome, it cannot be excluded that a subgroup of patients formerly characterized as high-risk
still may benefit from continuous perioperative hemodynamic monitoring and treatment.
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Improving surgical outcome by GOHT; matching the right treatment to the right
patient
When GOHT may have a crucial role in the outcome of a selected group of patients, the first
and major task is to identify these patients accurately. Risk scoring systems may help to
identify these patients.43,44 However, these systems are based on population-based data and
supply insufficient information on the risk of circulatory deficiencies for individual patients.
In the GUTS nearly all patients performed a simple exercise test preoperatively. HR,
respiration frequency (RF) before and after exercise were measured, the increase in HR and/or
RF was calculated and these values were also combined. However, none of the values could
be correlated to postoperative outcome variables, such as the number of (postoperative)
complications, ICU LOS and hospital LOS. In chapter 5 the work of Older et al. was
described.45-48 They measured the anaerobic threshold (AT) in high-risk patients by
preoperative bicycle testing. A level of VO2I < 11 mL/min helped to accurately identify
patients who are at risk of poor postoperative outcome. Identification of these patients may
have an important implication when their (hemodynamic) condition can be modified. When
postoperative outcome of these patients with a limited exercise capacity is related to
conditions of general hypoperfusion, a rationale for hemodynamic treatment may emerge. The
major goal in such patients is then characterized by prevention of a slide down to conditions
of general hypoperfusion, eventually resulting in organ dysfunction or organ failure.
The goal of GOHT needs to be clearly defined. Older et al. did not provide information on
hemodynamic goals and hemodynamic results of PAC-guided treatment. The classical
‘supranormal’ values of general perfusion have been shown not to be effective in large
populations. Moreover, in patients with limitations of the cardiorespiratory system, such high
values may not be attainable and may even be accompanied by serious (cardiac) adverse
events. For example, in 1988 Older et al.  suggested that the increase of VO2I from 100
mL/min to 140 mL/min could be of major importance.49 This value is still far below the
desired classical endpoint of 170 mL/min. It is of note that a condition of 100 mL/min may be
sufficient for daily life activities; in this hypothetical patient the increase of this value by 40%
may be crucial for surviving the insults of perioperative stress during major surgery. In 2004,
however, Older commented that striving for high values of VO2 does not seem to be logical50
– “One does not tune a car to obtain the highest use of petrol that is possible”. In this thesis it
is suggested that the best value of GOHT is the patient’s maximum attainable cardiac
performance as expressed by CI or SVI, while at the same time tachyarrhythmias are
prevented. These maximum attainable cardiac values may help to prevent a complicated
postoperative course as reflected by postoperative organ-dysfunction, -failure or even death.
To attain maximum attainable values, preloading by fluids is the first choice of potential
interventions. Older et al. used the PAC as instrument to optimize patients hemodynamically.
He suggested focusing on adequate postoperative DO2I as reflected by a stable O2ER, stable
and low lactate concentration and adequate urine volume. The heart plays a keyrole in
providing an adequate DO2I. SVI-measurements by echo Doppler during fluid loading is
highly informative of the maximum attainable values by preloading and were shown to be of
clinical relevance in elderly patients undergoing hip surgery and patients undergoing major
abdominal surgery.51-53 Continuous monitoring of cardiac output has become available
without dependency of instruments, such as the transesophageal ED,54-56 and may even be
more accurate in monitoring cardiac performance than the PAC.57
Inotropic support may further help to improve general perfusion. The use of
phosphodiesterase inhibitors instead of dobutamine may be benificial for improving
hepatosplanchic perfusion and in patients with congestive heart failure.58,59
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The correction of ‘pre-shock’ states, however, will not be attainable in all patients.
Hemodynamic management may elucidate the existence of severe restrictions of the
cardiorespiratory system. In clinical practice such monitoring results may help to decide
whether to limit the extent or even abandon a surgical procedure. This has a close relation
with the finding by Del Guercio et al. that was described in Chapter 1. They advised not to
perform major surgery in patients with uncorrectable deficiencies.60 Nevertheless, some of
these patients underwent major surgery. Uncorrectable hemodynamic conditions appeared to
be highly predictive for an increased mortality rate.
In the future the value of GOHT should be tested in randomized controlled trials, in which
only patients are included who have an AT < 11 mL/kg/min and are planned for major
(abdominal) noncardiac surgery. Identification of patients and/or testing of the AT in such
patients may be a task of the preoperative anesthesiologic assessment clinic. The target of
treatment should be the maximum attainable value of SVI of the individual patient in response
to fluid challenges. The SVI should be monitored continuously. The use of inotropics in such
patients needs careful evaluation, as due to the side effects their use may be more harmful for
the patient than beneficial. Lower and upper limits for HR have to be strictly defined for
reasons of safety, especially in patients with cardiac failure or (reversible) ischemic heart
disease.
Increasing general perfusion may be beneficial for overall improved outcome in patients with
a reduced AT. However, this does not exclude the occurrence of regional hypoperfusion.
Direct measuring and treatment of regional blood flow during esophageal and abdominal
aortic surgery may have implications for future intraoperative hemodynamic management, not
only in patients with a low AT.61,62
Pathophysiology of organ dysfunction and organ failure in major surgery
Prevention seems to be more effective than treatment of postoperative morbidity. A reduction
of morbidity may also reduce hospital mortality.
Regional hypoperfusion is presumed to result in an insufficient oxygen supply. This may
induce organ dysfunction, which under severe and long-lasting conditions may progress to
multi organ failure (MOF) -see Introduction-. Although this is the main pathway that causes
organ dysfunction, alternative mechanisms at cellular level have been proposed. The systemic
inflammatory response syndrome (SIRS) and sepsis responses have been thoroughly
investigated. However, the complexity of the inflammatory response and its genetic
backgrounds make it difficult to find a rationale for the best possible treatment.63,64 In major
surgery the correlation between the type and severity of SIRS and postoperative outcome has
been established.65,66 It is unknown whether these mechanisms can be triggered by surgical
trauma independent of circulatory conditions. They may be augmented by hypoperfusion or
hypoxemia. The interaction between both is a hypothetical one.
When the surgical patient has become a critically ill patient, characterized by one or more
postoperative complications or organ dysfunction, removal of causative (surgical) problems
does not automatically reverse the dysfunction. Efforts to improve outcome by GOHT
(increasing DO2) in critically ill (surgical) patients with established organ dysfunction, have
not been successful in reducing morbidity or mortality. Early hemodynamic interventions in
severe sepsis may be beneficial67 However, if the detrimental course is not timely interrupted,
organ dysfunction and/or failure become unavoidable. Attempts to reverse such a condition
by any type of GOHT may be in vain. Singer et al. recently described MOF as an adaptive
response to overwhelming inflammation.68 This is in close comparison with the cellular
mechanisms that result in stunning and hibernation of the heart during and after conditions of
hypoxia/reperfusion.69 Here we are at the edge of different cell responses after reperfusion:
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necrosis, apoptosis or regeneration. The elucidation of the molecular basis of these
mechanisms may help to understand disease from a pathophysiologic point of view. Until
now a gap remains between understanding and treatment of conditions that are effective in the
reversal of organ dysfunction and failure. Baue made considerations about the
pathophysiology of MOF and its treatment in critical care; modification of the SIRS has not
yet resulted in improved clinical outcome.63 When ‘hibernating-like responses’ play a role in
survival of cells and organs,70 manipulation of these mechanisms may be deleterious.
Tight regulation of glucose and treatment by recombinant activated protein C improves
postoperative outcome in critically ill patients.71,72 Till now, after the causes of critical illness
have been neutralized, in general we have nothing more to offer than supportive treatment of
critically ill (surgical) patients.
Conclusion
GOHT as a preventive strategy may improve postoperative outcome in a limited group of
formerly denoted ‘high-risk’ surgical patients. A well-designed prospective randomized
controlled trial of selected patients is needed to assess the additional value of GOHT amongst
other non-GOTH perioperative strategies that have been shown to be efficacious in improving
postoperative outcome as reflected in reductions of mortality, complications, ICU LOS and
hospital LOS. When (serious) postoperative complications occur, resulting in organ
dysfunction or organ failure, no data are available indicating that treatment directed at
enforced and/or accelerated recovery of function improves outcome. First the cause of organ
dysfunction/failure has to be eliminated. Thereafter, supportive treatment will help to achieve
the best possible outcome. Elucidating pathophysiologic mechanisms of disease at cellular
and organ level may hopefully result in novel therapies that help to improve a complicated
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In major surgical procedures the risk of accompanying complications is increased and
for this reason they are often referred to as ‘high-risk’ procedures. Both surgical and
patient factors are associated with the increased risk. Regional hypoperfusion and
shock result in an insufficient oxygen supply, which is considered a major
pathophysiologic mechanism for the development of postoperative morbidity and
mortality. Prevention or timely treatment of hypoperfusion and shock is presumed to
be of crucial importance for recovery of organ function in critical illness and surgery.
In this thesis prevention and early treatment of hypoperfusion and shock are indicated
by the term ‘goal-oriented hemodynamic treatment’ (GOHT).
Chapter 1
The literature on GOHT till 1996 was reviewed. Critically ill surgical patients were
hemodynamically monitored using pulmonary artery catheters (PACs) since the
nineteen-sixties. WC Shoemaker et al. identified significantly different hemodynamic
patterns between surviving and nonsurviving patients. Survivors were faster and more
accurately discriminated from nonsurvivors by differences in PAC-derived
hemodynamic values (CI, DO2I and VO2I) than by using the classically monitored
variables HR and BP. Shoemaker et al. hypothesized a causal relationship between the
observed increased hemodynamic values and rate of survival. The median
hemodynamic values of survivors were used to guide hemodynamic treatment in
randomized clinical trials. The efficacy of GOHT was tested in patients undergoing
major, noncardiac surgery. A few other prospective studies are described, different in
design, but also aiming at increasing general perfusion, with or without PAC guidance.
In some of these studies significant reductions in mortality, ICU and/or hospital length
of stay (LOS) were achieved.
Studies on GOHT in major noncardiac surgery were reviewed. Till 1996 the evidence
for the efficacy of GOHT was based on a small number of clinical trials. Mortality was
found to be significantly reduced in three studies of ‘high-risk’ patients by aiming at
survivors’ hemodynamic values. However, case mix and flaws in study design obscure
these results. Moreover, all the studies in which a significant reduction in mortality
was achieved had an unusual high mortality of 20-30% in the control groups. It
remains unclear whether the reduction of mortality is attributable to GOHT. Lower
values of CI, DO2I and VO2I, that cannot be manipulated into the direction of median
survivor’s values, may reflect a poor cardiorespiratory condition. Results of clinical
trials of GOHT in critically ill patients with severe trauma and/or sepsis also suggest
that such high values better should be considered as predictors of survival instead of
endpoints of GOHT.
Chapter 2
Till 1996 no studies were available in which the common preoperative preparation at
the ward was compared with preoperative GOHT (tune-up) at the ICU. We
hypothesized that GOHT would not reduce the number of postoperative complications
(H0). In this chapter the results of the Groningen University Tune-up Study (GUTS)
are described. The study had to be terminated preliminary for logistic reasons, after
including only half of the number of patients calculated in the sample size estimation.
Analysis was performed according to the protocol. Conclusions are discussed in the
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context of an underpowered study. The null-hypothesis could not be rejected. The
secondary endpoints ICU LOS and hospital LOS did not differ between both groups.
Hospital mortality in the GUTS was remarkably low (2.4%). The results were
unaltered after correcting for potential confounding variables by multivariate logistic
regression analysis. It is concluded that GOHT, preoperatively started at the ICU, does
not improve clinical outcome under the conditions present in our hospital.
Chapter 3
In Chapter 3, the mortality, ICU LOS and hospital LOS of the cohort of high-risk
surgical patients, eligible in the same period but not randomized for the GUTS (non-
GUTS patients), are explored. The aim of the study was to reveal potential bias in
selection and treatment of high-risk surgical patients. Eligible patients were searched,
who were scheduled to be admitted to the ICU postoperatively. Mortality, ICU LOS
and hospital LOS were compared to those of the patients of the GUTS who were
planned to be admitted to the ICU postoperatively. The GUTS and non-GUTS
populations were compared. Univariate analysis of preoperative and demographic data
showed that the non-GUTS patients used more pulmonary medication, had higher
ASA and NYHA risk classification scores than GUTS-patients, while the GUTS-
patients were older and had higher Goldman Cardiac Risk Index scores. These
differences remained the same after comparing both groups, using multivariate
regression analysis. Postoperative ICU LOS and hospital LOS were compared. The
results were analyzed with and without correction for (potential) perioperative
differences between the groups. Uncensored for mortality, non-GUTS patients had a
significant shorter LOS at the ICU and in the hospital. However, when censored for
mortality, ICU LOS and hospital LOS were similar. It is concluded that the principal
investigators might have used some clinical preferences in their search for eligible
patients. However, this has not resulted in clinically relevant differences. There were
also no indications that inclusion in the GUTS was of benefit in high-risk surgical
patients. Mortality of high-risk surgical patients in our hospital undergoing elective
major noncardiac surgery and scheduled postoperatively for ICU-admission is
relatively low compared to that in studies that claim significant reductions in mortality
by GOHT.
Chapter 4
In Chapter 4 some important economic aspects of GOHT in high-risk surgical patients
are described. Costs were calculated using available data on costs in 1996 and 2004.
Two analyses were performed. In the first analysis costs in both groups of the GUTS
were compared. Although postoperative costs of the ward were lower in the tune-up
group compared to the control group, the difference was offset by the extra costs in the
tune-up group, caused by the preoperative stay on the ICU. The second analysis
considers patients preoperatively scheduled for postoperative ICU-admission. Both
groups of the GUTS were compared with the non-GUTS group. Overall costs in the
non-GUTS group were significantly lower. It is concluded that at least in our hospital




In Chapter 5 studies on GOHT and PAC-monitored groups of high-risk (surgical)
patients from 1996 till 2005 are reviewed. Emphasis is laid on studies concerning
high-risk patients undergoing elective, major non-cardiac surgery. Studies on GOHT
in other groups of critically ill patients, such as trauma patients and patients with
(severe) sepsis, were also selected and described for main outcome variables. A few
studies are available in which GOHT reduced mortality or hospital LOS, but in most
studies, including a recent large multicenter study, the clinical outcome was not
improved.
GOHT as part of perioperative management in high-risk surgical patients has been
studied in various meta-analyses. The results indicate that GOHT may be beneficial
when applied in groups with a postoperative hospital mortality of more than 20%.
However, considering patients undergoing elective, major, non-cardiac surgery, such a
high mortality does not reflect results in any of the major surgical procedures currently
described as 'high-risk'. It also seems that the efficacy of GOHT in high-risk patients
has faded in time, possibly due to overall improvements in perioperative medicine. We
concluded that GOHT does not improve the clinical outcome in most patients
undergoing elective, major, non-cardiac surgery.
Chapter 6
In chapter 6 the conclusions of the thesis are reviewed in the context of the available
literature on GOHT and new developments in perioperative medicine considering
high-risk patients. Strategies different from GOHT have been shown efficacious in
accelerating postoperative recovery after major noncardiac surgery. A multimodal
approach of such strategies may result in significant reductions of hospital LOS.
Intraoperative echo Doppler-guided hemodynamic treatment seems to improve
postoperative recovery in patients with a fractured hip. GOHT may be efficacious in
selected groups of patients. The main problem is the identification of high-risk patients
who will benefit from perioperative GOHT. The limitations of current studies are
discussed and tests are explored that potentially can predict mortality and morbidity
with a high sensitivity. Risk scoring systems using demographic data help to describe
high-risk populations carefully and have been further refined in the last decade.
However, testing the physical tolerance may differentiate high-risk patients more
accurately, i.e. measuring the anaerobic threshold by bicycle testing. Using this
method, Older et al. reported that they identified patients with ischemic heart disease
and/or heart failure. Whether the preoperative ICU-admission and hemodynamic
treatment of such patients would reduce postoperative morbidity and mortality in thus
selected patients has not yet been evaluated in a randomized clinical trial. Potential
problems of GOHT in such patients are discussed because of their limited
cardiopulmonary reserve capacity. The patient’s individual maximal attainable values
are suggested as endpoints of GOHT. Otherwise GOHT may specifically be directed
at treatment of regional perfusion in selected surgical procedures (surgery of the
abdominal aorta and the esophagus).
When organ dysfunction already has developed, irrespective of the underlying
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Waldorf: “Hey, did you hear that?”
Statler: “Huh?”
Waldorf: “There's something new when you need major surgery.”
Statler: “Tell me more!”
Waldorf: “They turn you in an athlete before you go to theatre!”
Statler: “Really?! What's that good for?”
Waldorf: “They say your chances to survive increase and recovery
seems faster after surgery. Isn't that nice?”
Statler: “Well, I don't like running at my age, I rather stay here”
Waldorf: “Yeah, me too…  Do you think plastic surgery is also ‘major’
surgery?”
Statler: “Why do you ask that?!”











Chirurgische ingrepen kunnen gepaard gaan met complicaties tijdens en na de
operatie. De kans hierop neemt toe bij meer omvangrijke ingrepen. Tevens is de
algemene conditie van de patiënt een factor van betekenis. Indien een patiënt meer
bijkomende ziekten heeft kan dit de kans op complicaties eveneens vergroten en het
herstel na de operatie vertragen. Grote operaties worden daarom wel aangeduid met
‘hoog-risico’ chirurgie. Dit geldt in het bijzonder indien een patiënt één of meerdere
bijkomende ziekten heeft. De anesthesioloog heeft tijdens de operatie o.a. de taak er
voor zorg te dragen dat de circulerende hoeveelheid bloed in het hart en het gehele
vaatstelsel op voldoende niveau blijft. Het doel hiervan is dat de doorbloeding van de
diverse organen zodanig wordt gewaarborgd dat er voldoende zuurstof en voeding
wordt aangeboden. Echter, indien het aanbod hiervan tekort schiet kan er schade
ontstaan aan die organen. In milde vorm spreken we van plaatselijk onvoldoende
doorbloeding en wanneer dit optreedt in ernstige mate wordt dit shock genoemd.
Afhankelijk van het orgaan en de duur van zo’n inadequate doorbloeding kan dit
leiden tot milde of ernstige complicaties na de operatie, die de duur van de
ziekenhuisopname kunnen verlengen of waaraan de patiënt in het uiterste geval zelfs
kan overlijden. Daarom wordt verondersteld dat het voorkómen van een onvoldoende
doorbloeding of tijdig behandelen hiervan een doorslaggevende rol speelt in het
vermijden van complicaties en sterfte na grote operaties. Een dergelijke behandeling
wordt in dit proefschrift aangeduid met ‘Goal-oriented hemodynamic treatment’
(GOHT), d.w.z. een behandeling die al voorafgaande aan een grote operatie wordt
begonnen en specifiek gericht is op het bereiken en handhaven van een voldoende
bloeddoorstroming van alle organen.
Hoofdstuk 1
In hoofdstuk 1 wordt een overzicht gegeven van de literatuur over deze behandeling
tot het jaar 1996. Belangrijke waarnemingen werden tijdens de zestiger en zeventiger
jaren van de twintigste eeuw gedaan door de groep van WC Shoemaker. Om een
snelle en algemene indruk te krijgen van de toestand van de vulling van het hart en de
bloedvaten wordt, zoals gebruikelijk, de bloeddruk en de hartslag gemeten. Zij
onderzochten ernstig zieke, chirurgische patiënten tevens met behulp van een arteria
pulmonalis catheter (PAC), waarmee de hoeveelheid circulerend bloed in de
longslagader kan worden gemeten. Dit is een maat voor de totale hoeveelheid bloed
die per minuut wordt aangeboden aan alle organen, inclusief de hartspier zelf. Ook kan
het zuurstof transporterende eiwit in het bloed worden gemeten, uitgedrukt in het
hemoglobine gehalte (Hb). Meting van de bloeddoorstroming en het Hb maakte het
mogelijk de hoeveel zuurstof te berekenen die er per minuut aan de organen werd
aangeboden en ook hoeveel zuurstof er per minuut werd verbruikt. Toen deze
gegevens na afloop werden onderzocht bleek dat tijdens de ontwikkeling en
behandeling van shock een groot aantal met de PAC verkregen waarden duidelijk te
verschillen tussen overlevenden en overledenen. Een verlaging van het circulerend
bloed en het zuurstoftransport en verbruik door de organen traden eerder op dan een
voor shock verdachte verlaging van de bloeddruk en verhoging van de hartslag. Een
dreigende shock was op deze wijze veel vroeger op te sporen. De groep van
Shoemaker stelde dat de van de PAC-metingen afgeleide waarden van de hoeveelheid
circulerend bloed, het zuurstoftransport en verbruik niet alleen de kans op een fatale
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afloop beter voorspelde, maar ook dat deze gegevens konden leiden tot een tijdige en
adequate behandeling van shock. Zij onderzochten dit vervolgens in een studie met
patiënten die grote operaties ondergingen; patiënten die open hartoperaties moesten
ondergaan waren van deze studie uitgesloten. De patiënten werden willekeurig
verdeeld over twee behandelgroepen en een controlegroep. In 1988 toonden zij aan dat
de sterfte door GOHT kon worden verminderd van 33% in de controlegroep naar 4%
in de met een PAC behandelde groep. Door anderen werden ook studies gedaan
waarin de bloeddoorstroming van alle organen werd gestimuleerd voorafgaande of
tijdens grote operaties. Meestal werd een PAC gebruikt om de effecten van de
behandeling op het hart en de toename van de bloeddoorstroming te kunnen meten en
sturen. In drie studies werd een duidelijk lagere sterfte gevonden in de met een PAC
behandelde groep. Tevens hadden deze patiënten minder complicaties en verbleven zij
korter op de intensive care en in het ziekenhuis.
Een kritische beschouwing van deze studies brengt echter een aantal tekortkomingen
aan het licht m.b.t. het ontwerp van de studies alsook het feit dat de gepresenteerde
gegevens verkregen werden voor wat de aandoening betreft, sterk gemengd
samengestelde groepen van patiënten. Tevens is het opmerkelijk dat van de
onderzochte patiënten een uitzonderlijk hoge sterfte wordt vermeld van de controle
groepen, tot wel 30%. Het blijft onduidelijk of in deze studies de drastische
vermindering van de sterfte is toe te schrijven aan de resultaten van de GOHT. De
beduidend lagere waarden die werden gevonden in de bloeddoorstroming en het
zuurstoftransport en -verbruik voorafgaande aan sterfte zouden ook uiting kunnen zijn
van een verminderde functie van hart en longen. De hoge waarden zoals gevonden bij
overlevenden waren mogelijk niet haalbaar bij de patiënten die later overleden. In
andere groepen ernstig zieke patiënten werden vergelijkbare relaties gevonden tussen
een verlaagde waarde van bloeddoorstroming, een gedaalde zuurstoftransportcapaciteit
en een toegenomen sterfte. Het zou zo kunnen zijn dat dergelijke lage waarden voor de
operatie niet op het niveau kunnen worden gebracht als bij overlevenden. Het belang
van de bepaling van zodanig lage waarden zou dan wel kunnen zijn, dat het kan helpen
de mogelijk slechte uitkomst van een operatie in zo’n patiënt te voorspellen. Echter, de
aanbeveling dat deze hoge waarden als GOHT de kansen op overleving van hoog-
risico chirurgische en ernstig zieke patiënten zouden vergroten berustte nog steeds niet
op kwalitatief goede studies.
Hoofdstuk 2
Tot 1996 was in geen enkele GOHT-studie bij chirurgische patiënten de intensieve
voorbehandeling op de intensive care afdeling vergeleken met de doorgaans gangbare,
beperkte voorbereiding van een controlegroep op de verpleegafdeling. Daarom werd
een studie ontworpen waarin de behandelgroep op de intensive care afdeling werd
opgenomen om voorafgaande aan een grote operatie de functie van alle organen te
kunnen optimaliseren aan de hand van de met de PAC gemeten bloeddoorstroming,
zuurstoftransport en zuurstofverbruik (Tune-up studie). Toewijzing aan één van beide
groepen vond willekeurig plaats, d.w.z. door middel van loting. De studie was bedoeld
om te onderzoeken of door GOHT na de operatie het aantal complicaties zou afnemen.
Als meetbaar effect van de behandeling werd een totaal van 18 mogelijke complicaties
gedurende 30 dagen geregistreerd. Verwacht werd dat een afname van het aantal
complicaties de ligduur op de intensive care afdeling of de totale ligduur in het
ziekenhuis zou verkorten. In dit hoofdstuk van het proefschrift worden de resultaten
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van deze “Tune-up studie” beschreven. De conclusies moeten echter met enige reserve
worden bezien. Dit hangt samen met het feit dat de studie om organisatorische
redenen, namelijk het toenmalig bestaand landelijk tekort aan intensive care bedden,
voortijdig moest worden afgebroken. Slechts de helft van het vooraf berekende aantal
van 260 patiënten kon onderzocht worden. De analyse moest derhalve verricht worden
met 127 patiënten. Zij ondergingen ook daadwerkelijk een grote operatie. In dit
onderzoek kon niet worden aangetoond dat het aantal complicaties door GOHT werd
verminderd. Ook werd er geen verschil gevonden in het totaal van het aantal ligdagen
dat werd doorgebracht op de intensive care afdeling en die in het ziekenhuis tussen de
voorbehandelde patiënten en de patiënten van de controlegroep. Echter bij de
beschrijving van de aanwezigheid van risicofactoren in beide groepen bleek de
controlegroep in veel opzichten voordeliger uit te zijn. In tweede instantie werd
hiermee rekening gehouden tijdens de analyse, waarbij er werd gecorrigeerd voor dit
verschil. Dit veranderde de conclusie echter niet. De ziekenhuissterfte in de totale
groep was opmerkelijk laag (2.4%) t.o.v. percentages (>20%) die door andere
onderzoekers over hun niet-voorbehandelde patiëntengroepen werden gerapporteerd.
Er werd geconcludeerd dat de GOHT op de intensive care afdeling in ons ziekenhuis
geen betere resultaten oplevert dan de gangbare voorbereiding op de afdeling bij grote
operaties zonder spoedkarakter.
Hoofdstuk 3
In hoofdstuk 3 worden de resultaten beschreven van het ziektebeloop van hoog-risico
chirurgische patiënten die wel geschikt waren voor deelname aan de Tune-up studie,
maar daar om verschillende redenen niet aan hebben deelgenomen. Het eerste doel van
deze studie was het vaststellen of niet-deelnemers van de Tune-up studie vergelijkbaar
waren met de Tune-up deelnemers. Gekeken werd naar een aantal patiëntenkenmerken
en het type uitgevoerde operaties. Vervolgens werden van de niet-deelnemers de
klinische uitkomsten bekeken: ligduur op de intensive care afdeling, de ligduur in
ziekenhuis en de ziekenhuissterfte. De Tune-up studie deelnemers hadden goede
resultaten laten zien. De veronderstelling was dat niet-deelnemers een minder goede
uitkomst zouden hebben. Enerzijds zou dit verschil veroorzaakt kunnen zijn door een
onbewuste selectie die had plaatsgevonden, inhoudend dat alleen die patiënten
gevraagd werden deel te nemen aan de Tune-up studie die bij voorbaat al meer kans
hadden op een betere uitkomst (selectiebias). Ook werden aan de studie deelnemende
patiënten gedurende 30 dagen na de operatie in het kader van de studie dagelijks
nagekeken. Hierdoor was het mogelijk dat de onderzoekers als het ware bij de
behandeling betrokken raakten en daarmee het ziektebeloop hadden beïnvloed
(behandelingsbias).
Hiertoe werd een onderzoek gedaan waarin alle patiënten werden opgenomen die
tijdens de Tune-up studie grote operaties ondergingen en waarvan voorafgaande aan
die operatie bekend was dat zij aansluitend aan de operatie op de intensive care
afdeling zouden worden opgenomen. Vervolgens werden de groep van Tune-up studie
deelnemers vergeleken met deze niet-deelnemers. De soort en het relatieve aantal
operaties tussen beide groepen waren vergelijkbaar. Voor wat betreft de
patiëntenkenmerken bleek dat de niet-deelnemers meer medicijnen voor longziekten
gebruikten, hoger scoorden bij twee van de vier risico classificatie systemen, terwijl
anderzijds zij jonger waren en gunstiger scoorden voor één van de oudere
risicoclassificatiesystemen voor hartziekten. Deze verschillen bleven bestaan toen bij
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de vergelijking een correctie werd uitgevoerd voor een mogelijke onderlinge
samenhang van deze verschillen. Na de operatie leek op het eerste gezicht de ligduur
op de intensive care afdeling en in het ziekenhuis korter bij de niet-deelnemers aan de
Tune-up studie. Echter, de sterfte was in deze groep iets hoger, en indien hier rekening
mee werd gehouden bleken er tussen beide groepen geen verschillen meer te bestaan
in ligduur op de intensive care afdeling en in het ziekenhuis. Daarom werd
geconcludeerd dat de onderzoekers mogelijk voorkeuren hebben gevolgd tijdens de
selectie van potentiële Tune-up studiedeelnemers, maar dat dit geen invloed heeft
gehad op de klinische uitkomsten. Dezelfde conclusie kon worden getrokken ten
aanzien van de mogelijke invloed van de onderzoekers op de behandeling van de
Tune-up studie deelnemende patiënten. Deze mogelijke bemoeienis heeft geen invloed
gehad op het ziekenhuisbeloop. Uit dit onderzoek kwam tevens naar voren dat de
sterfte en het beloop na grote operaties in het UMCG relatief gunstig was ten opzichte
van wat onderzoekers hebben gepresenteerd van hoog-risico chirurgische patiënten in
andere ziekenhuizen.
Hoofdstuk 4
In hoofdstuk 4 worden economische aspecten aan de orde gesteld van een dergelijke
voorbehandeling op de intensive care afdeling (GOHT). De kosten werden berekend
van de behandeling van patiënten, die in voorgaande hoofdstukken werden
beschreven. Er werd gebruik gemaakt van gemiddelde prijzen van een ligdag op een
verpleegafdeling en op de intensive care afdeling. De kosten van een patiënt uit de
controlegroep, voorafgaande aan de operatie, werden gelijkgesteld aan de kosten van
één ligdag op de verpleegafdeling, terwijl voor een voorbehandelde patiënt de dag
voor de operatie als intensive care ligdag werd gerekend. Ook werden de kosten van
eventuele bloedtransfusie meegenomen in de berekening. In vergelijking van kosten
tussen niet en wel aan de Tune-up deelnemende patiënten werd er rekening gehouden
met de kosten van de bij de Tune-up studie gebruikte extra materialen, d.w.z. de
kosten van de PAC of andere centrale lijnen en een catheter die in de slagader van de
pols werd ingebracht. Ook werden de kosten van het gebruik van epidurale pijnstilling
in de berekening meegenomen. De kosten werden berekend op twee peildata, namelijk
voor 1996 en voor 2004.
Er werden twee analyses verricht. In de eerste werd een vergelijk gemaakt tussen de
behandelde groep en de controlegroep van de Tune-up studie. In de tweede analyse
werden alleen patiëntengroepen betrokken die na de operatie op de intensive care
afdeling werden opgenomen.
De eerste analyse liet zien dat de kosten van het verblijf op de verpleegafdeling in de
behandelgroep van de Tune-up studie lager waren dan in de controle groep. Dit
resultaat werd echter tenietgedaan door de hogere kosten van het verblijf van de
behandelgroep voorafgaande aan de operatie op de intensive care afdeling. In de
tweede analyse werden alleen patiënten vergeleken die na de operatie op de intensive
care afdeling werden opgenomen. De twee groepen van de Tune-up-studie, de
controlegroep en de behandelgroep, werden vergeleken met de niet-deelnemers aan
Tune-up studie. Het bleek dat de kosten van de niet-deelnemers beduidend lager
waren dan die van de deelnemers aan de Tune-up studie.
De conclusie was dat GOHT, althans in deze vorm, in ons ziekenhuis niet bijdraagt




In hoofdstuk 5 wordt een overzicht van de literatuur tussen 1996 en 2005 gegeven met
betrekking tot studies in hoog-risico patiënten waarin door middel van GOHT getracht
is de klinisch uitkomsten te verbeteren. Het betreft voornamelijk studies bij
chirurgische patiënten. Tevens worden studies beschreven waarin ernstig zieke
patiënten ten gevolge van ongevallen of septische shock worden behandeld met
GOHT om de ziekenhuissterfte te verminderen.
In enkele studies werd een duidelijk verminderde sterfte gevonden in de behandelde
groep. Maar in de meeste studies, waaronder een recente, grote in meerdere Canadese
ziekenhuizen uitgevoerde studie, werd geen verschil gevonden in sterfte. Enkele van
deze studies beschrijven wel een verkorting van de ziekenhuisverblijfsduur van de
behandelgroep.
De meeste van deze studies zijn opgenomen in een zestal zogenaamde meta-analyses
die GOHT tot onderwerp hebben. In een meta-analyse worden de resultaten van
diverse studies gezamenlijk geanalyseerd. Door auteurs werd geconcludeerd dat
GOHT van klinische relevante betekenis is indien deze behandeling blijft
voorbehouden aan groepen patiënten waarvan vastgesteld is dat het ziekenhuis
sterftepercentage 20% of meer bedraagt. Echter, een kritische beschouwing van
groepen patiënten die zorgvuldig geplande, grote operaties moeten ondergaan leert, dat
een ziekenhuissterfte van 20% ver uitgaat boven de toenmalige en hedendaagse
sterftepercentages tijdens en na grote, complexe operaties. Andere onderzoekers zijn
van mening dat alleen tijdige of vroege, d.w.z. voorafgaande aan of tijdens grote
operaties begonnen behandeling zinvol is, terwijl in een late fase gestarte GOHT,
nadat al complicaties zijn opgetreden, deze behandeling geen toegevoegde waarde
heeft. Over een periode van 40 jaar van grote vooruitgang in de chirurgie,
anesthesiologie en intensive care geneeskunde lijkt een gunstig effect van GOHT,
uitgezonderd enkele Britse studies, vooral aanwezig in de oudere studies. Tegelijk
laten de meest recente Britse studies zien dat ook in de controlegroepen ziekenhuis
sterftepercentages bij hoog-risico chirurgische patiënten nu ook op veel lager niveau
zijn en nu vergelijkbaar zijn met resultaten elders in de wereld.
Het geheel overziende van studies met betrekking tot GOHT bij hoog-risico
chirurgische patiënten blijkt dat GOHT het resultaat in de meeste gevallen niet blijkt te
verbeteren.
Hoofdstuk 6
In hoofdstuk 6 worden de conclusies van dit proefschrift samengevat. De belangrijkste
conclusie van de Tune-up studie is, dat GOHT van hoog-risico chirurgische patiënten
die geplande, grote operaties ondergaan, het aantal en de ernst van de complicaties niet
zodanig vermindert dat dit het herstel na de operatie bespoedigt. Het bleek tevens dat
de uitkomst in een groep vergelijkbare patiënten die dezelfde typen operaties
ondergingen in die periode niet verschilde van de onderzochte groep wat betreft de
ligduur op de intensive care afdeling en die in het ziekenhuis. Wel was de
ziekenhuissterfte iets hoger in deze groep. Aanvullend werden kosten berekend in deze
groep en de twee groepen van de Tune-up studie voor zover het patiënten betrof die na
de operatie op de intensive care afdeling werden opgenomen. De kosten bleken niet te




In dit hoofdstuk worden onze uitkomsten verder besproken in samenhang met de uit
de literatuur beschikbare resultaten van het ziekenhuisbeloop van hoog-risico
chirurgische patiënten. Studies bij open hartchirurgie werden buiten beschouwing
gelaten. Aan de hand van een overzicht wordt bediscussieerd waarom de resultaten
van GOHT-studies bij hoog-risico chirurgische patiënten tot op heden zulke
wisselende resultaten hebben gehad. Ook blijkt dat in de afgelopen 10 jaar heel andere
maatregelen dan GOHT bij een vergelijkbare groep hoog-risico chirurgische patiënten
aantoonbaar de herstelfase na een operatie bespoedigden en gepaard gingen met een
afname in de ziekenhuissterfte. Dit betreft een aantal nieuwe maatregelen die werden
genomen voor, tijdens en na de operatie. Deze maatregelen bestaan o.a. uit het
verbeteren van de voedingsconditie en voorbereiding met medicamenten als beta-
blockers, calcium-antagonisten en alpha-2-blockers bij geselecteerde patiënten, het
voorkomen van afkoeling tijdens de operatie, veranderingen in bloedtransfusiebeleid,
verandering van operatietechnieken, zoals de zogenaamde “minimaal invasieve
chirurgie” en een aantal maatregelen in de fase na de operatie, zoals de
pijnbehandeling, het snel weer voeden van patiënten en het stimuleren en helpen het
zo snel mogelijk uit bed te komen.
Het is echter niet onomstotelijk bewezen dat GOHT niet ook zou kunnen bijdragen
aan deze verbeterde uitkomsten bij specifieke patiëntengroepen of typen operaties. Het
probleem is met name dat de patiënten die er van zouden kunnen profiteren moeilijk
met zekerheid zijn aan te wijzen. Older onderzocht hoog-risico chirurgische patiënten.
Hij bepaalde voorafgaande aan de operatie met behulp van een inspanningstest het
zuurstofverbruik bij een groot aantal patiënten waarbij het aerobe metabolisme
overgaat in het anaërobe metabolisme. Indien de waarde van het zuurstofverbruik bij
dit omslagpunt lager was dan 11 milliliter per minuut, was de kans op sterfte na de
operatie aanzienlijk hoger, namelijk 18%. Indien het zuurstofverbruik bij dit
omslagpunt hoger was dan 11 milliliter per minuut was de sterfte minder dan 1%. Met
de door Older toegepaste onderzoeksmethode wordt hartfalen aan het licht gebracht.
Hij gebruikte dit type onderzoek om hoog-risico chirurgische patiënten te selecteren
om deze voorafgaande aan de operatie van de grote buikslagader of de slokdarm op de
intensive care afdeling op te nemen en te behandelen. De sterfte in deze selectie van
patiënten daalde in de loop van de tijd tot minder dan 5%. Andere onderzoekers
stelden een duidelijke verbetering vast bij bejaarde patiënten met botbreuken van de
heup bij wie tijdens de operatie de vulling van het hart en de bloedvaten zo werd
gehandhaafd dat de algehele bloeddoorstroming was verhoogd. Echter, voor al deze
onderzoeken geldt dat goede gerandomiseerde en gecontroleerde studies ontbreken.
Ook is onduidelijk wat de ideale meetmethoden zijn om de bloeddoorstroming te
meten voor, tijdens en na de operatie en welke eindpunten moeten worden nagestreefd
met GOHT in dergelijke, geselecteerde patiëntengroepen. Tegen de achtergrond van
het voorgaande lijkt het niet logisch dat er voor GOHT, zoals voorheen, vaste
eindpunten worden gekozen, maar dat gebruik wordt gemaakt van de individuele
reservecapaciteit van hart en longen van elke patiënt.
Er zijn meerdere studies gedaan bij hoog-risico chirurgische  patiënten waarbij
complicaties ontstonden na de operatie die vitale organen in hun functie zo ernstig
verstoorden dat opname op de intensive care afdeling noodzakelijk was. Er kan in zo'n
situatie al enige tijd van een verminderde orgaandoorbloeding of shock bestaan.
Hoewel deze situatie met vochttoediening en medicamenten snel kan worden
opgeheven, toch wordt hiermee zelden een direkt herstel van de gestoorde
orgaanfunctie bereikt. Het gebruikelijke beleid daarbij is de vitale functies zoveel als
mogelijk te ondersteunen. Waar nodig kan orgaanfunctie vervangende therapie worden
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ingezet in afwachting van het herstel van het betreffende orgaan. Een voorbeeld
hiervan is het gebruik van nierdialyse tijdens nierfalen. In meerdere onderzoeken is
getracht bij zulke ernstig zieke patiënten de algehele conditie van de patiënt en het
herstel van orgaanfuncties te verbeteren met GOHT. Hiermee werd een vergroting van
de kans op overleving beoogd. Sommige onderzoekers hebben recent geopperd dat in
zo'n situatie de verminderde functie van organen uiting is van een soort rustfase. Het is
onbekend of, wanneer en hoe dit proces zodanig kan worden beïnvloed dat de kans op
en de snelheid van herstel en de ziekenhuisoverleving wordt verbeterd. Patiënten met
septische shock die van buiten het ziekenhuis komen laten een zeer hoog
sterftepercentage zien. Indien deze patiënten direct na aankomst in het ziekenhuis
GOHT ondergaan blijkt dat zij meer kans hebben op overleving. Het is onbekend of
dit ook het geval zou kunnen zijn bij ver voortgeschreden orgaanfunctiestoornissen die
ontstaan zijn na grote operaties bij hoog-risico chirurgische patiënten. Vooralsnog
tonen bestaande cijfers aan dat de gangbare praktijk ten aanzien van het beleid gericht







De totstandkoming van dit proefschrift is mogelijk gemaakt door de betrokkenheid en inzet
van vele artsen, verpleegkundigen en studenten. Aan de basis ervan ligt de 'Tune-up-studie',
later omgedoopt tot de GUTS, de Groningen University Tune-up Study. Dit project ging
zomer 1996 van start.
Allereerst gaat mijn dank uit naar alle patiënten die hebben deelgenomen aan de Tune-up
studie. Allen ondergingen grote chirurgische ingrepen. Samen met de al dan niet aanwezige
co-morbiditeit waren dat levensgrote gebeurtenissen. De existentiële lading hiervan was
vooral merkbaar bij de patiënten met oncologische problematiek. De onzekerheid van wat het
zou worden, curatie, palliatie of nog minder, bracht hun leven rondom de operatie tussen hoop
en vrees. Het protocol van de Tune-up studie vormde daarbij een extra belasting, m.n. voor de
patiënten uit de protocolgroep die de dag voorafgaande aan de operatie werden opgenomen op
de intensive care unit.
Mijn promotor prof. dr. J.M.K.H. Wierda, beste Mark, je hebt me niet alleen geholpen dit
proefschrift te voltooien, je was ook gedurende een aantal jaren mijn opleider in de
anesthesiologie. Toen ik in het kader van de Tune-up studie voor het eerste kennis met je
maakte in 1997 had ik ongemerkt een sollicitatiegesprek voor de opleiding tot anesthesioloog.
'In somno securitas', voor de patiënt de slaap en verdoving, voor ons de zekerheid dat de
patiënt goed door de operatie heen zou komen. Je hebt me samen met alle andere stafleden
waakzaam en vaardig gemaakt om de anesthesiologische praktijk met plezier uit te oefenen.
Maar vooral kijk ik met dankbaarheid terug op je volhardende inzet achter dit proefschrift
totdat het 'af' was. Je houding was bij uitstek een principiële, doortrokken van visie,
creativiteit en relativeringsvermogen, met veel oog voor miniscule details en de grote lijnen.
Ik heb mogen profiteren van je grote staat van dienst in medisch wetenschappelijk werk. De
keuze voor een monografie was een logische waarvan je mij hebt kunnen overtuigen.
Mijn copromotor dr. V. Fidler, beste Vaclav, toen de Tune-up database een voldongen feit
was raakte je er op ons verzoek intensief bij betrokken. Je hebt me behoedzaam door de
massa's getallen van de database geleid. Zonder jouw hulp hadden we nooit zo grondig en
genuanceerd de resultaten kunnen beschrijven. Dank voor het geduld en de tijd die nodig was
om mijn kennis van statistiek op te frissen of bij te spijkeren. Dank ook voor je hulp en de
ideeën toen we het cohort van alle potentiële Tune-up-studie deelnemers in kaart brachten.
Prof. A.R.J. Girbes, beste Armand, je hebt het hele Tune-up project bedacht, geïnitieerd en
begeleid. Juli 1997 stapte ik op een 'lopende trein'. Belangrijke logistieke knelpunten waren
opgelost en we hadden een goed lopend project. Het was klinisch onderzoek op het terrein
waar bij uitstek mijn interesse ligt: complexe, perioperatieve zorg en de intensive care unit.
Tegelijk beoogde je mij een perspectief te bieden voor de toekomst. Mijn opleiding tot
anesthesioloog lag in het verschiet. Dank dat je me de uitvoering van Tune-up studie
toevertrouwde en mijn eerste schrijfsels en voordrachten in de medische wetenschappen tot
een goed einde hebt helpen brengen. Je hebt me geleerd dat de draagkracht van een over te
brengen boodschap ligt in het inperken van een overdaad aan nuances.
Dr. J.J.M. Ligtenberg, beste Jack, je hebt samen met Armand Girbes de pilot-studie van het
Tune-up-project uitgevoerd. Het pionierswerk voor de Tune-up studie is in grote mate door
jou verricht. De sleutel tot de database alleen al werd een indrukwekkend boekwerk.
Knelpunten in het protocol, het datamanagement, de logistiek van de heel verschillende
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verpleegafdelingen en intensive care units heb je moeten oplossen terwijl je tegelijk ook nog
je eigen proefschrift afrondde. De compleetheid van het al geleverde werk en hoe ik daar aan
verder kon bouwen had iets van het ontvangen van een onverwachte, rijke erfenis. Dank voor
je inzet en blijvende betrokkenheid, ook toen je al volop werkzaam was als internist-
intensivist op de ICB en je mij met raad en daad bijstond als er zich onverhoopt toch nog
problemen voordeden.
Dr. J. Kingma en R.J. Oostergo, beste Hans en René, jullie hebben met jullie bijdrage vanuit
het Datamanagement Bureau voortreffelijk werk geleverd in de ontwikkeling van de software
om de data naar een handzaam digitaal formaat om te zetten. Ook de aftersales waren
uitstekend.
Het MTA-bureau was nauw betrokken bij de ontwikkeling van de Tune-up studie. Dr. E.M.
ten Vergert, beste Els, bedankt voor alle adviezen en hulp voor en tijdens de uitvoering van
het project. Dank ook voor het commentaar tijdens de ontwikkeling van het manuscript van
dit proefschrift, in het bijzonder om de economische aspecten te belichten. Drs. CS van der
Hilst, beste Christian, bedankt voor de tips bij de kostenberekeningen; zonder jouw
handreikingen zat ik waarschijnlijk nog steeds te rekenen in het oerwoud van getallen dat het
polderlandschap van de gezondheidszorg rijk is.
Christel Schotpoort, je hebt als secretaresse vele uren achter de Tune-up computer
doorgebracht. De verzorging van het voorlichtingsmateriaal voor potentiële studiedeelnemers
was voortreffelijk. De invoering van de grote verzameling data heb je met 'Gründlichkeit' ter
hand genomen en voltooid. We hebben het zeer gewaardeerd dat je ook na 1 september 1998
nog hebt geholpen de Tune-up data op orde te krijgen. Het heeft een goede en mooie database
opgeleverd.
Jan Loonsta, bedankt voor de gelegenheid die je ons hebt geboden de 'simple exercise test' uit
te voeren op het functiecentrum. Helaas waren de resultaten van de inspanningen van onze
deelnemers niet zo dat we daar voor toekomstige patiënten iets nuttigs mee kunnen doen.
Dr. J.C. Swaanenburg, beste Joost, bedankt voor de vele extra laboratoriumbepalingen om
cardiale schade nauwkeuriger te kwalificeren en te kwantificeren.
Paul Berger en Robert Mollema, dank voor jullie inzet om de 'stress'-studie tot een goed einde
te brengen.
De leden van de Research Group van de afdeling anesthesiologie, Ann de Haes, Douglas
Eleveld, Hans Proost, Karel Kuizenga, Ton Beaufort en Sjouke Schiere, hartelijk dank voor
jullie kritische vragen en opmerkingen voorafgaande aan, maar vooral ook tijdens de
ontwikkeling van het proefschrift. Karel in het bijzonder bedankt voor je grote betrokkenheid
in de afronding van het proefschrift, vooral ook daar waar je taken van Mark tijdelijk
overnam. Je hebt me als kamergenoot prettig gestuurd en gestoord - zodoende ben ik op 'de
vierde verdieping' fysiek en mentaal niet verdroogd.
De dames van de balie van het Operatie Centrum van het UMCG, zonder jullie inzet was het
overzicht van alle potentiële deelnemers voor de Tune-up studie nooit compleet geworden.
Dank voor de historische gegevens die jullie uit het Ziekenhuis Informatie Systeem naar
boven hebben gehaald; ze hebben uiteindelijk hun plaats in hoofdstuk 3 gekregen. Mijn dank
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gaat ook uit naar de secretaresses van de betrokken verpleegafdelingen en de intensive cares.
Ook mede dankzij jullie inzet verliep het project zeer goed.
Mirella Wever, hoofdstuk 3 is eigenlijk de kroon op jouw werk. Ik noemde het voor het
gemak maar het 'Mirella-project'. Je bleek een ster in datamanagement. Op het resultaat kijk
ik met grote voldoening terug. We hebben de Tune-up studieresultaten zo beter in de context
kunnen plaatsen van de gangbare praktijk in het toenmalige AZG.
Collegae medisch-specialisten en arts-assistenten, werkzaam op de afdelingen
anesthesiologie, chirurgie (in het bijzonder C3VA, C4VA, B3VA en B4VA) en intensive
cares (de Chirurgische Intensive Care en de Intensive Care en Beademing). Allen waren jullie
op één of andere wijze betrokken bij de hoogrisico patiënten die al dan niet geschikt werden
bevonden voor deelname aan de Tune-up studie. Velen werden door jullie bij ons aangemeld.
De samenwerking verliep goed.
Eveneens bedank ik de vele verpleegkundigen, anesthesiemedewerkers en laboranten die op
welke wijze dan ook betrokken waren bij de Tune-up studie. We realiseren ons dat we als
uitvoerende onderzoekers nogal eens lastig zijn geweest zijn in de handhaving van het Tune-
up studie protocol. Dit gold in het bijzonder op de intensive care units. Wie als patiënt in het
kader van de studie een dag voor de operatie op de intensive care unit werd opgenomen werd
door jullie zodanig opgevangen dat het verblijf van die extra dag op de intensive care
dragelijk was.
Dank ook aan de verpleegkundigen van de recovery die enthousiast meewerkten om de laatste
metingen met de pulmonalis catheter mogelijk te maken bij enkele patiënten die na de
operatie onder jullie hoede vielen.
De leden van de beoordelingscommissie, prof. L.P.H.J. Aarts, prof. dr. J. Damen en prof. dr.
J. Klein bedank ik voor hun tijd en energie die ze gestoken hebben in het lezen en beoordelen
van het manuscript.
Ria Carpay, zeer veel dank voor de nauwgezetheid waarmee je taal en stijl van het
proefschrift hebt gecorrigeerd. Douglas Eleveld, je was onmisbaar in het persklaar maken van
het manuscript.
De leden van het dagelijks bestuur van de afdeling Anesthesiologie dank ik voor het
faciliteren van tijd en ruimte toen het aankwam op de finale uitwerking van het proefschrift.
De ‘planners’ van toen en nu, bedankt voor de uren dat jullie me vrijspeelden van de OK om
het 'Mirella-project' uit de grond te stampen en het proefschrift te schrijven.
Chris Kloos, dank voor je inzet en de oplossingen die je bood als zich weer computer
problemen voordeden..
De Raad van Bestuur van het Universitair Medisch Centrum Groningen wil ik bedanken voor
het in ons gestelde vertrouwen en de ons ter beschikking gestelde mensen en middelen om de
pilot-studie en een aansluitend jaar van de Tune-up-studie te kunnen voltooien.
Lieve familie en vrienden, mijn gang naar Groningen in 1997 was een hele verrassing. Het
heeft lang geduurd voordat de Tune-up studie heeft geresulteerd in een proefschrift. Jullie
belangstelling op afstand heeft er mede toe bijgedragen dat zover is gekomen. De combinatie
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van opleiding tot medisch specialist en wetenschappelijk werk had af en toe de schijn van een
ballingschap.
Lieve Pa en Ma, dank voor alles wat het jullie mij hebben gegeven om de weg in het leven te
vinden. Bijna 20 jaar na het verlaten van het ouderlijk huis heb ik nog steeds geen methode
gevonden om jullie een aantal van mijn huiselijke zorgen te ontnemen. Het is prachtig jullie,
ondanks gerezen beperkingen, op zo'n wijze de tijd te lijf te zien gaan. De sabbatsrust die wij
zoeken is inderdaad niet van deze aarde. Tegelijk hebben jullie mij de schoonheid en de
poëzie geleerd van de eenvoud en de weelderigheid van heel het aardse leven als het zich
uitdrukt in zoveel geur, kleur, vorm, taal en klank. Het beweegt.
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